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Microbial biofilms are wide-spread in nature and the organisms within them are 
often able to cause acute and chronic human diseases. The nature of biofilms is 
complex  and  the  organisms  behave  differently  from  their  planktonic 
counterparts. Many studies have been carried out on bacterial biofilms related to 
oral diseases, but little work has focused upon the potential clinical role of fungal 
and mixed fungal and bacterial biofilms.
The  aims  of this  project  were  to  develop  an  in  vitro  model  to  investigate  the 
development  and  structure  of fungal  biofilms  and  mixed  fungal  and  bacterial 
biofilms associated with Denture related Stomatitis (DRS) and the effectiveness 
of  antimicrobial  agents  against  them.  Single  species  Candida  albicans  and 
denture plaque derived from patients with DRS was grown in biofilms on dental 
materials in a Constant Depth Film Fermentor.
Initial colonisation (2 -  6 h) of C. albicans was dependent upon the material and 
the  roughness  of the  surface on which the biofilm  formed.  Higher numbers  of 
yeast  cells  were  present  on  enamel  compared  to  dentine  or  acrylic  whilst the 
highest  numbers  of  cells  were  found  on  the  roughest  surfaces  during  early 
biofilm  development.  Confocal  microscopy revealed  that the  hyphal  form  was 
associated with biofilm development and structure.
Candida albicans grown in the biofilm phase of growth was  more  resistant to 
fluconazole,  miconazole  and  chlorhexidine  than  when  grown  planktonically, 
although  drug  resistance  varied  between  agents  and  biofilm  growth  phases. 
Microcosm  biofilms  containing  similar proportions  of genera to those of DRS 
lesions were developed. Further, the delivery of DRS-associated treatments was 
mimicked  and  it  was  demonstrated  that  a  combination  of  miconazole  and
2chlorhexidine  was  able  to  reduce  the  total  bacterial  count  by  3  logio and  the 
number of Candida species by over 2 logio.
It can be concluded from this work that the initial phase of biofilm formation has 
a significant role to play in the development of biofilms on various oral surfaces 
and  their  subsequent  susceptibility.  Further,  the  development  of  an  in  vitro 
denture  plaque  model  allowed  the  determination  of  the  likely  clinical 
effectiveness of treatment regimes.
3Index of contents
Title  1
Abstract  2
Index of contents  4
Declaration  9
Acknowledgements  10
List of figures  11
List of tables  16
Abbreviations  18
Publications and presentations related to this thesis  20
CHAPTER 1
Introduction  22
1.1  Fungi  23
1.1.1 Candida albicans  24
1.1.2 Virulence of Candida albicans  27
1.1.2.1 Germ tubes formation and adherence of C. albicans  27
1.1.2.2 Production of enzymes  29
1.1.2.3 The cell wall  30
1.1.2.4 Phenotypic switching  30
1.1.3 Genotypic subgroups of Candida albicans  31
1.1.4 Candida and oral diseases  32
1.1.4.1 Predisposing factors for oral candidosis  33
1.1.4.2 Classification of oral candidosis  35
1.1.4.2.1 Pseudomembraneous candidosis or thrush  36
1.1.4.2.2 Atrophic (erythematous) candidosis  37
1.1.4.2.3 Hyperplastic candidosis (Candida leukoplakia)  37
1.1.4.2.4 Denture related stomatitis  38
1.1.4.2.5 Angular cheilitis (angular stomatitis, perleche)  38
1.1.4.2.6 Median rhomboid glossitis  39
1.1.4.2.7 Chronic mucocutaneous candidosis  39
1.1.4.3 Isolation and identification of Candida species  40
1.1.4.3.1  Smear  40
41.1.4.3.2 Swab  41
1.1.4.3.3 Imprint culture  41
1.1.4.3.4 Salivary culture  41
1.1.4.3.5 Oral rinse  41
1.1.4.3.6 Impression culture  42
1.1.4.3.7 Biopsy  42
1.1.4.4 Treatment of oral candidosis  45
1.1.4.4.1 Polyenes  46
1.1.4.4.2 Azoles  47
1.1.4.4.3 DNA analogues  49
1.1.4.4.4 Others  49
1.2 The oral environment  in health and disease  50
1.3 Biofilms  50
1.3.1 Defining a biofilm  51
1.3.2 The formation of a biofilm  53
1.3.3 Communication within a biofilm  55
1.3.4 Biofilm structure  57
1.3.4.1 Extracellular polysaccharides  58
1.3.5 Biofilm resistance  59
1.3.5.1 Delayed penetration of the antimicrobial agents  60
1.3.5.2 Altered growth rate of biofilm organisms  61
1.3.5.3 Unique biofilm physiology  63
1.3.5.4 Persisters  63
1.3.6 Biofilm detachment and death  64
1.3.7 Biofilm related diseases  65
1.3.8 Biofilm-based models  68
1.4 Candidal biofilms  71
1.4.1  Structure of Candida albicans biofilms  71
1.4.1.1 The nature of contact surface  73
1.4.1.2 Growth factors  73
1.4.1.3 Candida morphogenesis  74
1.4.1.4 Candida species involved  74
1.4.2 Resistance of Candida albicans biofilms  75
51.4.2.1 Delayed penetration of the antimicrobial agents  75
1.4.2.2 Altered growth rate of biofilm organisms  77
1.4.2.3 Efflux pumps  77
1.4.2.4 Unique biofilm physiology  78
1.5 Denture related stomatitis  79
1.5.1 Clinical features  79
1.5.2 Classification  79
1.5.3 Causes  80
1.5.3.1 Denture plaque and denture related stomatitis  81
1.5.4 Association of Candida albicans with DRS  83
1.5.5 Diagnosis  84
1.5.6 Treatment  84
1.6 Aim of the research  89
CHAPTER 2
Materials and methods  90
2.1 Preparation of substrata  91
2.1.1 Denture acrylic  91
2.1.2 Enamel and dentine  92
2.2 Organisms used in the study  93
2.2.1 Ethical approval  93
2.2.2 Clinical isolates of Candida albicans  93
2.2.3 Mixed-species clinical samples  93
2.3 Nutrient source  95
2.4 Constant Depth Film Fermentor  96
2.4.1 Assembly of CDFF  96
2.4.2 Inoculation of the CDFF and continuous media supply  100
2.4.2.1  Single-species  100
2.4.2.2 Mixed-species  100
2.4.3 Operating conditions  103
2.4.4 Sample removal  103
2.4.5 Analytical procedures  103
2.4.5.1  Single-species  103
62.4.5.2  Mixed-species  104
2.5 Susceptibility testing  107
2.5.1 Susceptibility testing for antifungal agents  107
2.5.2 Susceptibility testing for antimicrobial agent  108
2.6 Scanning Electron Microscopy  109
2.7 Confocal Laser Scanning Microscopy  111
2.8 Surface characteristics  112
2.9 Identification of Candida species  113
2.9.1 CHROMagar  113
2.9.2 API® Candida Kit  114
2.9.3 ComMeal agar  115
CHAPTER 3
The  characterisation  of  an  in  vitro  model  system  to  grow  biofilms  of  116 
Candida albicans on relevant oral surfaces
3.1 Introduction  117
3.2 Materials and methods  119
3.3 Results  120
3.4 Discussion  138
CHAPTER 4
The  effect  of surface  roughness  and  strain  variability  on  the  biofilm  143 
forming ability of Candida albicans
4.1 Introduction  144
4.2 Materials and methods  146
4.3 Results  147
4.4 Discussion  163
CHAPTER 5
The  susceptibility  of  Candida  albicans  biofilms  to  antifungal  and  167 
antimicrobial agents
5.1 Introduction  168
5.2 Materials and methods  170
75.3 Results
5.4 Discussion
175
185
CHAPTER 6
Composition  of in  vitro  denture  plaque  biofilms  and  susceptibility  to  189 
antifungals
6.1 Introduction  190
6.2 Materials and methods  192
6.3 Results  194
6.4 Discussion  205
CHAPTER 7
Conclusions and suggestions for further work  210
References  214
Publications arising from this thesis  260
8Declaration
I hereby certify that the findings reported in this thesis result entirely from my 
own work. The scanning electron microscopy sample preparation was carried out 
by  Ms  N.  Mordan  (Eastman  Dental  Institute,  UCL).  The  confocal  scanning 
electron microscopy work was  carried out in  collaboration with the  School  of 
Anatomy, UCL. Colleagues who helped in various aspects of the work are listed 
in the acknowledgments. The work has not previously been submitted, in part or 
in full, for a degree or diploma for this or any other University or examination 
board.
Hanadi Lamfon
Oral Medicine
Eastman Dental Institute, UCL 
University of London 
256, Gray’s Inn Road 
London WC1X 8LD
February 2005
9Acknowledgements
Firstly, I would like to thank God who has given me the strength and health to 
complete my thesis.
I  am  extremely grateful  to my supervisors,  Dr Jonathan Pratten  and  Professor 
Stephen  Porter  for their  helpful  guidance  and  support  and  without  whom  the 
completion of this thesis would not have been possible.
I am also grateful to Graham Palmer who helped me in the preparation of some 
materials, Zubaidah Al-Karrawi for her technical assistance and kindness, and all 
my  friends  and  colleagues  at  the  Eastman  Dental  Institute  for  their  help  and 
friendship.
I would also like to thank Umm-Alqura University for their generous funding of 
my studies.
Special  thanks  go  to  my parents  for their encouragement and  love  and  to  my 
husband for his warm support.
1 0List of figures
1.1  C. albicans showing yeast, hyphae and budding forms.  25
1.2  Figure showing the different forms of C. albicans with the possible  26
morphological transition between forms.
1.3  Diagrammatic  representation  of  stages  associated  with  biofilm  54
formation.
1.4  Diagrammatic  representation of the  mushroom-like microcolonies  58
that constitute the structural element of biofilm.
2.1  The Constant Depth Film Fermentor.  96
2.2  Schematic horizontal section through the fermentor.  98
2.3  Schematic  vertical  section  through  the  fermentor  with  insert  99
indicating one of the pans in greater detail.
2.4  Schematic diagram indicating inoculation of the CDFF.  101
2.5  Schematic diagram showing continuous media supply to the CDFF.  102
2.6  Scanning  electron  microscope  photograph  of the  surface  of self-  110
cured acrylic disks polished with different surface roughness.
2.7  Proscan  image  showing  roughness  readings  as  generated  by  112
Scantron software.
2.8  API  Candida  kit  strip  showing  the  identification  of  Candida  114
albicans.
3.1a  Viable counts of C. albicans biofilms grown on PTFE over a period  123
of 384 h.
3.1b  The percentage of yeast and hyphae of C.  albicans biofilms grown  125
on PTFE for a period of 384 h.
3.2a  Viable counts of C. albicans biofilms grown on self and heat-cured  126
11acrylic for a period of 72 h.
3.2b  The percentage of yeast and hyphae of C. albicans biofilms  grown  128
on self-cured acrylic for a period of 72 h.
3.2c  The percentage of yeast and hyphae of C. albicans biofilms  grown  128
on heat-cured acrylic for a period of 72 h.
3.3a  Viable  counts  of  C.  albicans  biofilms  grown  on  three  different  129
surfaces  over a period of 96 h using artificial  saliva as  a nutrient 
medium.
3.3b  The percentage of yeast and hyphae of C. albicans biofilms  grown  131
on acrylic surface over a period of 96 h using artificial saliva as a 
nutrient medium.
3.3c  The percentage of yeast and hyphae of C.  albicans biofilms grown  131 
on enamel surface over a period of 96 h using artificial saliva as a 
nutrient medium.
3.3d  The percentage of yeast and hyphae of C.  albicans biofilms grown  132 
on  dentine  surface  over  a period of 96  h using  artificial  saliva  a 
nutrient medium.
3.4  Overnight  suspensions  of C.  albicans  grown  in:  YPD,  artificial  133 
saliva, artificial saliva without Lab-lemco, artificial  saliva without 
mucin and artificial saliva without Lab-lemco and without mucin.
3.5a  Viable  counts  of C.  albicans  biofilms  grown  on  three  different  134 
surfaces over a period of 96 h using YPD as a nutrient medium.
3.5b  The percentage of yeast (white) and hyphae (black) of C.  albicans  136 
biofilms grown on acrylic surface over a period of 96 h using YPD 
as a nutrient medium.
123.5c  The percentage of yeast and hyphae  of C.  albicans biofilms grown  136
on enamel surface over a period of  96 h using YPD as a nutrient
medium.
3.5d  The percentage of yeast and hyphae  of C.  albicans biofilms grown  137
on dentine surface over a period of  96 h using YPD as a nutrient
medium.
4.1  The percentage  of yeast and hyphal  cells  of C.  albicans biofilms  153
grown on different surface roughness of self and heat-cured acrylic
(Ra = 2.5 pm, Ra = 3.6 pm and Ra = 9.3 pm) over 2 h.
4.2  The viable counts of two genotype A C. albicans biofilms grown on  154
acrylic over 72 h.
4.3  The number of yeast and hyphal cell counts of high adherence  C.  155
albicans biofilms genotype A grown on different surface roughness
of denture acrylic over 72 h.
4.4  The  number  of  yeast  and  hyphal  cell  counts  of low  adherence  156
genotype  A  C.  albicans biofilms  grown on  acrylic  with  different 
surface roughness over 72 h.
4.5  The  viable counts of two genotype B C. albicans biofilms grown on  157
acrylic over 72 h.
4.6  The  number  of  yeast  and  hyphal  cell  counts  of high  adherence  158
genotype  B  C.  albicans biofilms  grown  on  acrylic  with  different 
surface roughness over 72 h.
4.7  The  number  of  yeast  and  hyphal  cell  counts  of  low  adherence  159
genotype  B  C.  albicans  biofilms  grown on  acrylic  with different 
surface roughness over 72 h.
13CLSM images showing C.  albicans biofilms formation on denture  160 
acrylic of various surface roughness after 6 h growth in the CDFF.
CLSM images showing C.  albicans biofilms formation on denture  161 
acrylic of various surface roughness after 24 h growth in the CDFF. 
CLSM images showing C.  albicans biofilms formation on denture  162 
acrylic of various surface roughness after 72 h growth in the CDFF.
Almar blue  containing multiwell  plate  used to test the  antifungal  174 
susceptibility  of  C.  albicans.  Wells  arranged  within  columns 
contain  different  concentrations  of  fluconazole  and  each  row 
contains a different isolate.
Growth  of  genotype  A C.  albicans  biofilms  grown  on  denture  177
acrylic  for  72  h  and  exposed to  concentrations  up  to  2  pg/ml  of
fluconazole for 1, 24 and 48 h.
Growth  of genotype  A  C.  albicans  biofilms  grown  on  denture  178 
acrylic for 72 h and exposed to concentrations up to 256 pg/ml of 
fluconazole for 1, 24 and 48 h.
Growth  of  genotype  B  C.  albicans  biofilms  grown  on  denture  178 
acrylic for 72 h and exposed to concentrations up to 256 pg/ml of 
fluconazole for 1, 24 and 48 h.
Growth  of  genotype  A C.  albicans  biofilms  grown  on  denture  179
acrylic  for  2,  6,  24,  48  and  72  h  and  exposed  to  256  pg/ml  of
fluconazole for; 1, 24 and 48 h.
Growth  of  genotype  A  C.  albicans  biofilms  grown  on  denture  180 
acrylic for 72 h and exposed to concentrations up to 256 pg/ml of 
miconazole for 1, 24 and 48 h.5.7  Growth  of  genotype  B  C.  albicans  biofilms  grown  on  denture  180
acrylic for 72 h and exposed to concentrations up to 256  pg/ml of 
miconazole for 1, 24 and 48 h.
5.8  Growth  of  genotype  A  C.  albicans  biofilms  grown  on  denture  181
acrylic  for 2,  6,  24,  48  and  72  h  and  exposed  to  256  pg/ml
miconazole for; 1, 24 and 48 h.
5.9  Growth  of  genotype  A  C.  albicans  biofilms  grown  on  denture  182
acrylic  for 72  h  and  exposed  to  concentrations  up  to  2.5  %  of
chlorhexidine for 1, 5 and 15 minutes.
5.10  Growth  of  genotype  B  C.  albicans  biofilms  grown  on  denture  182
acrylic  for 72  h  and  exposed  to  concentrations  up  to  2.5  %  of
chlorhexidine for 1, 5 and 15 minutes.
5.11  Growth  of  genotype  A  C.  albicans  biofilms  grown  on  denture  183 
acrylic  for  2,  6,  24,  48  and  72  h  and  exposed  to  0.019  % 
chlorhexidine for; 1, 5 and 15 minutes.
6.1  Viable count of microorganisms present in a mixed-species biofilm  201
after growth in CDFF for 504 h.
6.2  Viable  counts  of Candida  spp.  of the  72  h  biofilm  in  different  202 
concentrations of fluconazole or miconazole.
6.3  Viable  counts  of Candida  spp.  of the  72  h  biofilm  in  different  202 
concentrations of chlorhexidine.
6.4  Viable counts of Candida species, aerobic and anaerobic bacteria of  203
the 72 h biofilm in different concentrations of chlorhexidine.
6.5  Number  of microorganisms  of a  mixed-species  biofilm  prior  to  204
pulsing with miconazole and chlorhexidine and after 240 h pulsing.
15List of tables
1.1  Classification of oral candidosis as proposed by Axell and co-workers  36 
(1997).
1.2  Table showing some of molecular methods for identification of Candida  44 
species.
1.3  Antifungal agents used to treat oral candidosis.  46
1.4  Table indicating biofilm related human infections.  67
2.1  Composition of artificial saliva.  95
2.2  Various non-selective and selective agars used for culturing organisms  105 
during the study.
2.3  Composition of CFATA from (Zylber and Jordan 1982).  106
2.4  Identification of Candida spp. using the CHROMagar method.  113
3.1  Composition  of YPD broth.  116
3.2  Mean ±  the  standard deviation of yeast  and hyphal  cell  counts of C.  124
albicans biofilms grown on PTFE over 384 h.
3.3  Mean ±  the  standard deviation of  yeast  and hyphal cell  counts of C.  127
albicans biofilms grown on self and heat-cured acrylic over 72 h.
3.4  Mean ±  the  standard deviation of yeast  and hyphal cell  counts of C.  130
albicans biofilms grown on acrylic, enamel and dentine over 96 h using 
artificial saliva as a nutrient medium.
3.5  Mean ±  the  standard deviation of  yeast  and hyphal cell  counts of C.  135
albicans biofilms grown on acrylic, enamel and dentine over 96 h using 
YPD as a nutrient medium.
4.1  Mean ± the standard deviation of viable counts of C.  albicans biofilms  151
grown  on  self and heat-cured  acrylic  with different  surface roughness
16(Ra = 2.5 pm, Ra = 3.6 pm and Ra = 9.3 pm) over 2 h.
4.2  Mean ±  the  standard  deviation  of yeast  and  hyphal  cell  counts  of C.  152
albicans  biofilms  grown  on  self and  heat-cured  acrylic  with  different 
surface roughness (Ra = 2.5 pm, Ra = 3.6 pm and Ra = 9.3 pm) over 2 h.
5.1  Different concentrations  of fluconazole  or miconazole used against C.  172
albicans biofilms related to the planktonic MIC.
5.2  Different  concentrations  of  chlorhexidine  used  against  C.  albicans  173
biofilms related to the planktonic MIC.
5.3  Concentration of fluconazole, miconazole and chlorhexidine  required to  184
inhibit growth of C. albicans.
6.1  Identification of different Candida spp. of control patients.  197
6.2  Identification of different Candida spp. of DRS patients.  198
6.3  The range in number (CFU) of selected genera from patients with  and  199
without DRS compared to the numbers obtained in vitro (72 -  240 h).
6.4  The  range  (%)  in  compositions  of genera present  on  the  mucosa  and  200 
denture surfaces of patients suffering from DRS and from the CDFF.
17Abbreviations
°C
CAMM
CBA
CDFF
CFATA
CFU
CLSM
DRS
dH20
EPS
FAA
g
HIV
h
L
log
MIC
Pg
Pi
ml
|iim
mm
Degrees Celsius
Cell Adhesion Measurement Module
Columbia Blood agar
Constant Depth Film Fermentor
Cadmium Fluoride Acriflavin Tellurite agar
Colony Forming Units
Confocal Laser Scanning Microscopy
Denture related Stomatitis
Distilled water
Extracellular polysaccharide
Fastidious Anaerobes agar
gram
Human Immunodeficiency Virus
hours
litre
logarithmic
Minimum Inhibitory Concentration
microgram
microlitre
millilitre
micrometre
millimetre
MSA Mitis Salivarius agar
18NCCLS National  Committee  for  Clinical  Laboratory 
Standards
PBS Phosphate-buffered saline
PMMA Polymethylmethacrylate
PTFE Polytetrafluoroethylene
RA Rogosa agar
Ra Average surface roughness
r.p.m revolutions per minute
SAP Secreted Aspartyl Proteinases
SDA Sabouraud’s Dextrose Agar
SEM Scanning Electron Microscopy
spp. species
V Voltage
VA Veillonella agar
YPD Yeast extract, peptone and dextrose
19Publications and presentations related to this thesis
Peer Reviewed Papers
Lamfon H, Porter SR, McCullough M, Pratten J (2003). Formation of Candida 
albicans biofilms on non-shedding oral surfaces. Eur. J. Oral Sci.  Ill, 465-471.
Lamfon  H, Porter SR, McCullough M, Pratten J  (2004).  The  susceptibility of 
Candida  albicans  biofilms  grown  in  a  constant  depth  film  fermentor  to 
chlorhexidine, fluconazole and miconazole:  a longitudinal study. J. Antimicrob. 
Chemother. 53, 383-385.
Lamfon  H,  Al-Karaawi  Z,  Porter  SR,  McCullough  M,  Pratten  J  (2005). 
Composition of in vitro denture plaque biofilms and susceptibility to antifungals. 
FEMS Microbiol Lett. 242, 345-351.
Chapters in Books
Pratten  J,  Lamfon  H,  Porter  SR,  McCullough  M  (2003).  Formation  and 
susceptibility  of Candida  albicans  biofilms.  In  Biofilm  Communities:  Order 
from  Chaos?  (Eds  McBain  A,  Allison  D,  Brading  M,  Rickard  A,  Verran  J, 
Walker J) pp. 299-308. BioLine: Cardiff. Antony Rowe Ltd, Chippenham, U.K.
Conference Proceedings
Lamfon H, Porter SR, McCullough M, Pratten J (2002). Formation of Candida 
albicans biofilms  on non-shedding oral  surfaces,  (poster presentation).  Annual 
Meeting of the British Society for Oral Medicine, Leeds, 9th-  10th May.
2 0Lamfon  H,  Pratten  J,  McCullough  M,  Porter  SR  (2002).  Susceptibility  of
tH
Candida albicans biofilms to  fluconazole,  (oral presentation).  The  6  Biennial 
Congress of the European Association of Oral Medicine, Lisbon, Portugal, 3rd -  
5th October.
Lamfon H, Porter SR, McCullough M, Pratten J (2003). In vitro evaluation of 
miconazole and chlorhexidine for the treatment of denture-associated stomatitis, 
(poster presentation). Annual Meeting of the British Society for Oral Medicine, 
Dundee, 9th -  10th May.
Lamfon  H,  Porter  SR,  McCullough  M,  Pratten  J  (2002).  Composition  and
th
susceptibility  of microcosm  denture  plaque,  (poster  presentation)  7  Biennial 
Congress of the European Association of Oral Medicine, Berlin, Germany, 23rd -  
25th October.
21Chapter 1
IntroductionChapter 1 Introduction
1.1  FUNGI
Fungi  are  found  throughout nature  and  survive  by  absorbing  their nutrients  from 
living or dead organisms and organic matter. There are groups of species which are 
parasites of plants or animals, as well as humans. The frequency of life-threatening 
fungal infections in humans is rising world-wide, for example, they represent  10 % 
of all nosocomial septicemia (Wey et al.,  1988; Beck-Sague and Jarvis,  1993) and 
are  considered as the  fourth leading cause of bloodstream infections in the United 
States (Collin et al.,  1999). The most important fungal infections of the oral cavity 
are caused by yeast species belonging to genus Candida (Sullivan et al., 2004). 
Candida species (spp.) reside harmlessly in the mouths of healthy individuals (Abu- 
Elteen and Abu-Alteen, 1998). However, if the balance of the normal oral microflora 
is disrupted or the immune defences are compromised, Candida spp. can give rise to 
clinical disease (Powderly et al.,  1999; Naglik et al., 2003). Candida albicans is by 
far the most common oral species (Ellepola and Samaranayake, 2000c;  Akpan and 
Morgan, 2002) and is present in up to 60 % of healthy individuals (Kleinegger et al., 
2001).
A  large  number  of non-albicans  Candida  spp.  can  also  be  found  in  the  mouth 
including C.  glabrata,  C.  tropicalis,  C. parapsilosis,  C.  krusei,  C.  dubliniensis,  C. 
lusitaniae,  and C. guilliermondii (Epstein and Polsky,  1998; Collin et al.,  1999; Al- 
Karaawi et al., 2002). Some of these non-albicans Candida spp. have the potential to 
give rise to clinical disease, particularly in immunocompromised persons. Indeed it 
has been suggested that the incidence of infections caused by non-albicans Candida 
spp. is increasing (Krcmery and Barnes, 2002). However, in the absence of lesions, 
the  isolation  of Candida spp.  from the  mouth  does not represent evidence  of oral 
candidosis (Cannon et al.,  1995) i.e. clinical illness, and indeed healthy individuals
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harbour those non-albicans Candida spp. without developing illness (Al-Karaawi et 
al, 2002).
1.1.1  Candida albicans
Candida albicans is a dimorphic yeast, however, this organism also has the ability to 
adapt itself to a range of morphologies thus it can be considered as a polymorphic 
yeast as reviewed by Chaffin et al.,  1998. C.  albicans does not have a reproductive 
cycle, but reproduces by multilateral budding (Farah et al., 2000). Macroscopically, 
Candida,  spp. colonies appear as a cream or yellowish colour with a variable texture 
depending upon species  (Eggimann et al, 2003).  Microscopically  (Figure  1.1),  C. 
albicans  can  grow  as  round  or  oval  unicellular  yeast  cells  (blastospore), 
pseudohyphae  (elongated  yeast  cells  with  branching  filaments  with  constrictions 
where they joined) and hyphae (Bagg et al,  1999a). Hyphae  are thread-like  tubes 
containing the  fungal  cytoplasm  and its organelles  are  divided by walls known as 
septa.  Hyphae  develop  as  a  result  of  germination  of  blastospores  and  are 
characterised  by  the  presence  of parallel  walls  with  the  absence  of constrictions 
(Kobayashi and Cutler,  1998). In addition, under specific environmental conditions, 
C.  albicans  can produce  chlamydospores  which  are round thick walled  structures 
produced  at the termini  of hyphae.  However, the functions of chlamydospores are 
unclear (Sonnebom et al., 1999, Sullivan et al., 2004).
Approximately  50  -   60  %  of  humans  carry  Candida  spp.  in  their  mouth 
(Samaranayake and Lamey,  1988). Colonization rates increase with illness and can 
be as high as  70 -  80 %  in severely infected patients as reviewed by Fidel et al, 
1999.  The prevalence  also  increases  with the  introduction  of oral  prostheses.  For 
example, the prevalence of Candida spp.  can increase in denture wearers to up to
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values of 60 -  100 % (Pires et al., 2002).
Local overgrowth may clinically manifest as candidal  infection of the mouth, and 
this gives rise to symptoms such as local mucosal discomfort or altered taste (Akpan 
and Morgan, 2002).
Figure 1.1: C. albicans showing yeast (a), hyphae (b) and budding (c) forms, (bar = 
10 pm).
The reversible conversion between the yeast cells to either hyphal or pseudohyphal 
growth (Calderone and Fonzi, 2001; Gow et al., 2002) is via the formation of germ- 
tube (Figure 1.2). Germ tubes resist phagocytic killing and facilitate yeast adherence 
to epithelial cells by promoting aggregation of yeast cells and bridging of adjacent 
hyphal  elements,  hence  bringing  organisms  into  immediate  contact  with  the 
epithelium  (Ellepola  and  Samaranayake,  2000a).  This  morphological  transition 
between forms depends upon certain environmental conditions such as temperature,
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pH and the availability of nutrients (Comer and Magee,  1997) and are stimulated by 
the  growth  in  the  host  and  invasion  (Gow  et al.,  2002).  The  hyphal  form  of C. 
albicans has long been regarded as essential for tissue invasion, but there is evidence 
to suggest that the yeast form may also be able to initiate host invasion or damage 
(Ray and Payne, 1988).
Figure  1.2:  Figure  showing  the  different  forms  of C.  albicans  with the  possible 
morphological transition between forms.
Thigmotropism is a recognized property of C. albicans grown on surfaces and within 
solid substrates. It can be defined as the ability to sense and respond to changes in 
surface contours and enables invasive growth (Davies et al., 1999). The direction of 
hyphal  growth  responds  thigmotropically  to  invade  surface  contours  and  follow 
grooves and ridges (Gow et a l,  1994; Watts et al.,  1998). Nikawa and co-workers 
suggested  that  hyphal  induction  by  thigmotropic  reaction  is  important  in  the 
formation of candidal biofilm on saliva- or serum-coated acrylic surfaces (Nikawa et
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al, 1998b).
1.1.2  Virulence of Candida albicans
Candida albicans possesses  several virulence  factors that promote  colonization or 
invasion by adhering to the host cells and release a variety of virulence factors that 
encourage successful colonization or invasion of host tissues (Calderone and Braun, 
1991; Haynes, 2001).  These virulence factors of C.  albicans include; the ability to 
adhere,  the  production  of enzymes  (e.g.  proteinase),  and  the  production  of germ 
tubes (Kretschmar et al., 1999; Haynes, 2001; Hube and Naglik, 2001). Other factors 
which also contribute to this virulence, include phenotypic switching, the cell wall 
and yeast morphogenesis (Calderone and Braun,  1991; Calderone and Fonzi, 2001). 
However, these virulence factors which cause clinical infections may vary upon the 
stage  and  site  of infection,  the  type  of infection  and  the  nature  of host  response 
(Hube and Naglik, 2001).
1.1.2.1  Germ tubes formation and adherence of C. albicans
As  previously  stated,  C.  albicans  can  germinate  forming  a  germ  tube  and 
subsequently  produce  filaments  which  may  appear  as  hyphae  or  pseudohyphae 
(Kobayashi and Cutler,  1998). This yeast to hyphae transition is considered to be a 
virulence factor that enables C. albicans to invade human tissues (Brown and Gow, 
1999; Hazan et al, 2002).
The  germ  tubes  may  improve  fungal  adherence  to  host  cells  and  facilitate  host 
penetration and later tissue damage (Kretschmar et al, 1999; Bernhardt et al., 2001). 
The ability of C.  albicans to adhere more effectively to host epithelium than other 
species may reflect the ability of the former to produce germ tubes. With regards to
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the mouth,  C.  albicans can easily adhere  to  oral  epithelial  cells  and colonize  oral 
surfaces such as the dorsum of the tongue and buccal mucosa. It can also be found in 
supra and subgingival plaque and within plaque associated with intra-oral appliances 
(Arendorf and  Walker,  1980;  Bagg  et  a l,  1999a).  C.  albicans  can  even  invade 
human dental hard tissues such as dentine (Kinirons,  1983; Damm et al.,  1988; Sen 
et  al.,  1997)  as  well  as  human  buccal  epithelial  cells  (Bailey  et  al.,  1995).  C. 
albicans  can  also  bind  to  salivary  components  including  mucin  (Hoffman  and 
Haidaris,  1993). Thus  C.  albicans utilizes a variety of different mechanisms to aid 
adherence to the oral tissues and hence invasion particularly of the soft tissues.
C.  albicans  can  adhere  to  non-host  surfaces  such  as  resin-composite  restorative 
dental materials (Maza et al.,  2002) and acrylic  (Verran et al,  1991).  It has been 
shown  that  the  increase  of  acrylic  surface  roughness  can  increase  retention  of 
microbial  cells  (Verran  et  al.,  1991;  Verran  and  Maryan,  1997;  Radford  et  al, 
1998b). Thus even if C. albicans does not adhere well to oral tissues, it can still exert 
a local action by its retention to dental restorative material or oral prostheses.
The ability of different Candida spp. to adhere to a surface varies. Such variation in 
adherence may underline the  differences  in virulence  ability  among  Candida  spp. 
(i.e.  their ability  to  colonize  mucosal  surfaces).  For  example,  C.  albicans  and  C. 
tropicalis can adhere in vitro to host cells to a greater extent than C.  krusei or C. 
guilliermondii (McCullough et al, 1996; Biasoli et al, 2002). Different strains of C. 
albicans also demonstrate differences in their ability to adhere to surfaces and hence 
strains with increased adherence have a greater ability to cause infection as reviewed 
by  Calderone  and  Braun,  1991.  In  addition,  C.  albicans  isolates  which  adhere 
strongly to buccal epithelial cells have the highest relative proteinase activity and are 
the most pathogenic (Ghannoum and Abu-Elteen, 1986).
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1.1.2.2  Production of  enzymes
The complex pathogenesis of C.  albicans is aided by the production of a range of 
extracellular  enzymes  that  facilitate  adherence  and  tissue  damage.  The  two  most 
significant  hydrolytic  enzymes  produced  by  C.  albicans  are  Secreted  Aspartyl 
Proteinases  (SAPs)  and  phospholipases.  These  enzymes  are  able  to  resist  host 
immune  defence mechanism and aid in penetration of host tissues  (Calderone and 
Fonzi, 2001; Haynes, 2001).
Proteinases  are  by  far  the  most prominent  virulence  factor  (Naglik  et  at.,  2003). 
These enzymes constitute a family of isoenzymes encoded by at least nine (Schaller 
et al., 1999a) or ten (Hube and Naglik, 2001; Naglik et al., 2004) related SAP genes 
that are implicated in the virulence of C.  albicans. Different SAP genes are crucial 
for mucosal and systemic infections and are involved in adherence of C.  albicans, 
tissue damage and evasion of host immune responses (Hube and Naglik, 2001). The 
production of these genes is a highly regulated process (Naglik et al., 2004) and their 
expression has been shown to be regulated differentially (Schaller et al., 1999b). The 
distinct role of SAP  genes is dependent upon the type  and  on the progress of the 
infection (Staib et al., 2000). These enzymes are capable of digesting host proteins 
for nutritional purposes and degrading IgA and complement proteins to  avoid and 
resist antimicrobial  attack (McCullough et al.,  1996;  Staib  et al.,  2000).  They are 
also  capable  of distorting  host  cell  surface  structures  and  intercellular  substances 
(Hube and Naglik, 2001).
Phospholipases are also associated with the virulence of C.  albicans (Ibrahim et al.,
1995). These enzymes are involved in the early steps of host invasion and have the 
ability to degrade phospholipids and facilitate yeast penetration (Ghannoum, 2000). 
Phospholipase-producing strains adhere well to epithelial cells  (Fidel et al.,  1999).
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Lipases  are  concentrated  at  the  tip  of fungal  hyphae,  facilitating  active  invasion 
(Scully et al., 1994).
1.1.2.3 The cell wall
The cell wall of the yeast mediates the initial physical interaction between the fungi 
and the environment (Chaffin et al., 1998). It protects the organism and promotes the 
colonization and growth of the cells (Calderone and Braun, 1991; McCullough et al.,
1996).
The  cell  wall  contributes  to  the  pathogenicity  of  C.  albicans  by  aiding  in  the 
adhesion  of the  organism  to  the host tissue.  It  also  acts  as  a permeability barrier 
against  host  immune  defences  and  antifungal  agents  and  maintaining  the 
characteristic shape of the fungi (McCullough et al., 1996; Chaffin et al., 1998).
1.1.2.4 Phenotypic switching
C.  albicans  frequently exhibits variant colony forms and has  the  ability to  switch 
reversibly  at  high  frequency  among  variant  phenotypes  (Scully  et  al.,  1994; 
Calderone and Fonzi, 2001). High frequency phenotypic switching is a phenomenon 
of cells emanating from a single progenitor that express different phenotypes which 
results  in high rate variant colony morphology (Soil,  1992).  For example,  smooth 
colony-forming yeast may produces colonies with a rough surface (smooth to rough 
switching). This switching can be triggered by low doses of ultra violet radiation as 
reviewed by Calderone and Fonzi, 2001.
Another  phenotypic  switching  system  known  as  white-opaque  transition  is 
recognised  by  colonies  changing  from  white  to  opaque  with  characteristic 
differences  in  cell  shape,  size  and  colour  (Slutsky  et  al.,  1987).  The  system  is
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reversible  with  high  frequencies  and  contribute  to  the  plasticity  of the  organism 
(Calderone and Fonzi, 2001).
It has been postulated that the switching mechanism of Candida spp. can potentiate 
its  pathogenic  features  by  altering  the  functional  activity  and  can  affect  cellular 
physiology and morphology (Soil,  1992). Switching can also help the yeast in rapid 
adaptation to the environment (Radford et al.,  1998a; Calderone  and Fonzi,  2001) 
hence  facilitating the  invasion of different environments.  It can elude the  immune 
system  by  altering  its  surface  antigenicity  and  by  escaping  from  the  action  of 
antifungals (Scully et al., 1994).
Thus  colonisation  of  the  oral  cavity  by  Candida  spp.  is  enhanced  by  specific 
adherence  interactions  with  oral  surfaces  that  resist  host  clearance  action. 
Subsequent tissue  invasion  is  facilitated by hyphal  formation,  contact sensing  and 
the  secretion  of hydrolytic  enzymes  (Cannon  et al.,  1995).  It  is  the  host  defence 
mechanism  that  determines  Candida  clearance,  colonisation  and  subsequently 
disease  formation  (Cannon  and  Chaffin,  1999).  Understanding  of  adherence 
mechanisms may lead to specific preventive treatments for individuals predisposed 
to candidosis.
1.1.3  Genotypic sub-groups of Candida albicans
Several  investigations  have  demonstrated  distinct  genotypic  sub-groups  of  C. 
albicans  which  may  have  varying  pathogenicity.  The  identification  of  these 
genotypically distinct subgroups (A or B) depends upon the presence or absence of 
the  25S  rDNA  transposable  intron  (Al-Karaawi  et  al,  2002).  Genotype  A  C. 
albicans  is  the  most  common  of these  genotypes.  However,  there  has  been  an
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increase in the incidence overtime of other genotypic subgroups of C. albicans such 
as genotype B and C (McCullough et al.,  1999b). All of these genotypic sub-groups 
of C. albicans have been found to be less susceptible to antifungal agents compared 
to other Candida species (McCullough et al., 1999a).
1.1.4  Candida and oral diseases
Clinical  illness  caused  by  Candida  spp.  have  been  described  as  “disease  of the 
diseased”  as  it usually arises  when host immunity is  reduced  (Marsh  and  Martin, 
1999a).  This  genus  of organism can  give  rise to  a wide  spectrum  of disorders  in 
humans  particularly  in  immunocompromised  individuals,  these  varying  from 
superficial mucosal  lesions to, albeit rarely,  life-threatening  disseminated invasive 
infections (Webb et al., 1998a; Haynes, 2001; Sullivan et al., 2004). The spectrum of 
such  diseases  is  perhaps  exemplified  by  the  candidal  infection  associated  with 
Human  Immunodeficiency  Virus  (HIV)  disease  in  which  oral  candidosis  is  a 
frequent  manifestation  and  most  common  opportunistic  infection  seen  in  these 
immunocompromised  individuals  (Powderly  et  al.,  1999;  Reichart,  2003).  The 
prevalence  of oral  candidosis  in HIV patients  ranges  between  9  %  to  over  90  % 
depending on the stage of HIV disease and the study population (Greenspan, 1994a). 
In  immunocompromised  patients,  infections  can  spread  through  the  bloodstream 
leading  to  severe  infection  with  significant  morbidity  and  mortality  (Akpan  and 
Morgan, 2002).
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1.1.4.1  Predisposing  factors for oral candidosis
Although  the  transition  from  commensalism  to  disease  is  associated  with  the 
virulence of the organism, host factors are important in the development of candidal 
infections. As mentioned earlier, immunosuppression is the most likely predisposing 
factor of oral candidal diseases; however, a wide range of other local and systemic 
factors can also increase oral carriage of yeast and can predispose to clinical disease. 
A number of local features can enhance candidal growth and resultant disease in the 
oral  cavity.  For example, the presence of dental prostheses  (Abu-Elteen and Abu- 
Alteen, 1998; Coelho et al., 2004) and xerostomia (e.g. Sjogren’s syndrome) (Leung 
et al.,  2000; Radfar et al., 2003; Porter et al., 2004) are common and can lead to 
clinically manifested disease.  Tobacco  smoking  (Crockett et al.,  1992;  Rindum  et 
al.,  1994), especially in those wearing dentures (Abu-Elteen and Abu-Alteen, 1998), 
can also predispose to oral candidosis. Furthermore, low salivary pH may increase 
the  oral  carriage  of Candida  species  (Arendorf and  Walker,  1980;  Bercier  et al., 
1999).
In particular, the wearing of dental prostheses is associated with an increase in oral 
colonization  by  Candida  species.  Dentures  can  produce  a  local  environment  that 
favour  fungal  growth  (Muzyka  and  Glick,  1995;  Budtz-Jorgensen  et  al.,  1996). 
Additionally, ill-fitting denture appliances and poor denture hygiene can cause local 
trauma and increase the risk of mucosal penetration and colonization (Darwazeh et 
al.,  2001).  Individuals  wearing  orthodontic  appliances  may  be  liable  to  candidal 
infection  of  the  mouth  (Bialasiewicz  et  al.,  1993).  An  increase  in  Candida 
colonization has also been observed in children with dental caries (Sziegoleit et al.,
1999).
33Chapter 1 Introduction
Oral mucosal diseases such as leukoplakia and lichen planus may increase the oral 
carriage of yeasts (Krogh et al., 1987; Lipperheide et al.,  1996). In addition, patients 
with moderate or severe epithelial dysplasia, oral squamous cell carcinoma, median 
rhomboid glossitis and squamous papillomas have been reported to have increased 
carriage  of Candida  spp.  in  the  mouth  (Barrett  et al.,  1998;  McCullough  et  al., 
2002). However, it remains unclear how yeast infection influences the development 
and the progression of dysplasia (McCullough et al., 2002).
Several  systemic  causes  are  important predisposing  factors  for  candidal  infection. 
Immunosuppresive disease (Patton et al., 2002; Samaranayake et al., 2002; Kerdpon 
et al., 2004), diabetes mellitus (Dorocka-Bobkowska et al.,  1996; Guggenheimer et 
al., 2000; Manfredi et al., 2004), long-term use of immunosuppressant regimes and 
corticosteroid therapy (Kennedy et al., 2000) all can enhance candidal infection of 
the mouth.
Leukaemias  and  other  diseases  of bone  marrow  white  cell  production  and  anti­
tumour  chemotherapy  and  sometimes  radiotherapy  can  increase  the  risk  of oral 
candidal  disease  (Samaranayake  et al.,  1984;  Jobbins  et al.,  1992).  Bone  marrow 
transplant recipients are also at risk of developing candidal infection (Tollemar et al.,
1999).  Down’s  syndrome and DiGeorge  syndrome may  increase  oral  carriage  and 
clinical  disease  of  C.  albicans  as  a  consequence  of  the  associated 
immunosuppression (Carlstedt et al., 1996; Atkinson et al., 2000). Nutritional factors 
such  as  deficiencies  of iron,  folic  acid,  vitamins,  and  diets  rich  in  carbohydrates 
(Samaranayake, 1986) can also predispose to oral candidosis.
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1.1.4.2  Classification of  oral candidosis
Because of the variable clinical manifestations of the disease and the multifactorial 
aetiology,  the  classification  of oral  candidal  infections  is  fraught with  difficulties 
(Farah et al., 2000; Ellepola and Samaranayake, 2000c). Over the years a number of 
classification  systems  have  been  suggested.  A  revised  reclassification  of  oral 
candidosis  (Table  1.1)  was  proposed  in  1997  (Axell  et  al.,  1997).  Primary  oral 
candidosis,  is  confined  to  the  oral  or  peri-oral  tissues,  while  secondary  oral 
candidosis  is  a  manifestation  of  a  more  generalized  mucocutaneous  disease  as 
categorised by Axell et al., (1997). However, a number of rare candidal infections do 
not strictly  fall  into either of these two categories  -  cheilo-candidosis and chronic 
multifocal  candidosis.  The  former  gives  rise  to  a  chronic  ulcerative  granulating 
lesion at the vermilion border of the lower lip (Samaranayake  and  Lamey,  1988). 
Multifocal candidosis is not considered to be a specific form of candidosis, but may 
used to describe the presence of erythematous candidosis, or Candida-associated or 
Candida-superinfected lesions either intra-orally or peri-orally (Axell et al., 1997).
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Table  1.1:  Classification of oral  candidosis as proposed  by Axell  and  co-workers 
(1997).
Primary oral candidosis Secondary oral candidosis
Acute forms Oral manifestations of  systemic mucocutaneous
Pseudomembraneous candidosis (as a result of diseases such a thymic
Erythematous aplasia and candidosis endocrinopathy
syndrome).
Chronic forms
Hyperplastic
Nodular
Plaque like
Erythematous
Pseudomembranous
Candida-associated lesions
Denture stomatitis
Angular chelitis
Median rhomboid glossitis
Keratinized primary lesions
superinfected with Candida
Leukoplakia
Lichen planus
Lupus erythematosus
1.1.4.2.1  Pseudomembraneous candidosis or thrush
Pseudomembraneous  candidosis  can  gives  rise  to  soft,  friable,  whitish  creamy 
plaques resembling milk curd. These are typically found on the hard and soft palates 
and  posterior  buccal  mucosa  that  can  be  scraped  off  to  leave  an  underlying 
erythematous and sometimes bleeding base (Scully et al.,  1994; Akpan and Morgan,
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2002).  Thrush  is  usually  painless  (Reichart  et  al.,  2000).  The  plaque  consists  of 
fibrin,  keratin,  necrotic  tissues,  desquamated  epithelial  cells;  it  is  penetrated  by 
bacteria and fungal hyphae or sometimes blastospores as well as inflammatory cells 
(Farah  et al.,  2000;  McIntyre,  2001).  Thrush commonly  arises  with  HIV  disease, 
age,  diabetes  mellitus,  leukaemia,  xerostomia,  and  recurrent  use  of topical  and 
systemic broad spectrum antibiotics (Scully et al., 1994; Akpan and Morgan, 2002).
1.1.4.2.2 Atrophic (erythematous) candidosis
This  usually manifests  as  a painless  erythematous  area  of the  buccal  mucosa and 
dorsum  of the  tongue  (Ellepola  and  Samaranayake,  2000c).  The  palate  may  be 
simultaneously affected giving rise to a “contact” or “kissing” lesion (Reichart et al.,
2000). Erythematous candidosis may arise de novo or as a result of shedding of the 
pseudomembrane  of  thrush  (Ellepola  and  Samaranayake,  2000a).  Erythematous 
candidosis  is  commonly  associated  with  recurrent  broad  spectrum  antibiotic  or 
corticosteroid therapies and HIV disease (Scully et al., 1994).
1.1.4.2.3 Hyperplastic candidosis {Candida leukoplakia)
Hyperplastic  candidosis  presents  as  an  adherent  white  patch  usually  at  the 
commissures  of  the  mouth  (Sitheeque  and  Samaranayake,  2003)  and,  less 
commonly,  at other oral mucosal  surfaces  (Akpan and Morgan, 2002).  The lesion 
reveals  a hyperplastic  reactions  of epithelial  and  connective  tissues  (Axell  et al., 
1997).  Hyperplastic  candidosis  may  also  manifest  as  homogeneous  or  speckled 
lesions  (nodular)  (Ellepola  and  Samaranayake,  2000a).  Chronic  hyperplastic 
candidiosis  typically  arises  as  a  consequence  of tobacco  smoking  (Epstein  and 
Polsky,  1998),  although much less common risk factors were  also involved which
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include; HIV disease and other immunosuppressive states (Lynch,  1994;  Sitheeque 
and  Samaranayake,  2003).  Unlike  pseudomembranous  candidosis,  chronic 
hyperplastic  candidiosis  is  characterised  by  oral  epithelial  hyperplasia  and 
sometimes dysplasia (Ellepola and Samaranayake, 2000a) and because of the latter, 
the disease is considered to be potentially malignant (McIntyre, 2001). There does, 
however,  remain  considerable  controversy  as  to  whether this  lesion  is  potentially 
malignant, and if Candida does indeed give rise to the dysplasia.
1.1.4.2.4 Denture related stomatitis
Denture  related  stomatitis  (DRS)  is  considered  as  a  Candida-associated  lesion 
(McIntyre,  2001).  It  is  a  chronic  inflammatory  condition  that  manifests  as 
erythematous  areas  of the  denture  bearing  mucosa,  either  localised  or generalised 
(Muzyka and  Glick,  1995) that affect mainly the  mucosa under maxillary  denture 
(Farah et al., 2000). Lesions are usually asymptomatic, although occasional patients 
report soreness and burning or tingling sensation beneath the denture, and may also 
be associated with angular cheilitis (Farah et al., 2000; Ellepola and Samaranayake, 
2000a). Denture related stomatitis is discussed in greater detail in section 1.5.
1.1.4.2.5 Angular cheilitis (angular stomatitis, perleche)
Angular  cheilitis  manifests  as  erythematous  cracking  or  fissures  of one  or  both 
angles of the mouth (Lynch,  1994), and in some patients may extend to facial folds. 
Angular  cheilitis  is  thought  to  be  caused  by  accumulation  of  saliva  containing 
Candida, occasionally streptococci and Staphylococcus aureus at the comers of the 
mouth (Lamey and Samaranayake,  1988; Akpan and Morgan, 2002). It can be seen 
with other forms of oral candidosis, mainly chronic atrophic candidosis (Russotto,
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1980;  Wilson,  1998).  Angular  cheilitis  typically  arises  due  to  decreased  vertical 
dimension of the denture occlusion due to underlying bone resorption or wear of the 
occlusal surface of old dentures (Penhall,  1980; Ellepola and Samaranayake, 2000a; 
McIntyre, 2001). Less common contributing factors may include deficiency of iron 
and/or vitamins B6 and B12 or folic acid (Akpan and Morgan, 2002; Blanck et al., 
2002) and poorly controlled diabetes mellitus (McIntyre, 2001). Angular cheilitis can 
also be a feature of HIV (Reichart, 2003; Ranganathan et al., 2004).
1.1.4.2.6 Median rhomboid glossitis
Median rhomboid glossitis manifests as a painless chronic symmetrical area on the 
tongue  anterior  to  circumvallate  papillae.  The  filliform  papillae  are  depapillated 
giving rise to a rhomboid or elliptical area of redness of the dorsum of the tongue 
(Scully  et  al.,  1994;  Sherman  et  al.,  2002),  although  occasionally  the  affected 
mucosa  can  have  a  hyperplastic  exophytic  or  lobuated  appearance  (Scully  et  al., 
1994). Median rhomboid glossitis can arise in HIV disease, xerostomia, long term 
tobacco  smoking  and  sometimes  may  be  a  feature  of  long  term  use  of topical 
corticosteroids (Kolokotronis et al.,  1994; Akpan and Morgan, 2002). It may also a 
feature  of erythematous candidosis as the  “kissing” palatal  lesion  (Reichart et al.,
2000), as mentioned earlier.
1.1.4.2.7 Chronic mucocutaneous candidosis
This is  a term  given to a group of rare diseases  characterised by recurrent and/or 
persistent Candida infection of mucocutaneous surfaces. Affected patients can have 
any of the  aforementioned  types  of candidal  infections  of the  mouth  and respond 
poorly to topical treatment (Scully et al., 1994; Ellepola and Samaranayake, 2000a).
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The underlying defect is related to the impairment of immune defences with a failure 
of the patient’s T-lymphocytes to produce cytokines that are essential for expression 
of cell-mediated immunity to Candida (Kirkpatrick, 2001). Chronic mucocutaneous 
candidosis  may  be  classified  as  familial,  diffuse,  candidosis  endocrinopathy 
syndrome and candidosis thymoma syndrome (Scully et al., 1994).
1.1.4.3  Isolation and identification of Candida species
Diagnosis  of  superficial  fungal  infections  is  through  their  characteristic  clinical 
signs, however, a variety of laboratory investigations may occasionally be required 
(Muzyka  and  Glick,  1995),  particularly  when  the  clinical  presentation  is  severe, 
atypical,  non-responsive  to  therapy  and/or  in  a  potentially  immunocompromised 
host.  Several  sampling methods  are  available  for the  diagnosis  of oral  candidosis 
include;  the  use  of  a  smear,  swab  from  a  suspected  oral  site,  imprint  culture, 
collection of whole saliva, oral rinse and biopsy. The indication and the use of these 
sampling  is  dependant  on the  type  of oral  candidal  infection  present  (Lamey  and 
Samaranayake, 1988).
1.1.4.3.1  Smear
This  method  is  based  upon  a  smear  being  taken  by  scraping  the  lesion  by  blunt 
instrument and smearing directly onto a glass slide. The specimen is then dried, fixed 
and stained with periodic acid-Schiff (PAS) or Gram  stain.  This method is widely 
used and allows a quick diagnosis, and can demonstrate candidal hyphae (Farah et 
al., 2000), but has a low sensitivity (Sitheeque and Samaranayake, 2003).
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1.1.4.3.2 Swab
In this technique, a sample is obtained by rubbing a sterile cotton-tipped swab over 
the area before inoculating the specimen onto Sabouraud’s dextrose agar (SDA) and 
incubating for 48 -  72 h, after which time the growth of fungal colonies is evaluated 
(Sherman et al., 2002). This method is simple and widely used, but may be limited 
by the ability to select a sample site (Sitheeque and Samaranayake, 2003).
1.1.4.3.3 Imprint culture
This  method  utilizes  sterile  plastic  foam-pads  previously  dipped  in  Sabouraud’s 
broth directly before use. The pad is applied to the site for 1  minute and then pressed 
on  Sabouraud’s  agar  for  incubation  and  culture  (Scully  et  al.,  1994).  This  is 
generally  a  reliable  method  which  can  target  the  infected  site  and  distinguish 
between infected and carrier states, although the  selection of a sample  site can be 
difficult if clinical signs are absent (Williams and Lewis, 2000).
1.1.4.3.4 Salivary culture
In  this  method,  subjects  expectorate  approximately  2  ml  of saliva  into  a  sterile 
container. The sample is then cultured on Sabouraud’s agar. This method is as useful 
as the imprint culture technique, but it is not suitable for patients with xerostomia, or 
when a site of infection cannot be identified (Sitheeque and Samaranayake, 2003).
1.1.4.3.5 Oral rinse
The oral rinse method is simple and entails the subject rinsing the mouth with 2 ml 
of sterile phosphate-buffered saline (PBS) or distilled water for  1   minute and then 
expectorating  the  rinse  into  a sterile  container.  The  solution  is  then vortexed  and
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cultured on SDA for 24 to 48 hours at 37°C. The Colony Forming Unit (CFU) of 
Candida can then be determined (Williams and Lewis, 2000). High candidal counts 
corresponds with high fungal loads in the mucus membrane areas (McIntyre, 2001). 
This  technique  allows  accurate  detection  of oral  yeasts,  but  cannot  identify  the 
possible  sites  of  candidal  disease  (Williams  and  Lewis,  2000;  Sitheeque  and 
Samaranayake, 2003).
1.1.4.3.6 Impression culture
Impression culture involves the use of alginate impressions of the maxilla and the 
mandible  and then casted in agar prepared with  Sabouraud’s broth and incubated. 
This  technique  allows  distribution  of yeasts  on  oral  surfaces  to  be  determined 
(Sitheeque and Samaranayake, 2003).
1.1.4.3.7 Biopsy
This is an invasive method and inappropriate for regular use. However, it is helpful 
and  accurate  method  to  confirm  diagnosis  of  oral  lesions  such  as  in  chronic 
hyperplastic candidosis (Williams and Lewis, 2000; Farah et al., 2000).
Relevant haematological  and  serological  investigations  should  also  be  performed, 
when  appropriate,  in  order to  identify  any  undiagnosed  diseases  such  as  diabetes 
mellitus (McIntyre, 2001). Additionally, correct identification of different Candida 
spp.  has  become  essential  for clinical  management as  well  as  for epidemiological 
studies.  After  isolation  of  Candida  from  the  mouth  using  one  of the  previous 
methods, different systems are available to identify Candida species. It is possible to 
discriminate Candida spp. by either phenotypic methods such as CHROMagar, germ
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tube testing, ComMeal agar and carbohydrate assimilation tests (API system) or by 
genotypic  method  including  the  investigation  of  gene  transcription  to  identify 
specific  genes  required  for  microbial  pathogenesis  and  survival  in  the  host.  The 
molecular methods provide  definitive  differentiation of species  to  characterize the 
genetic  difference  between different  Candida  species.  Some  of these methods  are 
indicated in Table 1.2.
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Molecular methods  Identification  Routine  Time  Reproducibility  References
at subspecies  screening  consuming/  /sensitivity
level  expensive
Restriction enzyme analysis  +  -  +  +  Pincus et al, 1999
DNA typing
Restriction fragment length 
polymorphism (RFLP)
+
+ +
+
+
+
+
Lupetti et a l 1995 
Deak et a l 2004
Randomly amplified 
polymorphic DNA (RAPD)
+ Reiss et al, 1998; Bautista-Munoz et 
a l 2003
rRNA sequencing analysis Reiss et al., 2000Chapter 1 Introduction
1.1.4.4  Treatment of  oral candidosis
Prevention and elimination of local  factors that predispose to oral  candidosis may 
reduce  the  incidence  of candidal  infections  (Sherman  et al.,  2002).  Treatment  of 
systemic disease that may predispose to oral yeast colonization and growth, such as 
diabetes  mellitus,  will  play  a  major  role  in  reducing  or  preventing  candidal 
colonization.  Management  of  candidosis  can  be  accomplished  with  topical 
applications  of antifungal  agents,  and  if this  is  not  controlled,  treatment  should 
include systemic medications (Epstein, 1990).
Several antifungal agents are available for the treatment of oral candidal infections. 
The most common antifungal drugs in current use are listed in Table 1.3.
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Table 1.3: Antifungal agents used to treat oral candidosis.
Class Agent
Polyenes Nystatin
Amphotericin B
Azoles Imidazoles:
Clotrimazole
Miconazole
Ketoconazole
Tri azoles:
Fluconazole
Itraconazole
DNA analogues 5-fluorocytosine
Others Chlorhexidine gluconate
1.1.4.4.1  Polyenes
Nystatin can inhibit the biosynthesis of ergosterol in the fungal cell membrane. This 
inhibition  of  ergosterol  biosynthesis  alters  the  permeability  of  the  yeast  cell 
membrane, resulting in leakage of cell constituents  and death  (Muzyka and Glick, 
1995;  Ellepola  and  Samaranayake,  2000c).  Nystatin  has  both  a  fungicidal  and 
fungistatic  action,  depending  upon  the  concentration  administered  (Ellepola  and 
Samaranayake,  2000c).  Nystatin  is  only  available  for  topical  application  (Budtz- 
Jorgensen  and  Lombardi,  1996)  due  to  being  too  toxic  for  systemic  application 
(Scully et al., 1994).
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The  mechanism  of  action  of  amphotericin  B  is  similar  to  that  of  nystatin. 
Amphotericin B inhibits fungi via interaction with ergosterol, resulting in a loss of 
membrane-selective permeability. It can exert either a fungistatic or fungicidal effect 
depending  upon  the  drug  concentration  (Ellepola  and  Samaranayake,  2000c). 
Amphotericin  B  is  the  broadest  spectrum  among  all  antifungal  agents  and  is 
commonly used against systemic fungal infections (Comely et al., 2003). It can be 
used topically for the treatment of oral candidal infections and available as; lozenges 
ointments,  suspensions  and creams  (Budtz-Jorgensen and Lombardi,  1996);  It can 
also be given intravenously for the treatment of systemic mycoses, but there is a risk 
of nephrotoxicities (Muzyka and Glick, 1995; Epstein and Polsky, 1998).
1.1.4.4.2  Azoles
Most  azoles  are  fungistatic  (Epstein,  1990)  and  work  by  interfering  with  the 
synthesis  of  ergosterol  fungal  cell  membrane  and  alter  membrane-associated 
function (Ellepola and Samaranayake, 2000c).
Clotrimazole  can  be  used  for  the  treatment  of  oral  candidosis  especially  in 
immunocompromised individuals such as HIV-infected patients (Greenspan,  1994b; 
Rex et al., 2000). Clotrimazole is available as a topical preparation (Sherman et al., 
2002).
Miconazole  acts  against fungal  infections  such  as  Candida  spp.  and  some  Gram- 
positive  bacteria  such  as  Staphylococcus  aureus  (Ellepola  and  Samaranayake, 
2000c). Miconazole is generally used topically (Scully et al.,  1994) as the systemic 
use  of miconazole  is  superceded  by  the  availability  of  other  less  toxic  azoles. 
Miconazole formulated into a lacquer has been shown to be effective in the treatment 
of DRS (Budtz-Jorgensen and Carlino, 1994; Konsberg and Axell, 1994).
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Ketoconazole has a broad spectrum  of activity.  It is  generally reserved  for severe 
infections  such  as  chronic  mucocutaneous  candidosis  or  HIV-related  candidal 
infections  (Epstein,  1990).  However,  the  associated  side  effects  such  as 
gastrointestinal  intolerance,  hepatotoxicity  and  nephrotoxicity  have  limited  its 
clinical application (Muzyka and Glick, 1995; Akpan and Morgan, 2002). 
Fluconazole has a broad spectrum activity against most strains of C. albicans, but is 
less  active  against  non  -albicans  Candida  species,  particularly  C.  krusie  and  C. 
glabrata  (Budtz-Jorgensen  and  Lombardi,  1996;  Ellepola  and  Samaranayake, 
2000c). Fluconazole has fewer serious side effects compared to ketoconazole and is 
prescribed when a long-term therapy is required (Sherman et al.,  2002).  It is well 
absorbed  by  the  gastrointestinal  tract  (Akpan  and  Morgan,  2002)  and  can  be 
administered systemically (orally or intravenously) (Scully et al., 1994). Fluconazole 
is  widely  used  as prophylaxis  against fungal  infection  in bone  marrow transplant 
recipients  for  75  days  following  transplantation  (Marr  et  al.,  2000).  An 
administration  of fluconazole  orally to patients  with  DRS  produces  a pronounced 
reduction of erythema and soreness (Budtz-Jorgensen et al., 1988).
Itraconazole  is  a  triazole  drug  that  has  a  broader  spectrum  of  activity  than 
fluconazole  that  includes  non-albicans  Candida  spp.  and  is  suitable  for oral  and 
intravenous  administrations  (Comely  et  al.,  2003).  It  is  well-absorbed  after  oral 
administration (Ellepola and Samaranayake,  2000c).  Itraconazole  may be  a useful 
agent  in  the  management  of some  azole-resistant  Candida  in  patients  with  HIV 
infection and oropharyngeal candidosis (Ruhnke et al., 1994).
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1.1.4.4.3 DNA analogues
Flucytosine (5-fluorocytosine) can interfere with nucleic acid synthesis of the yeast 
cells  (Scully  et  al.,  1994).  It  is  useful  as  oral  therapy  for  the  treatment  of deep 
systemic  candidal  infections  and  is  mainly  given  in  combination  with  other 
antifungal agents (particularly with amphotericin B) due to the rapid development of 
resistance among clinical yeast species (Pallasch, 2002).
1.1.4.4.4 Others
Chlorhexidine  gluconate  has  also  been  proposed  as  an  adjunctive  therapeutic 
supplement  for prevention and topical treatment of some  types  of oral  candidosis 
such as psudomembranous candidosis and DRS or as a denture disinfectant (Ellepola 
and  Samaranayake,  2000c).  It has  antimicrobial  activity  and  ability  to  inhibit the 
adherence  of  Candida  spp.  to  the  denture-acrylic  and  oral  mucosal  surfaces  as 
reviewed by Budtz-Jorgensen and Lombardi, 1996.
A number of new generation antifungal agents have been proposed.  These include 
voriconazole, posaconazole and ravuconazole, liposomal nystatin and echinocandins 
(caspofungin, micafungin) (Comely et al., 2003). Voriconazole is a broad spectrum 
azole that can be administered orally or intravenously (Richardson and Kokki, 1998). 
Voriconazole and caspofungin can be used for the treatment of invasive candidosis 
and  have  a  good  activity  against Aspergillus  (Bachmann  et  al.,  2002;  Ostrosky- 
Zeichner et al., 2003)
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1.2 THE ORAL ENVIRONMENT IN HEALTH AND DISEASE
Many  human  surfaces  are  available  for  bacterial  attachment  (skin,  respiratory, 
intestinal mucosa, oral cavity etc.). However, as the majority of these surfaces are 
continually being shed (along with the bacteria attached to them) and renewed, the 
opportunities  for  bacterial  attachment  are  more  limited  (Wilson,  2001).  The  oral 
cavity is similar to other parts of the digestive tract in having a resident microflora, 
which  develops  naturally  with  a  characteristic  composition  (Marsh,  1994).  These 
organisms  establish a harmonious  relationship  with the  host.  However,  when this 
balance is disturbed a variety of diseases can occur at different sites within the mouth 
(Bagg et al., 1999b).
Microbial adherence to an oral surface is an essential step for colonisation leading to 
subsequent tissue invasion and the ability to cause disease (Dorocka-Bobkowska et 
al.,  2003).  There are different distinct microbial habitats within the mouth include 
the  lips,  cheek,  palate,  tongue  (mucosal  surfaces)  and  teeth  (hard  non-shedding 
surfaces).  These habitats provides different ecological conditions which enable the 
growth of populations that are specific to that niche (Marsh and Martin, 1999b).
1.3 BIOFILMS
The  first  detailed  description of microbial  attachment to  surfaces  appeared  in the 
literature  60  years  ago  when  Claude  Zobell  first  noted  the  preference  of marine 
bacteria for growth on surfaces (Zobell,  1943).  However,  it was  not until the late 
1970’s that the term  ‘biofilm’  made its  first  appearance  in the  scientific  literature 
when  William  Costerton  put  forward  a  general  theory  of biofilm  predominance 
(Costerton et al., 1978).
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The  almost  universal  association  between  microorganisms  and  surfaces  is  now 
widely accepted.  Advances  in microscopic technology have  led to  an appreciation 
that  bacterial  biofilms  are  composed  of microcolonies  attached  to  a  surface,  on 
which  bacteria  and  other  microorganisms  are  able  to  develop  into  organised 
communities  (Costerton  et  al.,  1999).  Biofilm  formation  can  alter  the  local 
environmental  conditions  quite  considerably  and  this  has  important  ecological 
consequences as, for example, observed in the mouth. The resulting community will, 
in  turn,  alter  the  conditions  within the  growing  biofilm  and  create  environments 
suitable for other types of bacteria. As such, vast numbers of micro-habitats will be 
generated  within  the  biofilm  allowing  the  survival  of  species  with  different 
nutritional and physico-chemical requirements (Wilson, 2001).
1.3.1  Defining a biofilm
Bacteriologists have studied most aspects of bacterial structures and behaviour using 
cells that have been grown in suspension in a liquid medium. The organisms grown 
in  this  manner  are  termed  planktonic  organisms,  however;  in  most  natural 
environments they become associated with a surface, and this is now considered the 
‘normal’  microbial  lifestyle.  Cells in biofilm  expressed  markedly  different protein 
profiles  when  compared  to  their  planktonic  counterparts  (Sauer  et  al.,  2002). 
Growing in this form is an efficient means of persisting in a localised area protected 
from the surrounding environment (Watnick and Kolter, 2000).
Biofilms have been defined in a number of ways, but it is difficult to come up with a 
definition  of the  term  that  is  satisfactory  to  all  researchers  in the  field.  In  1978, 
Costerton and co-workers observed that communities of attached bacteria in aquatic 
systems  were  found  to  be  enclosed  in  a  polysaccharide  matrix  which  mediated
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adhesion (Costerton et al.,  1978). Further, in  1987 and  1995, the group stated that 
biofilms  consist  of  single  cells  and  microcolonies,  all  embedded  in  a  highly 
hydrated, predominantly anionic exopolymer matrix emphasizing that biofilm could 
adhere to surfaces and interfaces to each other (Costerton et al.,  1987; Costerton et 
al., 1995). Finally, a biofilm as a structured community of bacterial cells enclosed in 
a  self-produced  polymeric  matrix  and  adherent  to  an  inert  or  living  surface  was 
proposed as a definition in 1999 (Costerton et al., 1999).
Wilson (2001) described the main features of a biofilm  as;  a) a three dimensional 
structure  containing  one  or  more  bacterial  species;  b)  it  forms  at  interfaces  -  
solid/liquid,  liquid/air;  solid/air;  c)  it  shows  spatial  heterogeneity  due  to  physio- 
chemical and chemical gradients that develop within it; d) biofilm is often permeated 
by  water  channels  and;  e)  the  organisms  within  the  biofilm  exhibit  a  marked 
resistance to antimicrobial agents and host defence systems compared to planktonic 
microbes. Biofilms are therefore cellular communities with an ordered structure and 
circulatory system. They display different physiologies within different regions, have 
a form  of intercellular communication and can resist noxious chemicals and other 
threats  from  their  surrounding  environment.  Others  have  defined  a  biofilm  as  a 
population  of cells  growing  on  a  surface  and  enclosed  in  an  expolysaccharides 
matrix  (Lewis,  2001)  or as communities of microorganisms that are  attached to  a 
surface  (O’Toole  et al.,  2000).  Donlan  stated  that  “biofilm  is  a  process  whereby 
microorganisms  irreversibly  attached  to  and  grow  on  a  surface  and  produce 
extracellular polymers that facilitate attachment and matrix formation, resulting in an 
alteration in the phenotype of the organisms with respect to growth rate and gene 
transcription” (Donlan, 2001a).
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1.3.2  The formation of a biofilm
In natural  environments, bacteria rarely adhere to the  substratum  itself,  invariably 
this is coated with a layer of adsorbed molecules known as a “conditioning film” and 
it  is  to  this  film  that  the  organism  usually  adheres.  In  the  oral  cavity,  this 
conditioning film (up to 1.0 pm thick) is known as the salivary pellicle and is formed 
mainly from glycoproteins and other salivary molecules (Wilson, 2001).
Several  phases  or  stages  (Figure  1.3)  have  been  recognised  in  the  formation  of 
biofilm (Sauer et al., 2002; Stoodley et a l, 2002). Biofilm formation begins with the 
attachment of single cells to a surface-the substratum. Firstly, in the reversible step, 
cells  may  require  motility  or  may  have  random  contact  with  a  surface.  This  is 
followed  by  the  attachment  of the  cells  to  the  substratum  by  adherence  through 
surface appendages or by the production of extracellular polymeric substances. The 
attached cells then may grow into microcolonies depending upon the availability of 
nutrients  on the  surface  itself or from the  liquid phase  above the  substratum.  In a 
hydrodynamic environment the development of the microcolonies depends on cell­
cell  binding  interactions.  These  microcolonies  start  to  grow  and  form  a  mature 
biofilm in which the biofilm structure with its distribution of biomass. The presence 
of  fluid-filled  voids  illustrates  the  heterogeneity  of  the  biofilm  and  the  rigid 
properties  of the  developed  structure.  The  stability  of the  biofilm  is protected  by 
cell-cell  interactions  and  by  the  extracellular  polymeric  substance  (EPS)  both 
surrounding and integrated into the biomass of the biofilm. Finally, the biofilm may 
partially detach, releasing cells that may move away to other locations where a new 
cycle can begin (Molin and Tolker-Nielsen, 2003).
In order to progress from the reversible attachment stage to the irreversible adhesion 
phase  of  biofilm  formation,  the  attached  cells  up-regulate  genes  that  produce
53Chanter 1       Introduction
enzymes concerned with the synthesis of EPS which cement their adhesion to the 
surface and to other bacterial cells. The resultant biofilm structure has different cell 
envelope proteins  from those  found  in planktonic  cells.  Therefore,  once  bacterial 
cells adhered to the surface, they express different phenotypes from their planktonic 
counterparts (Costerton,  1999; Sauer et al., 2002). The features of the substrata may 
have a considerable effect on the rate and extent of attachment by microorganisms 
(Donlan, 2001a). For example, rougher surfaces which are preferentially colonised, 
provide niches for bacteria as they provide an increased surface area (Lytle et al., 
1989).
Figure  1.3:  Diagrammatic  representation  of  stages  associated  with  biofilm 
formation. Figure is reproduced from the Center for Biofilm Engineering at MSU- 
Bozeman.
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Biofilm formation on medical device may be composed of a single-species or multi­
species biofilms (Donlan, 2001b). These surfaces can be colonised by both bacteria 
and yeasts  (Marrie  and  Costerton,  1984;  Reid  et al.,  1992;  Hawser  and  Douglas, 
1994).  Microorganisms  on catheter surfaces  show two  forms:  the  sessile  form,  in 
which the organisms embedded in the biofilm and a planktonic  form  in which the 
organisms  disseminate  over  the  surface.  Microbial  colonisation  and  biofilm 
formation can occur within 24 h following the insertion of a device  (Raad,  1998). 
The formation of microbial biofilm on biomaterials  also involves  sequential steps. 
These include the absorption of the host conditioning film to the device surface and 
the adhesion of microorganisms anchored by EPS and growth (Reid, 1999).
1.3.3  Communication within a biofilm
Communication is a principal element in successful organisations. Bacteria have the 
ability to sense and respond to their external environment and many bacteria species 
are  also  able to  sense the presence  of other species  (Bassler,  1999;  de  Kievit and 
Iglewski, 2000). For example, the bacteria in the oral cavity have developed means 
by  which  they  communicate  and  form  successful  organisations.  These 
communications  are  essential  for initial  colonisation  and  subsequently  for biofilm 
formation (Kolenbrander et al., 2002). Most oral bacteria can physically interact with 
and adhere to other bacteria and all display specific recognition patterns with their 
respective partner cells. Many bacteria using  a quorum-sensing  system  to regulate 
their  physiological  properties  include;  virulence,  biofilm  formation  and  motility. 
This mechanism  works  through the production  of signals  that can be  detected by 
neighbouring cells (Cvitkovitch et al., 2003).
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Colonisation is successful if the adherent cells grow and contribute metabolically in 
the oral bacterial environment (Whittaker et al.,  1996). Metabolic interactions may 
occur through the breakdown of a substrate by the extracellular enzymatic activity of 
one organism that creates biologically available substrates for different organisms or 
when  the  excretion  of a  metabolite  by  one  organism  can  be  used  by  a  different 
organism as a nutrient source (Kolenbrander et al., 2002).
Bacterial  coaggregation  is  a  common  phenomenon  in  a  variety  of multi-species 
biofilm communities. It is a process by which genetically distinct bacteria attached to 
one  another  via  specific  molecules.  Such  interactions  are  able  to  influence  the 
development  of  complex  multi-species  biofilms  (Rickard  et  al.,  2003).  The 
multiplication  of  the  organisms  attached  to  the  already  adherent  cells  is  a 
phenomenon  knows  as  co-adhesion  (Wilson,  2001).  This  interaction  enables  cell 
communication through signalling and genetic exchange within a biofilm and also 
can signal other biofilm members, leading to metabolic communication that defined 
the  microbial  community  and  its  spatial  organisation  of  the  community 
(Kolenbrander, 2000).
Several interactions occur between Candida spp.  and other microorganisms which 
facilitate fungal  survival in mixed-species oral  communities and play an important 
role in colonisation by C.  albicans of hard and soft oral surfaces (Jenkinson et al., 
1990; Holmes et al., 1995; Jabra-Rizk et al., 1999).
Oral biofilms are an excellent example of species complexity within a biofilm as the 
total  species  diversity in the  oral  cavity has been postulated to be more  than 500 
species  (Paster  et  al.,  2001;  Foster  and  Kolenbrander,  2004).  Antagonistic  and 
beneficial  interactions  between  this  complex  microbial  community  will  exert  a 
homeostatic stable effect (climax community) (Wilson, 2001).
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1.3.4  Biofilm structure
Biofilms are dynamic with respect to structure and composition (Palmer and White,
1997). They display great differences in their structure and thickness. In humans, for 
example, biofilms which form on tooth surfaces are relatively thick, while biofilms 
which form on implanted medical devices tend to be thinner (Wilson, 2001). The use 
of Confocal  Laser Scanning Microscopy (CLSM) has  enabled the  examination of 
biofilms in their native hydrated state and allowed an accurate estimation of biofilm 
structure and dimensions (Baillie and Douglas,  1999b).  Complex structures such a 
mushroom-like stacks of micro-colonies (Figure  1.4) containing bacteria embedded 
in extracellular matrix and separated by water channels (Costerton et al., 2003) are 
known  to  exist  in  some  environments.  This  biofilm  structure  forms  under;  low 
nutrient concentration, high hydrodynamic shear stress and absence of mechanical, 
abrasive and compressive force (Wilson, 2001).  It also  influenced by  growth rate, 
cell signalling, motility, EPS production and physical growth environment (Stoodley 
et al., 2002).  Additionally, the chemical composition and physical  structure of the 
substratum, liquid flow rate, and the nature of the organism will also affect the final 
structure (Wilson, 1996).
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Figure  1.4:  Diagrammatic representation of the mushroom-like microcolonies that 
constitute the structural element of biofilm. Figure is reproduced from the Center for 
Biofilm Engineering MSU-Bozeman.
1.3.4.1  Extracellular polysaccharides
The key elements in biofilm structure are bacteria, the extracellular matrix and water. 
The synthesis of extracellular matrix molecules occurs during the colonisation stage 
that  follows the  initial  adhesion of bacteria  (Wilson  2001).  Bacterial  biofilms  are 
embedded in a thick, highly hydrated anionic matrix  (Costerton et al.,  1987).  The 
slow  bacterial  growth  observed  in  most  biofilms  would  be  expected  to  enhance 
production of EPS which varies greatly in composition and hence in chemical and 
physical properties.  Extracellular matrix  consists mainly of polysaccharides  and  a 
wide  range  of other molecules,  including  lectins,  proteins  and  lipids  (Sutherland, 
2001). It is a major component of the biofilm and may comprise 50 -  95 % of the dry
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weight  (Sutherland,  1999).  Zobell  (1943)  suggested  the  involvement  of  the 
extracellular cementing substances in the adhesion of cells to the substratum, indeed 
the matrix has been shown to play a major role in maintaining the integrity of the 
biofilm  and  may provide  receptors  for cell  induced  adhesion by  coating the  cells 
which  synthesise  it  as  well  as  adjacent  microbial  cells  and  inert  surfaces. 
Additionally,  EPS  assists in the protection of the microbial  cells  from  detrimental 
compounds and helps  to provide nutritionally rich environments  which favour the 
growth  of  specific  types  of microorganisms  and  is  effective  in  maintaining  the 
biofilm  structure  through  the  formation  of  a  network  of  cross-linked  linear 
macromolecules  (Sutherland,  1999).  It may  interact with  antimicrobial  agents  and 
prevent access of the compounds or reduce their concentration (Sutherland, 2001). 
Freeman and Lock (1995) have suggested that the EPS could act as a buffer against 
changes  in  the  available  organic  substrates.  Understanding  the  chemical  and 
structural characteristics of the biofilm matrix may help to understand the structure 
and function of the biofilms.
1.3.5  Biofilm resistance
Biofilms are  especially difficult to eradicate and are  a source  of many recalcitrant 
infections. Infections due to microbial biofilms are a major cause of morbidity and 
mortality  and  treatment  of  such  infections  is  difficult.  Due  to  resistance  to 
antimicrobial agents, biofilms may act as a source of persistent infection and may 
harbour pathogenic organisms (Donlan, 2001a). Pathogenic yeast such as Candida 
albicans can also form recalcitrant biofilms (refer to section  1.4.2). Resistance can 
be defined as the ability of a microorganism to grow in the presence of an elevated 
level of antimicrobial  (Lewis, 2001).  There  are two main mechanisms of bacterial
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resistance to biocides, intrinsic (as in the natural biofilm growth mode) or acquired 
(acquisition of resistance plasmid or transposons)  (Russell,  1995;  Donlan,  2001a). 
Roberts  and  co-workers  showed that bacteria in a biofilm  may transfer resistance 
genes (Roberts et al., 1999).
Biofilms form highly organised structured communities and their formation follows 
an  ordered  sequence  of  events  (Schembri  et  al.,  2003).  Biofilms  formed  in  a 
protected  environment  may  shed  individual  cells  into  the  surrounding  tissues  and 
causing acute illness that resist treatment (Davies, 2003).  Costerton and colleagues 
published a review article that was the first to articulate the general phenomenon of 
biofilm resistance to antimicrobial agents compared to their planktonic counterparts 
(Costerton et al., 1987). It has been shown that there is up to a 1000-fold decrease in 
susceptibility of biofilms  compared to planktonic  cells  (Nichols  et al.,  1989).  The 
reasons for the differing susceptibilities of organisms when grow as a biofilm and 
those  grown  in  suspension  are  a subject of continuing  debate.  It  is  clear that the 
mechanism of biofilm resistance to antimicrobial agents is extremely complex and 
several mechanisms have been proposed to account for the extraordinary resistance 
of biofilm to antimicrobial agents as detailed below.
1.3.5.1  Delayed penetration of the antimicrobial agents
In order to inactivate the encased cells, antimicrobial agents must diffuse through the 
biofilm matrix. It has been supposed that EPS might exclude or limit the access of 
drugs to  organisms  within the biofilm  (Douglas,  2003).  EPS  may act as  a barrier 
against the penetration of the agent either by influencing the rate of transport or the 
reaction of antimicrobial agents with the matrix (Costerton et al.,  1987; Donlan and 
Costerton, 2002). This EPS is negatively charged and acts as an ion-exchange resin
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that is capable of binding a positively charged antimicrobial molecule and preventing 
it  reaching  the  embedded  biofilm  cells  (Anwar  et  al.,  1992).  Reaction  sink 
(neutraliser)  is  another mechanism  by which  a matrix  may play  a role  in biofilm 
resistance.  This  is augmented by the retention of extracellular products  and drug- 
inactivating enzymes or degenerative enzymes that are  able to break down certain 
antibacterial agents (Morton et al., 1998; Gilbert et al., 2002).
However,  there  appears  to  be  some  debate  over  whether  the  EPS  hinders  the 
diffusion  of  antibacterial  agents  into  biofilms  (Morton  et  al.,  1998;  Mah  and 
O'Toole, 2001). Anderl and co-workers showed that an antibiotic (ciprofloxacin) was 
able to penetrate the biofilm quickly, yet was unable to kill the bacteria (Anderl et 
al.,  2000).  It  has  also  been  shown  that  EPS  has  a  minimal  effect  against  the 
penetration  of some  other antibiotics  (tobramycin  and  cefsulodin)  (Nichols  et al., 
1988; Nichols et al., 1989). This suggests that other mechanisms may contribute to 
the resistance of these cells.
Hence,  the  biofilm  matrix  does  represent  a  barrier that  delays  the  penetration  of 
certain  compounds  of antimicrobial  agents,  but  it  may  not  form  an  impenetrable 
barrier to diffusion and does not appear to be the sole explanation for the increased 
resistance of biofilm (Mah and O'Toole, 2001).
1.3.5.2  Altered growth rate of  biofilm organisms
Depending  on  their  location  within  the  biofilm,  different  cells  are  metabolically 
active or inactive. For example, cells in the outer layer of biofilms tend to be more 
viable  and  more  metabolically  active  and  surround  an  internal  core  of nonviable 
bacteria  (Hope  and  Wilson,  2003).  Their  cell  envelope  is  more  permeable  to 
nutrients such as oxygen and these have better ability to discharge metabolic waste
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products  (Anwar  et al.,  1992).  In  contrast,  cells  that  are  deeply  situated  within a 
biofilm, have reduced growth rates due to nutrient limitation and therefore exist in a 
slow-growing or starved state (Brown et al.,  1988). Additionally, the accumulation 
of the metabolic waste products may cause unfavourable growth conditions and the 
cells may become dormant (Anwar et al., 1992).
The slow bacterial growth rate is strictly proportional to the decrease in antibiotic- 
induced  killing  effect  and  hence  the  increase  in  biofilm  resistance  (Evans  et al., 
1991;  Duguid  et al.,  1992).  In  fact,  some  antibiotics,  such  as  penicillin,  kill  only 
growing cells (Lewis, 2001).
The  encapsulated  community of a biofilm  are  at a lower risk from  environmental 
stresses (Anwar et al., 1992). Under these circumstances, the embedded biofilm cells 
may have sufficient time to switch on the expression of antibiotic-resistant factors 
(Giwercman  et  al.,  1991).  This  may  contribute  to  the  inherent  resistance  to 
antibiotics  that  are  active  in  planktonic  bacteria.  Cells  situated  at  the  bulk  water 
interface  of biofilms are  killed more rapidly than  cells  found  more  deeply within 
clusters  and  which  remain  unaffected  by the  agent  (Davies,  2003).  These  deeply 
situated  bacteria  can  potentially  form  a  nidus  for  continued  dissemination  of the 
infection.  Additionally,  biofilm  associated  cells  grow  more  slowly  compared  to 
planktonic  cells  (Williams  et  al.,  1997;  Donlan  and  Costerton,  2002)  and  the 
production of EPS is also higher for attached bacteria (Evans et al.,  1994). This will 
provide an increase in EPS production within the  slow growing centre of biofilms 
and consequently alter the distribution and cell  density throughout the  matrix and 
confer a spatial structural organisation upon the community to provide customised 
microniches  at  various  point  within  a  biofilm  (Costerton  et  al.,  1994).  Hence, 
antimicrobial agents are either taken up more slowly (Donlan and Costerton, 2002)
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or possibly the cells are less permeable to the agents or have altered the antibiotic 
target sites (Anwar et al., 1992).
1.3.5.3 Unique biofilm physiology
Biofilm bacteria are physiologically distinct from their planktonic counterparts. As a 
consequence  of attachment,  bacteria  express  unique  genes  that  possibly  enhance 
resistance  to  antimicrobial  treatments  and  host  immune  defence  responses.  These 
biofilm-specific  genes are different from  genes expressed in the  free floating cells 
(Becker et al.,  2001;  Schembri et al.,  2003).  Hence, the  activated  genes  modified 
biofilm  susceptibility toward antimicrobials  (Gilbert et al.,  1997).  To  enhance the 
effectiveness of the existing antibiotics, these genes need to be identified and could 
become possible targets for chemotherapeutic treatment and disrupt the multicellular 
structure of biofilms (Stewart and Costerton, 2001).
1.3.5.4 Per  sisters
A  recent  and  novel  hypothesis  for  biofilm  resistance  relates  to  the  presence  of 
persistent  cells  (persisters).  A  persister  is  a  hypothetical  cell  state  in  which 
microorganisms  are  protected  from  all  types  of antimicrobial  agents  in  a  similar 
manner to a dormant, spore-like cell. The physiological  state  of these  cells allows 
them  to  survive  during  antibiotic  treatment.  It  is  suggested  they  are  present  in 
relatively  small  numbers  but  are  able  to  ‘reseed’  the  biofilm  in the  event of,  for 
example,  a chemical  challenge.  At this point they  are  able to  grow rapidly in the 
presence of nutrients released from their lysed community partners and survive in the 
post-treatment phase. It has been suggested that they are formed in higher numbers 
in  biofilms,  because  of nutrient  limitation,  than  they  do  in  a  planktonic  culture
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(Gilbert et al., 2002).
Thus the biofilm EPS can delay the penetration of some antimicrobial agents, while 
the reduced growth rate and nutrient limitation within a biofilm can also influence 
the  physiology  and  the  sensitivity of bacteria.  However,  multiple  mechanisms  are 
required  for  overall  antimicrobial  resistance  (Mah  and  O’Toole,  2001)  and  the 
intrinsic  phenotypic  resistance  of cells  within  a biofilm  may be  a primary  factor. 
Together with cell-cell communication and organised structure, a biofilm can act as a 
community  that  can  control  physiological  processes  and  responses  via  gene 
expression (Morton et al., 1998).
1.3.6  Biofilm detachment and death
Detachment  from  biofilms  is  an  important  consideration  in  the  dissemination  of 
infection. Bloodstream and urinary tract infections could result from these detached 
bacteria  (Donlan  and  Costerton,  2002).  Detachment  is  a  general  term  used  to 
describe the release of cells from the biofilm or substratum, either individually or in 
groups (Stoodley et al., 2002). Salivary flow may also contributes to the detachment 
of cells from the oral biofilm (Kolenbrander, 2000).  It has been shown that single 
cells and small clusters in mixed-species biofilms detached more frequently than the 
larger clusters (Stoodley et al., 2001). The detached section can either re-adhere to 
the  surface  and  could  comprise  an  effective  means  of colonising  a  large  area  of 
substratum (Wilson, 2001) or may return to the planktonic mode of growth (Stoodley 
et al., 2002).
Death of organisms comprising biofilms has been also observed in monoculture and 
mixed-species biofilms. Death in monoculture biofilms can be defined as cessation
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of cellular activity, whereas in mixed-species population it can be assessed in a term 
of loss of a particular member of the species in the community as a consequence of 
environmental changes. This may involve a change  in the proportion of species or 
their function. Importantly, the loss may cause a shift to different population (Palmer 
and White, 1997).
1.3.7  Biofilm related diseases
Biofilms  are  responsible  for  a  number  of  diseases  in  humans  (Table  1.4)  and 
detached cells can cause systemic infections, depending on the response of the host 
immune system (Donlan, 2001a).
Microorganisms may adhere to a wide range of surfaces including inert, non-living 
materials  or  living  tissues  (Donlan,  2001b).  Advances  in  medical  and  surgical 
techniques have resulted in the use of a wide range of medical devices implanted into 
the body which provide non-shedding surfaces on which a biofilm can form. Thus 
medical  implants  such  as  catheters,  urethral  stents,  cardiac  pacemakers  can  be 
colonised by microorganisms and subsequently form  a biofilm.  These  surfaces are 
not well protected by host defences and can offer a focal point for organisms to grow 
(Reid,  1999).  Millions  of these  devices  are  in  use  each  year  and  cause  frequent 
vascular-catheter-related bloodstream  infections  (Raad,  1998).  As well  as bacteria, 
species  of yeast  are  also  able to  form  a biofilms  on  the  surface  of these  catheter 
materials (Hawser and Douglas, 1994). The associated sepsis of these biofilms is one 
of the  most  serious  complications  of intravenous  therapy  and  removal  of these 
devices becomes necessary to cure the patient from the infection thus increasing the 
cost  and  trauma  to  the  patient  (Khardori  and  Yassien,  1995;  Mah  and  O'Toole, 
2001).
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The structure of biofilms has the highest impact on the outcome of chronic bacterial 
infections such as infective endocardidtis, where individual microcolonies break off 
and detach, causing a serious risk of infective emboli in the capillary bed (Donlan 
and  Costerton,  2002).  Advances  in  technology  have  decreased  the  problems 
associated  with  biomaterial  related  infections,  however,  there  is  still  a  need  to 
overcome  these  problems  and  there  is  limited  evidence  to  suggest  that  bacterial 
colonisation on devices can be prevented over the long time (Reid, 1999).
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Table 1.4: Table indicating biofilm related human infections.
Infections caused 
by biofilms
Specific example Reference
Implanted medical Prosthetic valve Parsek and Singh, 2003; Kojic and
devices related endocarditis Darouiche, 2004
infections Central venous catheter Donlan, 2001b; Kojic and Darouiche, 2004
Intravascular catheter Raad, 1998
Urinary catheter Choong and Whitfield, 2000; Trautner and 
Darouiche, 2004
Joint prostheses Kojic and Darouiche, 2004
Lung disease Cystic fibrosis Costerton, 2001; Parsek and Singh, 2003
Ear infections Otitis media Post, 2001; Donlan and Costerton, 2002
Oral infections Caries and periodontal Marsh and Bradshaw, 1995; Rosan and
diseases Lamont, 2000; Donlan and Costerton, 
2002
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1.3.8  Biofilm-based models
Traditionally  microbiologists  have  studied  organisms  in  broth  culture  in  their 
planktonic phase. However, in order to study biofilm communities in the laboratory, 
researchers have had to devise methods to study organisms in this phase of growth. 
One  of the  most  studied  in  vitro  biofilms  are  those  representing  dental  plaque. 
Researchers  have  studied  dental  plaque  grown  in  the  laboratory  for  a  number  of 
years in artificial mouth models. Interestingly, many of the biofilm models available 
today are derived from these earlier systems. An artificial mouth was used to grow 
dental plaque in vitro with a specific focus on dental caries research (Pigman et aL, 
1952). The models were  specifically constructed to mimic the  situation in the oral 
cavity.  Dental plaque formation was studied on an extracted mounted human teeth 
inoculated with saliva and then supplied with a mucin-containing artificial saliva as 
reviewed by Spratt and Pratten, 2003. The model has been used to study root surface 
caries and enamel caries and the effect of fluoride (Shu, 1998).
There are  a wide range of available biofilm model systems including; the Robbins 
device,  Rototorque  and  the  Cell  Adhesion  Measurement  Module  (CAMM). 
However,  many  of  these  models  tend  not  to  be  used  to  study  oral  biofilms 
(Wimpenny, 1997).
The  difficulties  associated  with  in  vivo  studies  of  dental  plaque  include;  the 
complexity and  heterogeneity  of plaque  structure,  problems  related to  access  and 
sampling  and  ethical  issues.  Additionally,  high variability  of in  vivo  experimental 
protocols and the results are difficult to interpret (Sissons,  1997; Spratt and Pratten, 
2003).
In order to be able to explain plaque ecology and behaviour, these models must be 
realistic and reflect the behaviour that is under investigations (Sissons,  1997). There
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are a number of biofilm-based models that have been used, or could be used to study 
oral  biofilms  (Wilson,  1996;  Wimpenny,  1997).  These  different  biofilm  systems 
have strengths and limitations and hence compromise between the reality of the in 
vivo ecosystem  and the  simplicity  and  controllability  of the  model  needing to  be 
evaluated (Sissons, 1997).
The flow cell is often the system of choice for short-term adhesion and colonisation 
studies, as it enables the non-destructive observation of biofilm development in real 
time  (Busscher and  van  der Mei,  1995).  It permits  adherence  of early  colonizing 
bacteria to  a saliva-conditioned solid substratum  and can be  examined directly by 
CLSM without disruption of the growing biofilm (Foster et al., 2004). The Flow cell 
can also be used for the development of multi-species oral bacterial biofilms (Foster 
and Kolenbrander, 2004). Additionally, it can be employed as a rapid assessment of 
antimicrobial efficacy against bacterial biofilms (Foster et al., 2004). It consists of a 
transparent chamber of fixed depth through which the growth medium passes. When 
mounted  on  a  microscope  stage,  this  system  allows  observation  of  biofilm 
development inside the chamber (Spratt and Pratten, 2003). Sterile saliva is used as a 
sole  nutrient  source  and  is  also  used  to  coat  the  glass  before  inoculation  with 
bacteria.  Bacteria  will  adhere  to  the  saliva  conditioning  film  leading  to  biofilm 
formation (Kolenbrander et al., 2002).
Chemostat-based  systems  have  also  been  used  to  model  oral  biofilm  formation 
(Wilson,  1996;  Wimpenny,  1997;  Sissons,  1997).  A  large  number  of  replicate 
samples and variety of experimental surfaces, such as hydroxyapatite disks, can be 
submerged in the fluid phase. Multi-species oral bacterial biofilms have been also 
produced using chemostats (Bradshaw et al,  1996). However, a disadvantage of this 
system is that biofilm thickness can not be defined and it is not consistent with the in
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vivo situation where only a thin film of fluid is present on oral  surfaces unlike the 
large fluid mass in a chemostat (Spratt and Pratten, 2003).
When using an antimicrobial agent over a period of time, data must be comparable 
and  reproducible  from  one  experiment  to  another.  In  order  to  study  biofilm 
development and  susceptibility,  a Constant Depth Film  Fermentor (CDFF)  can be 
used (for more details refer to section 2.4).  It is a steady-state device (Wimpenny, 
1997) that allows the production of biofilms under conditions similar to those found 
in the  oral  cavity.  Biofilm  is  grown on  solid  substrata with  a thin  liquid  film  of 
nutrients supplied. The scraper blade can control the thickness of formed biofilm by 
removing  excess biofilm.  This imitates the  continuous  removal  of the upper most 
layers  of the  biofilm  due  to  shear  forces  present  in  the  oral  cavity  which  exist 
through  eating  and  tongue  movement  (Wilson,  1996).  The  system  is  a  versatile 
biofilm model and has been used in many investigations concerning the formation of 
oral  biofilms  and  their  susceptibility to  antimicrobial  agents.  For  example,  it  has 
been  used  in  the  study  of microbial  microleakage  around  the  dental  restorations 
(Matharu  et  al.,  2001),  oral  malodour  generation  (Pratten  et  al.,  2003),  and  the 
composition  of  dental  plaque  on  orthodontic  bonding  materials  (Badawi  et  al., 
2003).
Wilson (1996) stated several advantages of the CDFF to generate oral biofilms; these 
include: a) the ability to produce many replicates (up to 90) in one single experiment, 
b) allows pulsing of the nutrients or antimicrobial agents, c) at various intervals, it 
allows biofilm sampling (with replicates), d) mixed plaque samples or pure cultures 
can be used for inoculation (continuously or intermittently), e) it can be autoclaved 
and temperature-controlled, f) a different substrata can be investigated, and finally g) 
it can be used to investigate the effect of antimicrobial agents on biofilms.
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1.4  CANDIDAL BIOFILMS
In contrast to the extensive  literature describing  bacterial biofilms, relatively  little 
attention  has  been  paid  to  fungal  biofilms.  C.  albicans  biofilms  share  several 
properties  with  bacterial  biofilms,  including  their  structural  heterogeneity,  the 
presence  of EPS  and  their  associated  resistance  to  antifungal  agents.  However, 
Candida  spp.  differ  from  bacteria  in  several  important  characteristics  which  are 
relevant to biofilms. These include; the dimorphic or polymorphic forms of Candida, 
the larger size of Candida,  the chemical composition and overall architecture of its 
cell  surface  compared  to  bacteria  and  finally,  the  presence  of hyphal  forms  that 
complicate biofilm treatment (Baillie and Douglas, 1999a).
The  increase  use  of  transplantation  procedures  and  chronic  indwelling  devices, 
which  can  act  as  substrata  for  biofilm  growth  and  subsequent  infections,  have 
increase in the prevalence of fungal diseases, C.  albicans being the most commonly 
associated fungus (Chandra et al., 2001a).
Other  non-albicans  Candida  spp.  also  form  biofilms  of clinical  importance.  For 
example,  candidemia  due  to  C.  parapsilosis  infections  is  associated  with  the  use 
central  venous  catheter  (Shin  et  al.,  2002).  C.  dubliensis,  closely  related  to  C. 
albicans,  also  produces  a  biofilm  with  the  defining  characteristic  of high  matrix 
content and antifungal resistance (Ramage et al., 2001).
1.4.1  Structure of Candida albicans biofilms
Microorganisms appear to share common basic phases during biofilm formation. C. 
albicans  biofilms  form  distinct  organised  developmental  structures  through  three 
phases;  early,  intermediate  and  maturation  (Chandra  et  al.,  2001a).  Following 
attachment of fungal cells to a surface, a three dimensional structure is formed that is
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composed  of  cells  surrounded  by  expolymeric  matrix  (Kumamoto,  2002).  C. 
albicans biofilms are typically composed of a layer of yeast cells  adhering to the 
surface  with  a  layer  of  filamentous  cells  above  it  (hyphal  form)  (Hawser  and 
Douglas,  1994) all surrounded by exopolymeric matrix (Baillie and Douglas,  1999b; 
Chandra et al., 2001a). Previous studies on biofilm formation by Scanning Electron 
Microscopy  (SEM)  demonstrated that  at early  stages  of biofilm  formation,  yeast- 
phase  cells  of C.  albicans adhered to the  surface  of catheter disks  and  during the 
subsequent 48 h, a dense biofilm consisting of yeast cells, germ tubes, pseudohyphae 
and  hyphae  was  observed.  Extracelluler  polymeric  material  was  visible  on  the 
surface of some of these morphological forms (Hawser and Douglas, 1994).
As  in  their  bacterial  counterparts,  expolysaccharide  material  is  also  found  in  C. 
albicans biofilms. Baillie and Douglas isolated the EPS of C.  albicans biofilms and 
compared its composition to that produced by planktonic cells. They found that EPS 
from both cultures contained carbohydrate, protein and other components. However, 
the biofilm EPS contained significantly less total carbohydrate and protein than the 
planktonic EPS with a higher glucose proportion, and galactose, which was unique 
to  the  biofilm.  These  results  suggest that C.  albicans,  unlike  many  bacteria,  may 
produce biofilm-specific EPS (Baillie and Douglas, 2000).
It has been shown that the synthesis of EPS in biofilms is not extensive under static 
conditions, however, EPS synthesis increases markedly when the developing biofilm 
are subjected to a liquid flow under gentle shaking (Hawser et al., 1998).
Generally, the  overall organisation of biofilms formed by  C.  albicans is similar to 
that of bacterial  biofilm.  The detailed structure  of C.  albicans biofilms  are highly 
dependent upon the conditions under which the biofilm formed (Kumamoto, 2002). 
Indeed  numerous  experimental  parameters  can  influence  the  formation  and  the
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structure of C.  albicans biofilm such as; nature of contact surface,  growth factors, 
Candida morphogenesis,  and the  Candida spp.  involved.  These  will  be  discussed 
separately.
1.4.1.1 The nature of  contact surface
The nature of contact surface has been shown to influence biofilm formation of C. 
albicans. For example, C. albicans biofilms formed on acrylic denture material such 
as  polymethylmethacrylate  (PMMA),  are  much  thinner  than  biofilms  formed  on 
catheter  material  such  as  silicon  elastomer  (Chandra  et  al.,  2001a).  Hawser  and 
Douglas also reported that in vitro formation of C.  albicans biofilm was increased 
when grown on latex  or silicone elastomer compared with polyvinyl  chloride, but 
decreased on polyurethane or silicone (Hawser and Douglas,  1994). Results to-date 
have  indicated that the  structure of C.  albicans biofilm  architecture  depends upon 
highly specific contact-induced gene expression (Douglas, 2003).
1.4.1.2 Growth factors
C. albicans biofilm grown on PMMA denture material in one medium, for example, 
YNB medium have been shown to be composed predominantly of yeast cells form, 
whereas  biofilm  grown  in  another  medium  (e.g  RPMI)  were  composed 
predominantly of filamentous form. These results suggest that biofilm growth is not 
morphology specific as both the yeast and hyphal forms of C.  albicans were able to 
form a biofilm (Chandra et al., 2001a).
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1.4.1.3 Candida morphogenesis
One  distinguishing  feature  of C.  albicans  is  its  ability to  survive  in  a number of 
morphological forms which can affect biofilm formation. Baillie and Douglas have 
investigated  the  role  of morphogenesis  in the  structure  of C.  albicans biofilm  on 
catheter using SEM. In this study, they compared a biofilm produced by wild-type 
strains of C. albicans with those formed by two morphological mutants, incapable of 
yeast  and  hyphal  growth,  respectively.  They  found  that  the  wild-type  strains 
produced a distinct two-layered biofilm, a thin basal yeast layer and a thick hyphal 
layer. The hyphae-negative mutant produced only a basal layer, whereas the yeast- 
negative  mutant  produced  only  the  thicker  hyphal  outer  layer  which  was  easily 
detached  from  the  surface.  This  suggests  that  dimorphisim  can  affect  biofilm 
formation and that the basal yeast layer has an important function in anchoring the 
biofilm to the surface. However, as both mutants were capable of forming a biofilm, 
dimorphism is not an absolute prerequisite for biofilm formation, albeit of different 
thickness, and that dimorphism might be necessary for the development of a spatially 
organised  structure  (Baillie  and Douglas,  1999b).  More recently,  Ramage and  co­
workers  have  demonstrated  that  C.  albicans  mutants  lacking  a  regulator  protein 
(Efgl) of hyphal morphogenesis, failed to produce a filament-containing layer which 
was observed in wild type C. albicans biofilms. This demonstrated that filamentation 
is required for normal biofilm development (Ramage et al., 2002c).
1.4.1.4 Candida species involved
Studies on different Candida spp. have shown that biofilm growth varied between 
species.  An  in  vitro  study  on  biofilm  formation  of  different  Candida  spp. 
demonstrated that biofilm formation by C. parapsilosis,  C. pseudotropicalis and C.
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glabrata produced significantly less biofilm compared to C.  albicans (Hawser and 
Douglas,  1994). Recently, another study by Kuhn and co-workers, confirmed these 
findings  in that  C.  albicans produced more  biofilm  than biofilms  produced by  C. 
parapsilosis,  C. glabrata and C.  tropicalis and additionally C.  albicans was able to 
form a more complex biofilm than C. parapsilosis biofilms, which were composed 
of only clumped blastospores (Kuhn et al., 2002a).
1.4.2 Resistance of Candida albicans biofilms
As  observed  in bacterial  biofilms,  Candida biofilms  are  known  to  be  resistant to 
antifungal agents (Hawser and Douglas,  1995). The mechanisms by which Candida 
biofilms resist the action of antifungal agents are not known.  Wroblewska and co­
worker concluded that frequent use of triazoles in prophylaxis of fungal infections, 
especially in immunocompromised patients, may be responsible  for the  increasing 
rate of C. albicans biofilm resistance (Wroblewska et al., 2002).
Because  the  structure  of C.  albicans  biofilm  varies  in  response  to  environmental 
conditions,  it  is  thought  that  the  mechanism  of drug  resistance  of these  biofilms 
could also vary (Kumamoto, 2002). The possible mechanisms for bacterial biofilm 
resistance (refer to section  1.3.5) may also play a role in the increased resistance of 
Candida  biofilm  to  antifungal  agents.  In  this  section,  the  resistance  related  to 
Candida biofilms is discussed.
1.4.2.1  Delayed penetration of the antimicrobial agents
Developing  C.  albicans  biofilm  are  associated  with  the  presence  of extracellular 
material  (Chandra  et  al.,  2001a),  which  could  act  as  a  physical  barrier  against 
antibiotics and contribute to drug resistance as in bacterial biofilms (Gilbert et al.,
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1997).  However,  it is unclear whether C.  albicans biofilm resistance is due to the 
production  of extracellular  material  or  due  to  genetic  biochemical  alterations  in 
fungal cells.
Most studies  of bacterial biofilm matrix indicates that the matrix does not form a 
major barrier to drug diffusion, although for certain compounds penetration can be 
delayed (Mah and O’Toole, 2001). To assess the possible role of the matrix material 
in the resistance of C.  albicans biofilms to antifungal agents, susceptibility profiles 
of C.  albicans biofilms incubated statically (i.e.  containing relatively little matrix) 
were  compared  with  those  biofilms  incubated  in  gentle  shaking  (which  produced 
more matrix material). Both biofilms grown with or without shaking did not exhibit 
significant differences in susceptibility to any of drug tested. These results indicate 
that the matrix does not constitute a significant barrier to antifungal drugs, and thus 
extensive  matrix  production  may  not  enhance  biofilm  resistance  (Baillie  and 
Douglas,  2000).  However,  other  studies  with  biofilms  produced  under  flow 
conditions showed that re-suspended cells (which had lost most of their matrix) were 
20  %  less  resistance  to  amphotericin  B  than  intact  biofilms  suggesting  that  the 
biofilm  matrix  might  play  a  minor  role  in  excluding  antifungal  agents  from  the 
biofilm (Baillie and Douglas,  1998a; Baillie and Douglas,  1998b). Ramage and co­
workers  also  demonstrated  that  intact  biofilms  were  not  affected  by  high 
concentration of fluconazole.  Additionally,  sessile  cells  (1  h  adherence)  can resist 
fluconazole at the  same concentrations as of intact biofilms,  indicating that sessile 
resistance was not entirely related to biofilm ultrastructure and matrix material. They 
also  showed that re-suspended biofilm  cells were  resistance to  fluconazole (MICs 
increased 64 -  1000 times compared to planktonic cells), but were up to 8 times less 
resistance  to  fluconazole  than  intact  biofilms.  This  suggests  that  the  matrix  may
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contribute to overall resistance, but is not considered as a sole determinant of biofilm 
resistance (Ramage et al., 2002a).
1.4.2.2 Altered growth rate of biofilm organisms
Biofilms  cells  are  thought  to  grow  slowly  because  of the  limited  availability  of 
nutrients particularly at the base  of the biofilm.  This  is  frequently associated with 
changes in composition of the cell surface which may in turn affect the susceptibility 
of biofilms to antimicrobial agents (Douglas, 2003). To investigate this possibility, 
Baillie  and Douglas  have  examined the  importance  of growth rate  of C.  albicans 
biofilms on antifungal resistance. They used a perfused biofilm fermentor to generate 
C.  albicans biofilms  at  different  growth rates.  The  susceptibility  of these  biofilm 
cells  was  compared  with  planktotic  organisms  grown  at  the  same  rates  in  a 
chemostatat.  They  found  that  biofilms  were  resistance  to  amphotericin  B  at  all 
growth rates  tested,  whereas planktonic  cells were  resistant  only  at a low growth 
rates (Baillie and Douglas,  1998a). A separate study (Baillie and Douglas,  1998b), 
using a cylindrical cellulose filter, have demonstrated that at the  same low growth 
rate,  glucose-limited  and  iron-limited  biofilms  were  equally  resistance  to 
amphotericin  B.  These  results  suggest  that  growth  rate  does  not  have  a  major 
influence on the susceptibilities of a biofilm to the drug.
1.4.2.3 Efflux pumps
The role of efflux pumps in the drug resistance of mature C.  albicans biofilm has 
been studied previously.  Ramage  and  co-workers  investigated the  effect of efflux 
pumps  in  relation  to  resistance  of  C.  albicans  biofilm  to  fluconazole  and 
demonstrated that the expression of genes encoding efflux pumps were up-regulated
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during biofilm formation, suggesting a possible role in biofilm resistance. However, 
the mutant strains deficient in transporters  for efflux pumps were also resistant to 
high concentrations of fluconazole when grown as a biofilm, but hypersusceptable to 
fluconazole in planktonic (Ramage et al., 2002a).
1.4.2.4  Unique biofilm physiology
Since drug resistance of Candida biofilms can not be solely attributed to a matrix 
barrier effect or to a low growth rate, it seems that the biofilm mode of growth on a 
surface in which a contact induced gene expression occurs may be the mechanism by 
which drug resistance is acquired (Baillie and Douglas, 2000). A study by Bailey and 
co-workers  investigated  the  key  events  which  occur  following  adherence  of  C. 
albicans to human buccal epithelial cells. They found that following the adherence 
of C. albicans to epithelial cells, synthesis of new specific proteins took place by C. 
albicans indicating possible signalling events (Bailey et al.,  1995). This observation 
may  explain  the  events  that  involve  C.  albicans-host  interactions.  Hence,  drug 
resistant may  arise  because  of the  expression  of specific,  surface-induced  contact 
genes (Kumamoto, 2002).
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1.5  DENTURE RELATED STOMATITIS
1.5.1 Clinical features
Denture related stomatitis or chronic atrophic candidosis is the commonest clinical 
form of oral candidosis associated with denture wearers, orthodontic appliances and 
obturators  for cleft palate (Webb et al,  1998b).  The prevalence  of DRS  has  been 
reported  to  vary  from  11-67  %  in  complete  denture  wearers  as  reviewed  by 
Arendorf and Walker (1987) and a more recent study showed the prevalence of DRS 
in the denture wearing group was 26.8 % (Fenlon et al,  1998).  The reason of this 
large  reported  variation  is  probably  multifactorial  including  the  choice  of study 
population, the diagnostic criteria and the date of the study (Radford et al.,  1999). 
Denture  related  stomatitis  typically  affects  the  palatal  mucosa  beneath  the  fitting 
surface of partial  or complete dentures while the lower mucosa beneath the  lower 
denture is seldom affected (Wilson, 1998; Bagg et al.,  1999a). The condition is more 
common  in  females  than  males  (Davenport,  1970;  Pires  et al.,  2002)  and  can be 
accompanied  with  other  forms  of candidosis  particularly  angular  chelitis,  median 
rhomboid glossitis and chronic hyperplastic candidosis (Webb et al.,  1998b). DRS is 
usually  asymptomatic,  although  patients  may  complain  of mucosal  bleeding  and 
swelling,  burning  sensation,  halitosis,  taste  changes  and  dryness  of  the  mouth 
(Arendorf and Walker, 1987).
1.5.2 Classification
The  condition  can  be  classified  according  to  Newton  classification  based  on  the 
clinical appearance of the inflammed mucosa under the maxillary complete denture 
(Newton,  1962). Type I is localized simple inflammation or a pin-point hyperaemia. 
Type  II  is  the  most  common  type  and  is  characterised  by  erythematous  or
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generalized inflammation presenting as more diffuse erythema or oedema involving 
a part of, or the entire, denture-covering area of the palatal mucosa. Finally, Type III 
is a granular type (inflammatory papillary hyperplasia) hyperplastic reaction result in 
nodular lesion that commonly involving the central part of the hard palate and the 
alveolar  ridge.  All  three  types  may  be  found  simultaneously  and  in  varying 
combinations.  It was thought that the papillary type  of the  condition is  due to the 
presence of the prostheses, however, a similar condition has been reported in patients 
with HIV infections (Reichart et al., 1994), suggesting that the presence of a denture 
is not the prime aetiological factor for this condition (Ellepola and Samaranayake, 
2000a). Although the Newton classification is well reported, its exact role in aiding 
the  treatment  of DRS  is  questionable,  as  it  does  not  provide  useful  information 
regarding the aetiology and hence the management of DRS.
1.5.3  Causes
Denture  related  stomatitis  is  now  assumed  to  be  multifactorial  (Wilson,  1998; 
Ramage  et  al.,  2004).  The  condition  is  principally  due  to  a  microbial  infection 
caused by poor oral and denture hygiene (Budtz-Jorgensen et al.,  1996; Sakki et al., 
1997; Pires et al., 2002) and continuous wearing of denture while sleep (Aguirre et 
al., 1996; Jeganathan et al., 1997; Barbeau et al., 2003).
Rarely,  a  range  of other predisposing  factors  may  cause  the  condition  including; 
depressed  host  defences  such  as  HIV  disease  (Reichart  et  al.,  1994),  diabetes 
mellitus  (Dorocka-Bobkowska  et  al.,  1996),  smoking  (Cumming  et  al.,  1990; 
Barbeau et al., 2003), neoplastic diseases, chemotherapy, radiotherapy (Dorko et al., 
2001) and frequent use of antibiotics or corticosteroids (Budtz-Jorgensen, 1990).
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The  majority  of patients  with DRS,  however,  do  not have  any  systemic  diseases 
likely  to  predispose  to  such  condition.  In  addition,  some  of  the  suggested 
associations  are  disputed,  for  example,  while  diabetes  mellitus  is  suggested  to 
predispose to DRS, some of these patients are known to carry some oral Candida, 
but do  not have  features  of DRS.  Hence,  the  amount  of oral  yeast may  be  more 
strongly  influenced  by  local  oral  factors,  such  as  the  presence  of dentures,  than 
systemic aspects of diabetes mellitus (Manffedi et al., 2002). Thus local factors are 
much more  likely to predispose to DRS  such as denture trauma caused by an ill- 
fitting denture, incorrect jaw relationships or occlusal errors (Budtz-Jorgensen, 1990) 
or wearing  a  denture  during  sleep  (Aguirre  et al.,  1996;  Jeganathan  et al.,  1997; 
Barbeau et al., 2003).
1.5.3.1  Denture plaque and denture related stomatitis
The microbial plaque that forms on the fitting surface of the denture (denture plaque) 
is of great importance.  It is a dense microbial layer comprising of microorganisms 
and their metabolites, containing more than  101 1  organisms per gram in wet weight 
(Nikawa  et  al.,  1998a).  Denture  plaque  forms  on  the  denture  of  both  healthy 
individuals and patients with DRS (Barbeau et al., 2003). It is more evident on the 
denture fitting surfaces than on other denture surfaces (Keng and Lim, 1996). 
Microbiological  studies  have  shown  that  the  composition  of  microbial  flora  of 
denture  plaque  in  DRS  is  similar  to  that  of  dental  plaque,  but  with  a  greater 
proportion of Candida species (Theilade et al., 1983; Budtz-Jorgensen and Theilade, 
1983). The microenvironment present underneath the denture favours the formation 
of denture plaque which is formed in the space between the mucosa and the fitting 
surface of the denture. This protected environment allows the formation of a plaque
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which is very different from,  for example,  supra-gingival plaque both in terms  of 
structure  and  microbial  composition.  Factors  which  influence  the  compositional 
structure  include  low  shear  forces  and  the  creation  of  different  environmental 
gradients  through  the  denture  plaque  which  harbours  more  obligatory  anaerobic 
bacteria. Hence, in the relatively stagnant area on the denture fitting surface, plaque 
tends to be more acidogenic (favouring streptococci) and Candida species (Verran, 
1988).
Radford and Radford have investigated the structure of denture plaque using SEM 
and revealed that denture plaque mainly consists of cocoid and rod-shaped bacteria 
with  a  few  yeast  cells  (Radford  and  Radford,  1993).  Recently,  Ramage  and  co­
workers  (2004)  have  examined  two  denture  samples  retrieved  from  patients  with 
DRS  using  SEM.  These  samples  revealed  the  presence  of  Candida  biofilms 
consisting of an intricate network of yeast cells and hyphae (Ramage et al., 2004). 
Studies  have  indicated that  C.  albicans is more  likely to be present  on the fitting 
surface of upper dentures than the palatal mucosa in patients with DRS (Davenport, 
1970). The presence of close denture contact upon the oral mucosa alters the local 
environmental conditions as the cleansing action of the tongue on the palate is absent 
and the salivary flow containing antimicrobial factors is prevented from contacting 
the microorganisms (McIntyre, 2001). Additionally, the denture acts as a reservoir of 
a mixed-species biofilm and creates an acidic and anaerobic environment (Muzyka 
and  Glick,  1995;  Budtz-Jorgensen  et  al.,  1996).  It  has  been  suggested  that  this 
unique  microenvironment  provided  by  the  denture  may  promote  C.  albicans 
proliferation  and  facilitate  the  disease  progression without the  need  for any other 
predisposing factors (Konsberg and Axell, 1994; Maver-Biscanin et al., 2004).
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1.5.4  Association of Candida albicans with DRS
Candida albicans has been widely associated with the aetiology of DRS (Arendorf 
and Walker,  1979). It is generally considered that C. albicans is the causative agent 
of this condition and it is the most frequently isolated species in such patients (75 —  
92 %) (Martin-Mazuelos et al., 1997; McMullan-Vogel et al., 1999). However, it has 
been suggested that a combination of C. albicans and other microorganisms is more 
likely to be responsible for DRS (Kulak et al., 1997). For example, several genera of 
bacteria  have  been  isolated  from  DRS  patients  including  (e.g.  Streptococcus, 
Veillonella,  Lactobacillus,  Prevotella  and  Actinomyces  spp.)  (Koopmans  et  al., 
1988).  Additionally,  some  other non-albicans  Candida  spp.  have  been  identified 
including; C. tropicalis, C. glabrata, C. parapsilosis, C. krusei,  C. guilliermondii, C. 
kefyr,  C.  lusitaniae,  C. freyschusii,  C.  zeylanoides  and  Saccharomyces  cerevisiae 
(McMullan-Vogel et al., 1999; Dorko et al., 2001).
The attachment of C.  albicans to oral surfaces is a critical event in the colonisation 
of the oral cavity and in the development of oral diseases. Adhesion of C. albicans to 
the  fitting  surface  of the  denture is an important step  in the pathogenesis of DRS 
(Budtz-Jorgensen and Lombardi,  1996). The secreted acid proteinase is likely to be 
involved in the pathogenesis of this condition,  however,  because  of the decreased 
salivary flow and low pH under the denture, the secretion of the acid proteinase may 
not be required (McMullan-Vogel et al.,  1999). It has been shown that the presence 
of yeasts on the denture is associated with the extent of inflammation (Barbeau et al., 
2003). Budtz-Jorgensen and co-workers showed a significant correlation between the 
high  density  of yeasts  in  7  day  old  denture  plaque  in  patients  with  DRS  and  a 
positive  clinical  response to  antifungal  treatment  indicating that  yeasts  of denture 
plaque may play an important role as a pathogen in DRS  (Budtz-Jorgensen et al.,
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1983).
Aguirre and co-workers have investigated the cytological changes of the oral mucosa 
in patients  with DRS.  They found that the  smears  from  DRS  patients presented a 
higher amount of cytological cellular material,  fungal cells and inflammatory cells 
compared to the control group (Aguirre et al., 1996).
1.5.5 Diagnosis
Diagnosis of DRS can usually be established from a clinical examination alone. The 
erythema and oedema of the denture bearing areas is confined to the area covered by 
the denture. White plaque (oral thrush) may sometimes also be associated (Wilson,
1998).  The  microbiological  demonstration  of  C.  albicans  on  the  denture  or 
underlying mucosa may also help to confirm the diagnosis (Barbeau et al., 2003), 
however, it must be appreciated that this organism will often also arise in the mouth 
of persons without DRS.
1.5.6 Treatment
Although  DRS  is  usually  asymptomatic  and  the  patient  usually  unaware  of the 
condition, there is a risk that with time papillary hyperplasia of the palatal mucosa 
will arise which may requires surgical treatment (Wilson, 1998). The management of 
DRS requires both removal of the source of candidal infection and the elimination of 
the infection from the oral tissues (McIntyre, 2001). The existing denture should be 
examined for any inaccuracies and any obvious  faults which need to be  corrected 
such as ill-fitting denture or vertical dimension of occlusion. Construction of a new 
denture may be required if the existing appliance  is  difficult to treat (Farah et al., 
2000). This should be considered after the resolution of DRS (Wilson, 1998).
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Because of the build-up of denture plaque which is considered as a primary factor in 
patients with DRS, there is a need to improve oral and denture hygiene (Keng and 
Lim,  1996; Kulak-Ozkan et al., 2002) and when relevant, advise the patient not to 
wear  the  denture  while  a  sleep  (Farah  et  al.,  2000).  Regular  denture  hygiene 
instruction and patient motivation are fundamental to maintain adequate oral hygiene 
and  to  improve  DRS  (Pires  et  al.,  2002).  The  dentures  have  to  be  soaked  in 
disinfecting  agent  such  as  0.2  %  chlorhexidine  overnight  (Budtz-Jorgensen  and 
Lombardi, 1996; Farah et al, 2000). Lai and co-workers have investigated the use of 
chlorhexidine gluconate as a mouth rinse and as a denture soak for the treatment of 
DRS  for 24 days.  The  mouth rinse (0.12%) was used twice  daily  and the denture 
soaked overnight. They found that chlorhexidine completely eliminated C. albicans 
on  the  acrylic  denture  surface  and  significantly  reduced  palatal  inflammation. 
However, after termination of treatment, C. albicans recolonised the denture surface 
and palatal inflammation recurred.  They suggested that continued daily used of an 
effective  over-the-counter  antifungal  denture  soak  and  mouth  rinses  would  be 
desirable  and  that  treatment  of  the  DRS  should  include  antimicrobial  topical 
application to both denture and mucosa (Lai et al.,  1992). Barasch and co-workers 
have also used chlorhexidine as a mouth rinses (0.12 %) for HIV-infected children 
who have oral candidosis. They suggested that topical chlorhexidine rinses can treat 
and  prevent  oral  fungal  disease  produced  by  C.  albicans  (Barasch  et  al.,  2004). 
Chlorhexidine gluconate at 0.2 % concentration can also be used as a mouth rinse 
and  a  2  %  suspension  is  used  as  an  overnight  denture  disinfectant  (Ellepola and 
Samaranayake, 2000b). Additionally, beside chemical denture cleansing, mechanical 
plaque  control  of the  denture  fitting  surface  such  as  denture  brushing  should  be 
accompanied (Jeganathan et al., 1997).
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Topical  treatment  with  antifungal  agents  such  as  nystatin,  amphotericin  B, 
miconazole, and ketoconazole has produced a significant reduction of inflammation 
and oral symptoms of DRS (Budtz-Jorgensen, 1990). DRS is most commonly treated 
with polyene antifungal agents such as nystatin which is applied as a thin layer of 
cream to the fitting surface of the denture and simultaneously to the denture bearing 
mucosa (Sherman et al.,  2002;  Diaz-Amold  and  Marek,  2002).  Topical  treatment 
with  nystatin  or  amphotericin  B  suspensions  or  lozenges  are  also  useful  in 
eliminating  the  yeast  from  the  mucosal  surfaces.  The  patient  should  remove  the 
denture while undertaking the treatment and dissolve  antifungal tablets four times 
daily (Farah et al., 2000; Sherman et al., 2002). Epstein and co-workers have showed 
that treatment of oral candidosis with topical nystatin (mouth rinse) four times daily 
for two weeks resulted in a significant reduction in the number of Candida in saliva 
with a marked improvement in the disease. However, the condition recurred rapidly 
after cessation of treatment (Epstein et al., 1981). Egusa and co-workers showed that 
the in vitro exposure of denture acrylic to sub-theraputic concentrations of polyenes 
(nystatin and amphotericin B) can suppress the adhesion of Candida species (Egusa 
et al., 2000).
A  number  of studies  have  been  carried  out to  test  the  efficacy  of denture  lining 
materials  that  contain  antifungal  agents  for  the  treatment  of DRS  (Douglas  and 
Walker,  1973; Thomas and Nutt,  1978). Thomas and Nutt have showed that when 
tissue  conditioner  (Visco-gel)  was  combined  with  nystatin  powder,  a  successful 
inhibition of the  growth of C.  albicans,  C.  krusei and C.  tropicalis was observed. 
However,  there  was  a  lack  of  inhibition  with  Visco-gel  alone  or  a  Visco­
gel/amphotericin B combination (Thomas and Nutt, 1978).
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The use of fluconazole as a mouth rinse was also investigated and shown to be useful 
in the management of patients with oral candidiasis (Epstein et al., 2002). Another 
option for treatment of DRS  is to use a ketoconazole  lozenges  or miconazole  gel 
applied  to  the  denture  fitting  surface  while  the  denture  is  being  worn.  The 
inflammation  is  usually  cleared within  7-14  days  (Farah  et al.,  2000)  with the 
associated angular cheilitis if present (Budtz-Jorgensen and Lombardi, 1996).
A sustained drug-delivery device releasing miconazole can also be used to treat some 
cases of DRS which had previously resisted antifungal therapy (Lamb and Douglas, 
1988).  Miconazole  has  shown  to  be  effective  in  the  treatment  of DRS  with  an 
observed  reduction  of  yeast  scores  and  palatal  erythema.  The  agent  can  be 
formulated into  a lacquer and applied to the  denture  fitting  surface  after thorough 
cleansing and drying the denture (Konsberg and Axell,  1994; Budtz-Jorgensen and 
Carlino, 1994; Ellepola and Samaranayake, 2000b).
Topical treatment is often safe, satisfactory and less expensive (Farah et al., 2000), 
however,  if all these measures failed to resolve  the  condition,  systemic  antifungal 
therapy can be prescribed (Webb et al., 1998c). This treatment can be considered for 
immunocompromised  patients  and  with  those  with  poor  compliance  (McIntyre, 
2001)  or  when  candidal  infection  respond  poorly  to  topical  antifungal  agents 
(Sherman et al., 2002).
Oral  administration  of fluconazole  in  patients  with  DRS  produced  a  pronounced 
reduction of yeasts in the oral cavity with decreased inflammation (Budtz-Jorgensen 
et al., 1988), however, a high rate of clinical relapse and recurrence after therapy was 
reported (Budtz-Jorgensen et al., 1988; Bissell et al., 1993).
Itraconazole in the form of solution or capsules have also shown to be effective in 
the treatment of DRS (Cross et al., 2000). However, there may be a strain persistence
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and subsequent recolonization of the oral cavity by other less sensitive Candida spp. 
(Cross  et  al.,  2004).  Cross  and  co-workers  have  compared  the  effect  of  two 
antifungal agents (fluconazole and itraconazole) for the treatment of DRS and found 
that  both  drugs  reduce  palatal  inflammation  in  patients  with  DRS  (Cross  et  al., 
1998).
The most important therapeutic measure in the prevention of DRS is to instruct the 
patient in efficient oral  and denture hygiene measures.  This may include methods 
such as mechanical cleansing of the denture and daily use of denture soaking agents. 
These  measures  are  critical  for  the  elimination  of  infection  and  in  preventing 
recurrence’
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1.6 AIM OF THE RESEARCH
Many studies have been carried out on bacterial biofilms and their association with 
oral diseases. However, in comparison, little work has been focused on oral fungal 
biofilms.  Better  understanding  of the  process  of biofilm  formation  may  impact 
clinical  decision-making  and  provide  a  clear  picture  of  the  limitations  of 
conventional therapies for the treatment of fungal infections. The aim of this project 
was  to  develop  an  in  vitro  model, previously  used  to  grow  bacterial  biofilms,  to 
investigate  biofilm  development,  structure  and  effectiveness  of  antifungal  and 
antimicrobial  agents.  Furthermore,  to  study  mixed  fungal  and  bacterial  biofilms 
which are associated with denture related stomatitis.
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2.1 PREPARATION OF SUBSTRATA
2.1.1 Denture acrylic
Acrylic resin was employed as a biofilm substratum for the growth of C. albicans in 
several sections of the study. Both self and heat-cured polymethylmethacrylate were 
used  (Dentsply  Limited,  Weybridge,  Swindon,  U.K.).  Cylinders  of the  materials, 
with  a  diameter  of  5  mm,  suitable  in  size  to  be  placed  into  the 
polytetrafluoroethylene (PTFE) pans of the fermentor, were constructed as described 
below.
For  heat-cured  acrylic  disks,  a  filling  wax  replica  of each  cylinder  was  initially 
constructed  (Kemdent  Associated Dental Products  Ltd,  Swindon,  U.K.).  The  wax 
replica was then embedded in plaster and stone and boiled out. The acrylic polymer 
and monomer were mixed using the manufacture’s instructions. The plaster was then 
coated with sodium  alginate as a separator and the resultant space was filled with 
heat-cured acrylic, which was then polymerized by heating in a water bath for 7 h at 
70 °C and a further 3 h at 100 °C before slowly cooling to minimize the stress within 
the  acrylic.  The  heat-cured  acrylic  cylinders  were  then  sectioned  using  a  lathe 
(Boxford AUD, Halifax, U.K.) to a final depth of 1  mm.
The  self-cured  acrylic  (Dentsply)  was  prepared  according  to  manufacturer’s 
instructions  and  placed  directly into the  PTFE  moulds  to  achieve  disks  of 5  mm 
diameter and 1  mm depth. Acrylic was mixed and applied to the CDFF pan mould in 
a semi-liquid phase to facilitate loading.  To decrease free monomer, the curing of 
self-cured  acrylic  was  carried  out  under  pressure  using  a  hydro-flask  (DB 
Orthodontics  Ltd,  Skipton,  U.K.)  to  decrease  porosity  and  to  complete  the  curing 
cycle.  Additionally,  the  disks  were  stored  in  water to  leach  out  excess  monomer 
present.
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To facilitate polishing the acrylic disks were fitted onto the plugs in such a manner 
as  the  top  of the  disks  exceeded  the  height  of the  CDFF  pans.  The  pans  were 
subsequently inverted and prepared to a specific  surface roughness using different 
grades of silicon carbide grit on a Knuth Rotor (Struers Limited,  Glasgow, U.K.). 
This was achieved by manual grinding of the surface with water used as a lubricant. 
The cutting  was  in one direction with  constant pressure  applied.  The papers used 
were grit numbers of 1000, 500 and 80 corresponding to particle sizes of 16 - 20 pm, 
28 - 33  pm and  180 - 230 pm respectively. The polishing of the materials did not 
significantly affect the thickness of the disk.
2.1.2  Enamel and dentine
Disks of enamel and dentine of appropriate size for insertion into PTFE pans of the 
fermentor  were  prepared.  Extracted  permanent  teeth  were  stored  in  37  % 
formaldehyde  (Sigma,  Poole,  U.K.) before being  sterilized by autoclaving  (121 °C 
for 60 minutes).  The teeth were then washed with distilled water before handling. 
The  enamel  or  dentine  surfaces  of the  teeth  were  then  prepared  to  the  same 
roughness using silicon carbide grit number 1000 as described for acrylic disks (the 
Ra value of the materials was confirmed as 2.5 pm, however this was not confirmed 
by SEM). The teeth were then cut into 5 mm diameter cylinders using a trepanning 
tool  on  a  Metal  Worker  Lathe/Drill  (Clarke  International,  London,  U.K.)  before 
being  sectioned  using  a Rotary Diamond  Saw  (Testboume  Limited,  Basingstoke, 
U.K.).
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2.2  ORGANISMS USED IN THE STUDY
2.2.1 Ethical approval
Ethical  approval  for  the  study  was  granted  by  the  joint  University  College  of 
London/University  College  London  Hospitals  Trust  Committee  on  the  ethics  of 
Human  Research.  The  purpose  and  nature  of the  project  was  explained  to  each 
participating patient. A written consent form was signed by each patient.
2.2.2 Clinical isolates of Candida albicans
Clinical samples were obtained from patients attending the Eastman Dental Hospital, 
University  College  London  Hospitals  (UCLH),  as  part  of a  separate  study  (Al- 
Karaawi  et  al.,  2002).  All  of the  patients  underwent  a  clinical  oral  examination. 
Mouth swills, using  10 ml of sterile distilled water were collected from each patient 
and 1  ml was cultured on Sabouraud Dextrose Agar (Oxoid Ltd, Basingstoke, U.K.) 
to assess the number of yeast cells present. All of the isolates were defined to species 
level  by  both  phenotypic  and  molecular  methods  (Al-Karaawi  et  al.,  2002).  Six 
strains of defined species of C. albicans were used for the present study, three strains 
with genotype A and three strains with genotype B.
2.2.3 Mixed-species clinical samples
After receiving an informed consent from each patient, samples were taken from 10 
individuals (mean age 70 years; 2 males and 8 females), attending the Oral Medicine 
and  Prosthetic  Dentistry  clinics  at  the  Eastman  Dental  Hospital,  UCLH.  All  10 
patients were wearing upper full or partially removable dentures, 5 had clinical signs 
of DRS  (refer to  section  1.5) and showed Type  1   Newton classification while the 
remaining 5 had no clinical signs of the disease. None of the patients had a history of
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systemic disease  likely to predispose to oral  candidosis and none were taking any 
systemic  or  local  radiation  or  using  antimicrobial  agents  for  the  management  of 
DRS.
Two  samples  were  obtained  from  each  subject  using  a  calcium  alginate  swab 
(Technical Service Consultants, Heywood, U.K.) on the mucosa beneath the denture 
and a separate swab was taken to sample the denture fitting surface. Each swab was 
then immediately placed into 4 ml Calgon-Ringer's solution (Oxoid) in a sterile bijou 
containing 5 sterile glass beads (Sigma, Poole, U.K.).
The  sample  was  immediately  vortex-mixed  for  one  minute  or  until  the  calcium 
alginate  swab had  dissolved.  Serial dilutions  of the  suspension was  carried out in 
PBS (Oxoid) were then prepared to a final dilution of 1   :  106. Stock samples of each 
specimen were then stored at -70 °C in 1   ml of LB Broth (Sigma) storage medium 
containing 50 % glycerol (BDH, Poole, U.K.) until required for use as an inoculum 
for the Constant Depth Film Fermentor (refer to section 2.4.2.2).
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2.3  NUTRIENT SOURCE
Artificial  saliva  as  developed  by  Russell  and  Coulter  (1975)  was  employed  as  a 
nutrient source in all experiments. The composition of the artificial  saliva is listed 
per one litre of distilled water and detailed in Table 2.1.
Table 2.1: Composition of artificial saliva.
Constituents Quantity (g/L 
dH20)
Supplier
‘Lab-lemco’ powder* 1 Oxoid
Yeast Extract* 2 Oxoid
Proteose Peptone* 5 Oxoid
Mucin  Type  III:  Partially  Purified  from 
Porcine Stomach
2.5 Sigma
Sodium chloride 0.35 Sigma
Calcium chloride 0.2 Sigma
Potassium chloride 0.2 Sigma
*Contains average  % w/w:  Total nitrogen:  11.63  %,  Amino nitrogen:  3.36 % and 
NaCl: 4.66 %.
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2.4  CONSTANT DEPTH FILM FERMENTOR
The Constant Depth Film Fermentor (CDFF; Figure 2.1) used throughout this study 
was a modified version of the fermentor described by Peters and Wimpenny (1988) 
and engineered by John Parry-Jones Engineering (Cardiff, U.K.).
Figure 2.1: The Constant Depth Film Fermentor.
2.4.1  Assembly of CDFF
The CDFF consists of a stainless steel turntable which holds fifteen PTFE pans flush 
around its rim (Figure 2.2). Each pan is inserted and held flush with the turntable by 
silicone  rubber  ‘O’  rings.  Each  of the  pans  contains  a  central  threaded  hole  into 
which a tool is inserted for removal and replacement and 5 -6  cylindrical holes, 5
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mm  in  diameter,  which  contain PTFE plugs.  Biofilms  can be  grown  either on the 
PTFE  plugs  or  on  disks  of various  materials  (e.g.  acrylic,  enamel  and  dentine) 
supported by these plugs. The disks sit on the PTFE plugs of the same diameter and 
can be accurately recessed using a template 300  pm. The removal of each film pan 
produces 5 biofilm samples which allows for different investigations to be performed 
and statistical variations to be determined.
The turntable is attached to a vertical central spindle running through the base plate via 
an autoclavable bearing assembly. The base plate is supported by three stainless steel 
legs to accommodate the detachable gearbox motor (RS, Corby, U.K.). The gearbox is 
driven by a 15 V power supply (Famell, Leeds, U.K.) housed in the support in which 
the fermentor sits. The steel disk, rotating at 3 revolutions per minute (r.p.m.), passes 
beneath two angled PTFE scraper blades which are forced onto the  surface of the 
steel disk by pressure exerted from loaded springs (Figure 2.3). A borosilicate glass 
section, sealed to the top and bottom plates by PTFE seals and high vacuum silicon 
grease (Dow Coming,  Wiesbaden, U.S.A.),  surrounds and completely encloses the 
turntable and scraper blades assembly. The top plate is fitted with a number of inlets 
for medium and supplements as well as a sample port and air inlet. The air inlet has 
two Whatman Hepa-vent air filters (0.2 pm) (Arbor Technologies, Ann Arbor, MI, 
U.S.A.) attached. The bottom plate contains a medium outlet port.
As with all fermentation work, there is a large amount of tubing required to supply 
nutrient  medium  and  other  liquids  to  and  from  the  fermentor.  Silicone  tubing 
(Versilic, Chamy, France) was used for the CDFF for several reasons: it is flexible, 
durable,  non-toxic,  autoclavable  and  can  be  visually  inspected  for  contamination. 
Separate silicone pump tubing (Watson-Marlow Ltd., Falmouth, U.K.) was required 
for  use  with  the  peristaltic  pumps  and,  where  required,  quick-disconnect  fittings
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(Nalgene,  Hereford,  U.K.)  were  used.  The  CDFF  was  sterilised  by  autoclaving 
(steam under pressure) at 121 °C for 15 minutes.
position of  main 
medium inlet
FITE pan
FITE pan 
plug
FTFE angled scraper blade
position of silicone 
rubber ring
QVF glass cylinder
direction of disc revolution stainless steel disc
Figure 2.2: Schematic horizontal section through the fermentor.
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scraper blade
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disk of material
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turntable
nr
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drive shaft
effluent
Figure 2.3:  Schematic vertical section through the fermentor with insert indicating 
one of the pans in greater detail.
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2.4.2  Inoculation of the CDFF and continuous media supply
2.4.2.1 Single-species
A  10 ml overnight culture of Candida albicans in artificial saliva was added to 500 
ml of sterile artificial saliva, mixed and then pumped into the CDFF for 8 h (Figure 
2.4). The inoculum was continuously mixed by using a magnetic stirrer. After this 
time, the inoculum flask was disconnected and the  CDFF was fed from  a medium 
reservoir of sterile  artificial  saliva, the waste  being  collected  in an effluent bottle 
(Figure 2.5). The artificial saliva was delivered at a rate of 0.72 liter/day, the mean 
salivary flow rate in humans (Guyton, 1992).
2.4.2.2 Mixed-species
200 pi from each DRS patient sample, (refer to section 2.2.3) (5 mucosa samples and 
5 denture samples) was pooled under aseptic conditions to provide an inoculum of 2 
ml. This was added to 500 ml of artificial saliva (Figure 2.4 and 2.5), and pumped 
into  the  CDFF  inoculated  for  8  h  before  being  attached  to  the  sterile  medium 
reservoir.
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CDFF
37 °C
air outlet
inocuhuu vessel
Figure 2.4: Schematic diagram indicating inoculation of the CDFF.
101Chapter 2__________     Materials and methods
grow back trap
CDFF
air outlet 
"\
air outlet
waste
medium
container
medium reservoir
Figure 2.5: Schematic diagram showing continuous media supply to the CDFF.
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2.4.3 Operating conditions
The CDFF was housed in a 37 °C incubator during all experiments and was operated 
aerobically.
2.4.4 Sample removal
At various time  intervals, the turntable of the  CDFF  was  stopped by reducing the 
voltage on the power supply to zero, allowing the PTFE pans to be removed from the 
sampling port.  In order to allow aseptic removal of the pans, the sample port area 
was first sterilized by flaming using a portable bunsen burner.  The PTFE pan was 
then removed  from  the  CDFF  and the  sampling  port  quickly  replaced.  The  disks 
were  removed  from  the  pans  using  pre-sterilised  forceps  and  placed  into  an 
appropriate vessel.
2.4.5 Analytical procedures
All  of the  experiments  were  carried  out  in  duplicate  and  statistical  analysis  was 
performed  using  the  student’s  t-test  (two-sample  assuming  equal  variances)  to 
determine p-values.
2.4.5.1  Single species
For  the  single-species  biofilms  CFU  per  biofilm,  hyphae  and  yeast  counts  were 
determined. Pans were removed from the CDFF at various time intervals and 3 disks 
were aseptically removed and each placed into 1  ml PBS before being vortexed for 1  
minute  to  disrupt  the  biofilm,  and  a  serial  dilution  was  carried  on  and  used  to 
inoculate  a  SDA.  The number of yeast and hyphal  cells  were  determined using a 
haemocytometer (Hawksley, London,  U.K.).  Five  aliquots from  each  sample were
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counted under a light microscope with a 40 x long working distance objective (Leitz 
Wetzlar, Germany).
2.4.5.2  Mixed-species
Serial  dilutions  were  carried  out  and  plated  onto  a  range  of  non-selective  and 
selective agars  in order to ascertain the predominant bacterial  and candidal  genera 
present (Table 2.2). Preliminary identification (colony morphology and Gram stain) 
was made of all types of colonies on each medium in order to confirm the selectivity 
of the  media  for  the  required  genera/groups.  Colonies  isolated  from  the  selective 
agars were considered to be ‘genera-group’ organisms. Any bacteria that were not of 
the expected genera were excluded from these data.
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Table 2.2:  Various non-selective and selective  agars  used for culturing organisms 
during the study. *CFATA was prepared as detailed below (Table 2.3).
Media used Abbreviation Selectivity Supplier
Columbia Blood Agar CBA Non-Selective Oxoid
Fastidious Anaerobes 
Agar
FAA Non-Selective Bioconnections, 
Leeds, U.K.
Sabouraud’s Dextrose 
Agar
SDA Candida species Oxoid
Mitis Salivarius Agar MSA Streptococcus species Difco
Laboratories, 
Detroit, MI
Rogosa Agar RA Lactobacillus species Oxoid
Veillonella Agar VA Veillonella species Difco
Cadmium Fluoride 
Acriflavin Tellurite Agar*
CFATA Actinomyces species See Table 2.3
SDA and CBA were incubated aerobically at 37°C  for 24 h, while all other agars 
were incubated anaerobically for 48 -  72 h at 37°C.Chapter 2 Materials and methods
Table 2.3: Composition of CFATA (Zylber and Jordan, 1982).
Constituents Quantity per L 
in dH20
Supplier
Tryptone soya broth powder 30 g Oxoid
Agar technical powder 15 g Oxoid
Glucose 5g BDH
Horse blood 50 ml E and O Laboratories, 
Bonnybridge, U.K.
Cadmium sulphate 13 mg Sigma
Sodium fluoride 85 mg Sigma
Neutral acriflavin 1.2 mg Sigma
Potassium tellurite 2.5 mg Sigma
Basic fuschin 1.25 mg SigmaChapter 2 Materials and methods
2.5  SUSCEPTIBILITY TESTING
The  antifimgal  agents  used  in this  study were  fluconazole  (Pfizer Ltd,  Tadworth, 
U.K.)  and  miconazole  (Johnson  and  Johnson,  Beerse,  Belgium).  Additionally,  an 
antimicrobial agent, chlorhexidine digluconate (Sigma, Poole, U.K.), was also used.
2.5.1  Susceptibility testing for antifungal agents
Antifimgal susceptibility testing to determine the Minimum Inhibitory Concentration 
(MIC) of planktonic cells for fluconazole or miconazole against planktonic cells was 
employed using the National Committee for Clinical Laboratory Standards (NCCLS) 
M27-A  microdilution  method  (NCCLS  M27-A,  1997).  Alamar  blue  (Trek 
Diagnostic  Systems  Ltd,  East  Grinstead,  U.K.)  was  employed  for  accurate 
assessment of growth endpoints. The medium used for dilution was  10.4 gm RPMI 
1640  (Sigma-Aldritch,  Dorset,  U.K.) medium  buffered  with  34.35  gm  MOPS  (N- 
morpholino propanesulfonic acid, Sigma-Aldritch) in 1   L of distilled water to give a 
final  molarity  of 0.165  and  adjusted to pH  7.0  with NaOH  (BDH  Merck,  Poole, 
U.K.).
The antifimgal agents (fluconazole and miconazole) were diluted in RPMI to give a 
concentration ranging from 0.125 - 1024 pg/ml. These microdilutions were loaded in 
sterile disposable microtitration multiwell plates (Nunclon ™ A Delta, BDH Merck, 
U.K.) as described in NCCLS M27-A (1997).
Yeast  cells  were  then prepared  after 24  h  culture  on  SDA.  The  yeast  cells  were 
suspended  in  sterile  0.85  %  saline  and  the  mixture  was  adjusted  by 
spectrophotometer (at 530 nm wavelength) to give a final transmission between 0.08 
-   1.  The  yeast  cell  suspension  was  further  diluted  in  RPMI  to  give  a  final 
concentration 1  X 106 to 5 X 106 cells/ml. The cell suspension was then loaded to the
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multiwell  plates  that  contained  the  test  concentrations  of agents.  The  yeast  cell 
suspension was then incubated at 35°C and the results were observed at 24 and 48 h 
for the presence or absence of visible growth with the aid of a reading mirror and 
compared with the control well. Additionally, Alamar blue determined the endpoint 
when the colours change from blue to pink.
The antifungal susceptibility of biofilms were determined by placing a biofilm disks 
for 1, 24 and 48 h in a multi  well plate that contain different concentrations of the test 
agents  according  to  NCCLS  broth  microdilution  method  as  described  previously 
(Hawser and Douglas, 1995).
2.5.2  Susceptibility testing for antimicrobial agent
The same protocol of MIC determination was used for chlorhexidine. Chlorhexidine 
was  diluted  in  sterile  water (instead of RPMI)  with a concentration ranging  from 
0.000019 - 20 % which were also loaded in microtitration multiwell plates. The yeast 
cell suspension was then incubated in microtitre plates at 35 °C for 5 minutes. A 20 
pi sample from each well was then placed into SDA and incubated 37 °C for 24 h. 
The results were observed after 24 h for the presence or absence of visible growth 
compared with the control.
The antifungal susceptibility of biofilms were determined by placing a biofilm disks 
for 1, 5 and  15  minutes in a multiwell plate that contain different concentrations of 
chlorhexidine.
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2.6  SCANNING ELECTRON MICROSCOPY
Cylinders for electron microscopy were fixed in 3 % (v/v) gluteraldehyde buffered 
with  sodium  cacodylate  (0.1  M) at 4°C  overnight,  and then post-fixed in osmium 
tetroxide (1  % v/v) for 2 h before being dehydrated in a graded series of alcohols (20 
%, 50 %,  70  %,  90 % ethanol,  15 minutes each;  100 % ethanol, 3  x  10 minutes). 
They were placed in hexamethyldisilazane for 5 minutes, removed to filter paper and 
allowed to dry. The dried specimens were mounted onto aluminium stereoscan stubs 
with  either  conductive  carbon  cement  (Leit-C,  Neubauer,  Munster,  Germany)  or 
rapid  set Araldite  (Devcon Ltd,  Shannon,  Ireland).  The  dried, mounted  specimens 
were coated with a thin metallic layer of gold / palladium in a Polaron E5000 sputter 
coater (BioRad, Hercules, CA, U.S.A.) and viewed in a Cambridge Stereoscan 90B 
Electron Microscope (Cambridge Inst., Cambridge, U.K.) (Figure 2.6a-c).
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Figure 2.6: Scanning electron microscope photograph of the surface of self-cured 
acrylic disks polished to different surface roughness; a) Ra = 2.5 pm, b) Ra = 3.6 pm 
and c) Ra = 9.3 pm. Bar = 200 pm.
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2.7  CONFOCAL LASER SCANNING MICROSCOPY
Confocal microscopy uses focused laser light to illuminate a specimen and gather the 
emitted fluorescent light through a pin-hole aperture. This results in images with a 
very narrow focal plane that excludes most of the  light from  outside the plane of 
focus.  In  this  study,  CLSM  was  used  in  conjunction  with  fluorescent  dyes, 
LIVE/DEAD® Yeast Viability Kit (Molecular Probes, Oregon, U.S.A.).  It is a two 
component stain, component A: Fun-1™ Cell stain (10 mM solution in DMSO) and 
component B: Calcofluor™ White M2R Fluorescent brightener 28; Tinopal LPW (5 
mM in water). In the normal viewing of the stain images, the viable cells fluoresce 
green while the non-viable cells fluoresce red.
Single-species biofilm disks were placed into 10 ml of distilled water containing 2 pi 
of component A:  Fun-1™ Cell  stain. This  labels the  cell  walls of yeast and fungi 
regardless of the cell's metabolic state.
The  suspension of stained biofilm was incubated in the  dark to  allow the  stain to 
develop  for  15  minutes.  Scans  of the biofilms  were  taken using  a Leica  DMLFS 
fixed stage microscope with a Leica TCS SP confocal laser scan-head (Leica, Milton 
Keynes, U.K.).  The objectives used were an infinity corrected 20 X PL APO with 
numerical aperture 0.6 and 5 X PL FLUOTAR with numerical aperture 0.12. The dry 
lens was used so not to disturb the biofilm.  CLSM was used to obtain a series of 
optical sections through the depth of the biofilm.  The Leica confocal software was 
employed to produce maximum-intensity projections from the Z-series. Two to three 
biofilm images were taken according to the representative organisms. The resulting 
collections of confocal optical were saved on CD as TIF files.
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2.8  SURFACE CHARACTERISTICS
A Proscan  1000 scanning laser profilometer (Scantron Industrial Products Limited, 
Taunton,  U.K.)  was  used  to  measure  the  average  surface  roughness  (Ra)  of the 
different  surface  finish of the  substrata  (Figure  2.7).  Using  this  technique  the  Ra 
values for ten evenly distributed lines across the surface (5 in the X direction and 5 
in the Y direction) were obtained and the mean for these ten values were calculated. 
Measurements were carried out in triplicate and the average Ra was determined.
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Figure 2.7:  Proscan image showing roughness readings  as generated by  Scantron 
software.
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2.9  IDENTIFICATION OF CANDIDA SPECIES
Candida spp.  were defined to the species level by using several  different methods 
including,  CHROMagar  (M-Tech  Diagnostics  Ltd,  Warrington,  U.K.),  API® 
Candida kit (BioM’erieux, Basingstoke, U.K.) and ComMeal Agar (Oxoid).
2.9.1  CHROMagar
CHROMagar  is  a  differential  cultural  medium  that  allows  selective  isolation  of 
yeasts  and  additionally allows  identification to  species  level  for some  of Candida 
species.  It facilitates the detection and identification of yeasts from mixed cultures 
through colour of colonies.  It is a powdered medium which requires no additional 
supplements.  A  20  pi  sample  from  each  patient  was  used  to  inoculate  the 
CHROMagar  plates  which  were  incubated  for  48  h  at  37°C.  All  yeast  isolates 
observed  on  CHROMagar  were  identified  by  colony  colouring  according  to  the 
manufacturer’s instructions (Table 2.4).
Table 2.4: Identification of Candida spp. using the CHROMagar method.
Species Colony colour / Morphology
Candida albicans Green
Candida tropicalis Metallic blue/grey
Candida krusei Rose-pink fuzzy
Other spp. White to pink
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2.9.2  API® Candida Kit
This is a standardised kit system for the identification of yeasts in  18 -  24 h. The 
API  Candida  system  (bioMerieux,  Marcy-TEtoile,  France)  works  by  spontaneous 
colour change  during incubation.  The microorganisms were  first isolated on  SDA 
medium to ensure pure colonies. The ampule of API Nacl 0.85 % Medium (2 ml) 
was opened carefully and inoculated with one, or several, well isolated identical pure 
colonies using a swab until the solution became turbid. Immediately after preparation 
the yeast suspension was homogenized and used.  This  suspension was distributed 
into the tubes avoiding bubble formation.  Some of the tests needed to be covered 
with mineral oil (underlined test) immediately after inoculating the strip.  The strip 
was then incubated for 18 - 24 h at 37 °C in aerobic conditions. After this time, the 
results of the reaction were obtained (Figure 2.8) by referring to the reading table 
and recorded as + or -  on the result sheet. The reaction revealed spontaneous colour 
changes and the results obtained visually and coded as a numerical profile on the 
result sheet. The tests separated into groups of three and subsequently assigned. By 
adding together the numbers corresponding to positive reactions with each group, a 
4-digit numerical profile was obtained. The identification of Candida spp. was then 
obtained by using APILAB Plus V 3.3.3 software.
i f l g k   *
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Figure 2.8: API Candida kit strip showing the identification of Candida albicans.
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2.9.3  CornMeal agar
ComMeal  agar (Oxoid) was used to  study the  morphology of yeasts.  Colonies  of 
Candida spp. were streaked out from a pure colony and a microscope slide coverslip 
placed  on  to  the  top  of the  streaked  culture.  The  agar  with  the  top  slide  was
o
incubated for 24 -  48 h at 25 -  28 C. The agar plate was then placed directly onto the 
microscope stage and viewed using x 40 long working distance objective (Olympus 
microscope, Southall, U.K.).
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3.1  INTRODUCTION
Candida albicans is the most common fungal pathogen isolated from the human oral 
cavity.  One  of the most important virulence factors of this  species  is  its ability to 
adhere to a surface. Adherence is considered as a first step of the infection process 
by  Candida  spp.  (Haynes,  2001)  and  a  prerequisite  for  initial  colonisation.  This 
adherence mechanism, exhibited by C. albicans, contributes to the persistence of this 
pathogen within the host and enables it to colonise many oral niches (Cannon et al., 
1995).
Changes on the surface of the Candida albicans may be brought about by yeast/host 
interactions. For example, adherence of C. albicans to human buccal epithelial cells 
induces the synthesis of new proteins and the expression of signal proteins (Bailey et 
al.,  1995).  Additionally,  Tronchin  and  co-workers  demonstrated  specific  proteins 
that are involved in the process of germ tube adherence (Tronchin et al., 1988).
The mouth provides a large number of diverse surfaces onto which C.  albicans can 
adhere. Examples include soft shedding surfaces of the buccal mucosa and hard non­
shedding  surfaces  such  as  teeth  and  oral  prostheses.  These  surfaces  are  rapidly 
bathed in saliva and adsorb salivary proteins. This acquired pellicle of proteins may 
promote or inhibit binding and yeast growth, however, clean enamel has been shown 
to reduce attachment of C. albicans (Cannon et al., 1995).
The availability of a well-characterised, reproducible  laboratory model  is essential 
for  understanding  the  nature  of  C.  albicans  biofilms,  and  facilitates  in  vitro 
performing studies related to biofilm formation, structure and antifungal properties. 
Several artificial biofilm systems have been developed to grow C.  albicans.  These 
are generally adhesion assays where the organisms are allowed to adhere to various 
materials such as catheters (Hawser and Douglas,  1994), acrylic (Samaranayake and
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MacFarlane, 1980), denture soft lining materials (Nikawa et al., 1993; Radford et al., 
1998b;  Bulad  et  al.,  2004),  or  resin-composite  restorative  material  (Maza  et  al., 
2002).
In particular,  adherence  of Candida  spp.  to  acrylic  surfaces  has  previously  been 
studied (Segal et al.,  1988; Verran and Maryan,  1997; Radford et al.,  1998a). The 
factors  implicated  in the  adhesion  of C.  albicans  to  acrylic  surfaces  are  complex 
(Samaranayake et al.,  1980), and the degree of biofilm activity formation on acrylic 
surfaces  has  been  shown to  be  affected  by  both  the  dietary  sugar,  nature  of the 
pellicle and the Candida isolates (Nikawa et al.,  1997; Nikawa et al., 2000). These 
findings  have  important  clinical  implications  as  any  material  inserted  in  the  oral 
cavity  is  instantaneously  coated  by  saliva  or  crevicular  exudates  (Nikawa  et al., 
1997).
Hence, when developing a model to grow organisms in a similar manner to the in 
vivo  scenario,  it  is  important to take  in  account the  nature  of the  substratum, the 
growth medium and the formation of a suitable pellicle. The initial aim of this work 
was  to  develop  an  in  vitro  model  to  establish  the  conditions  necessary  for  the 
development of C. albicans biofilm formation on a series of orally relevant substrata. 
The establishment of such a model will thus permit studies of the features that may 
influence biofilm formation related to DRS.
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3.2 MATERIALS AND METHODS
The aim of the first experiment was to grow Candida albicans to a steady state in the 
CDFF  with PTFE used  as  the  substratum.  In later experiments,  acrylic  resin was 
used together with enamel and dentine prepared to the appropriate size for insertion 
into  CDFF  as  described  previously  (refer  to  section  2.1.1  and  2.1.2).  A  clinical 
isolate of C.  albicans genotype A, defined to the species level by both phenotypic 
and genotypic methods (refer to  section 2.2.2),  was cultured in  10 ml of artificial 
saliva overnight  and  was  added to  500 ml  of sterile  artificial  saliva  before  being 
pumped into the CDFF. The CDFF was incubated at 37°C and operated aerobically. 
Samples were removed at various time intervals up to a maximum of 384 h.
YPD broth was used  in one experiment as a nutrient medium, the  composition of 
which is listed in Table 3.1.
Table 3.1: Composition of YPD broth.
Constituents Quantity in g per L 
in dH20
Supplier
Yeast extract 10 Oxoid
Peptone 20 Oxoid
Dextrose 20 Sigma
The CFU, hyphae  and yeast counts were determined (refer to  section 2.4.5.1) and 
representative  images taken using a light microscope  (400 x magnification)  (Leitz 
Wetzlar, Germany).
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3.3. RESULTS
Biofilm growth of C. albicans was carried out on a range of substrata using artificial 
saliva as a  general  growth medium.  The viable  counts  of C.  albicans biofilms  on 
PTFE are shown in Figure 3.1a. The number of CFU increased over time from 24 h 
to a maximum  at  144 h. The viable counts then reduced by approximately  1   logio 
between  168  and  336 h.  Table  3.2  shows the number (mean)  of yeast and hyphal 
cells  of  C.  albicans  biofilm  from  the  same  experiment.  The  yeast  cell  counts 
increased from the time of the inoculum and reached a maximum at 216 h, before 
reducing until  the  end of the  experiment at 384  h.  There  were  fewer numbers  of 
hyphal  cells  compared  to  yeast  cells  over  the  whole  period  of the  experiment. 
Between 24 and 48 h, the percentage of hyphae represented 0.6 % of the total cell 
count, this proportion increased until 312 h when 20 % of the population were in the 
hyphal form (Figure 3.1b).
The  development  of  C.  albicans  biofilms  on  self  and  heat-cured  acrylic  were 
investigated over a period of 72 h (Figure 3.2a). The CFU of the biofilms increased 
over  time  for  both  types  of acrylic  denture  material.  There  was  no  significant 
difference (p > 0.05) between the self and heat-cured acrylic during the course of the 
experiment.  The  yeast  and hyphal cell  counts  (Table  3.3)  indicated  that the  heat- 
cured acrylic had a higher number of yeast cells attached than the self-cured acrylic; 
however,  this  was  not  significant  (p  >  0.05).  Interestingly,  during  the  early 
development of the biofilm (2 h), there was no hyphal growth on either of the acrylic 
surfaces.  At  6  h,  hyphae were  observed on  the  heat-cured  acrylic, but none  were 
detected on self-cured. After this time, the heat-cured acrylic showed higher hyphal 
cell  counts  than  self-cured  acrylic,  however,  these  differences  were  also  not 
significant (p > 0.05). The percentage of hyphae on both acrylic (Figure 3.2b and c)
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were similar between 24 and 72 h.
Biofilm growth over 96 h was determined on acrylic, enamel  and dentine surfaces 
using artificial saliva as nutrient medium. Figure 3.3a shows the viable counts during 
biofilm development. The numbers of CFU comprising the biofilm grown on enamel 
was significantly higher (p < 0.05) than acrylic and dentine at early stages of biofilm 
formation (6 h). Growth on the acrylic surfaces was generally seen to be the lowest, 
except at 6 and 48 h, when the dentine had the lowest CFU.  The total number of 
yeast and hyphal cells observed from the three surfaces are shown in Table 3.4. The 
yeast cell counts present on the enamel were significantly higher (p < 0.05) than the 
other  surfaces  at  6  h.  After  this  time,  the  number  of yeast  cells  on  the  enamel 
continued  to  remain  higher  than  on  the  other  materials  until  the  end  of  the 
experiment  at  96  h,  although  only  at  48  h  was  this  significant  (p  <  0.05).  In 
comparison, the numbers of yeast cells on the acrylic surface was always less than 
on the other two materials. There were fewer hyphal cells compared to yeast cells on 
all of the surfaces at all of the time periods. At 6 h the highest numbers of hyphal 
cells detected were  on the dentine surfaces and this  continued to increase on both 
dentine and acrylic surfaces over time. In contrast, the number of hyphae present on 
the enamel surfaces increased from 6 h to 48 h by approximately 2 logio. At 72 h the 
numbers dropped, which also corresponded to a fall in the number of yeast cells and 
hence the total cells comprising the biofilm, before the numbers recovered at the end 
of the  experiment  (96 h).  The percentage  of yeast  and  hyphal  cells  are  shown in 
Figures  3.3b-d.  The highest percentage of hyphal  cells  on acrylic  (4.8  %)  (Figure 
3.3b) and dentine (12.6 %) (Figure 3.3d) were observed at 6 h. In contrast, at 6 h the 
percentage of hyphae present on enamel (Figure 3.3c) was at the lowest level during 
the course of the experiment (0.6 %).
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In order to determine the effect of the inoculum on C.  albicans biofilm growth, the 
morphology  of planktonically  grown  cells  (Figure  3.4)  was  determined  in  YPD, 
artificial saliva and in artificial saliva with or without Lab-lemco or mucin. Figure 
3.4a shows C.  albicans grown in YPD where only the yeast form was observed. In 
contrast, the growth of C. albicans in artificial saliva (Figure 3.4b) showed both the 
yeast and the hyphal forms of C. albicans. The same diversity was also demonstrated 
when  artificial  saliva  was  used  without  Lab-lemco  (Figure  3.4c),  without  mucin 
(Figure 3.4d) and without both (Figure 3.4e).
YPD  was  used  as  a  nutrient  medium  for  C.  albicans  biofilm  grown  on  acrylic, 
enamel and dentine over 96 h (Figure 3.5 a). The CFU on the enamel surface was 
higher than acrylic  and  dentine  at  6  and  24  h,  although the  differences  were  not 
significant (p > 0.05). However, at 48 and 72 h biofilms grown on dentine contained 
the highest number of CFU compared to the other surfaces. Acrylic surfaces always 
showed the lowest CFU compared to enamel and dentine. Enamel showed a higher 
number of yeast  cells  present at 6  (p  < 0.05)  and 24  h  (Table  3.5).  At 48  h,  the 
number of yeast cells dropped, but recovered again at 72 and 96 h. Acrylic surfaces 
again showed the lowest number of yeast cells compared to enamel and dentine over 
96 h. Enamel also contained a higher number of hyphal cells than the other surfaces 
at 6 (p < 0.05)  and 24 h. Figures 3.5b-d show the percentage of yeast and hyphal 
cells of all three  surfaces. The percentage of hyphal  cells  increased over time and 
reached a maximum of approximately 20 % at the end of the experiment (96 h).
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Figure 3.1a: Viable counts of C. albicans biofilms grown on PTFE over a period of 
384 h. Error bars represent standard deviations (n = 6).
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Table  3.2:  Mean  ±  the  standard  deviation  of yeast  and  hyphal  cell  counts  of C. 
albicans biofilms grown on PTFE over 384 h (n = 6).
Biofilm age Yeast cell counts Hyphal cell counts
24 h 4.6x10s ± 1.9xl05 2.7xl03± 5.8x102
48 h 4.9x105± 2.2x105 3x103± 1.7x103
72 h 1.3x106± 9.7x105 8.4x104±7.1x104
96 h 3xl06 ± l.lxlO6 1.2x10s ± 3.8x104
120 h 5.5x106± 1.9x106 2.4x105± 4xl04
144 h 7.5x106± 4.3x106 3.1x105± 2.4xl05
168 h 5.9xl06± 2.5xl06 4x105± lxlO5
192 h 6.5xl06± 7.9x1  05 6.7x105± 7xl04
216 h 8.6x106± 7.9x106 4.5xl05± 3.2x10s
312 h 1.8x106± l.lxlO6 4.6xlOs± 3.2x10s
384 h 1.1x106±3.1x105 1.4x105± 9x104
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Figure  3.1b:  The  percentage  of yeast  (white)  and  hyphae  (black)  of C.  albicans 
biofilms grown on PTFE for a period of 384 h. (Shown is the average percentage n = 
6).
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Figure 3.2a: Viable counts of C.  albicans biofilm grown on self (filled diamonds) 
and  heat-cured  (filled  squares)  acrylic  for  a period  of 72  h.  Error  bars  represent 
standard deviations (n = 6).
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Table  3.3:  Mean ±  the  standard  deviation  of yeast  and  hyphal  cell  counts  of C. 
albicans biofilms grown on self and heat-cured acrylic over 72 h.
self-cured acrylic Heat-cured acrylic
Biofilm age Yeast cell 
counts
Hyphal cell 
counts
Yeast cell 
counts
Hyphal cell 
counts
2 h 2.3x103 0 4xl03 0
±5.8xl02 0 ± lxl 03 0
6 h 1.2xl04 0 1.7xl04
C
*
*
)
o
X
±6xl03 0 ±4.7xl03 ± lxlO3
24 h 7.2x104 7xl03 9.4x104 7.3x103
± 1.4xl04 ± 4.4x103 ± 4.5xl04 ±5.5xl03
48 h 2.4x105 2.6x104 3xl05 2.8xl04
±2.6xl05 ± 1.2xl04 ± l.lxlO5 ±3.6xl03
72 h 7.4x105 3.4x104 8.5x105 4.3x104
± 4.2x105 ± 1.9xl04 ± 6.8x105 ± 2.3x104
127Chapter 3  The characterisation of an in vitro model system to grow biofilms of Candida albicans on relevant oral surfaces
100%
90%
80%
70%
60%
50%
£   40%
30%
20%
10%
0%
24
Time (hours)
Figure  3.2b:  The  percentage  of yeast  (white)  and  hyphae  (black)  of C.  albicans 
biofilms  grown on  self-cured acrylic for a period of 72  h.  (Shown  is the  average 
percentage n = 6).
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Figure  3.2c:  The  percentage  of yeast  (white)  and  hyphae  (black)  of C.  albicans 
biofilms  grown on heat-cured acrylic for a period of 72 h.  (Shown is the average 
percentage n = 6).
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Figure 3.3a: Viable counts of C. albicans biofilms grown on three different surfaces 
over a period of 96 h using artificial saliva as a nutrient medium. Filled diamonds - 
acrylic,  filled  squares  -   enamel,  filled  triangles  -   dentine.  Error  bars  represent 
standard deviations (n = 6).
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Table  3.4:  Mean ±  the  standard  deviation  of yeast  and  hyphal  cell  counts  of C. 
albicans biofilms grown on acrylic,  enamel  and  dentine  over 96 h using  artificial 
saliva as a nutrient medium (n = 6).
Acrylic  Enamel  Dentine
Biofilm
age
Yeast cell 
counts
Hyphal 
cell counts
Yeast cell 
counts
Hyphal 
cell counts
Yeast cell 
counts
Hyphal 
cell counts
6 h 3.3xl04 1.7xl03 8.3x10s 5xl03 5.8xl04 8.3xl03
± 7.6x103 ± 5.8X102 ± 7x10s ±2xl03 ± 2.5x104 ±4xl03
24 h 4.3xl05 3xl03 1.3xl06 2.9x104 8x10s lxlO4
± 1.3xl05 ± 2xl03 ±4.2x10s ±7.1xl03 ± 2x10s ± 1.5xl03
48 h lxlO6 8.7xl03 9xl06 2.9x10s 1.2xl06 1.7xl04
± 6.6x105 ± 1.5xl03 ±1.2xl07 ± 2.3x10s ± 2.6x10s ± 1.2xl04
72 h 5.3x10s 1.2xl04 1.3xl06 3.7xl04 1.2xl06 2.6xl04
±3.7xl04 ± 1.2xl04 ± 4.4x10s ± 1.7xl04 ± 5x10s ± 1.2xl04
96 h 7.9x10s 2.3x104 3.3xl06 1.5x10s 1.9xl06 1.4x10s
± 3.5x10s ± 8.5xl03 ± 3.8x10s ±5.8xl04 ± l.lxlO6 ± 1.2x10s
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Figure  3.3b:  The  percentage  of yeast  (white)  and  hyphae  (black)  of C.  albicans 
biofilms grown on acrylic surface over a period of 96 h using artificial saliva as a 
nutrient medium. (Shown is the average percentage n = 6).
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Figure  3.3c:  The  percentage  of yeast  (white)  and  hyphae  (black)  of C.  albicans 
biofilms grown on enamel surface over a period of 96 h using artificial saliva as a 
nutrient medium. (Shown is the average percentage n = 6).
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Figure  3.3d:  The  percentage  of yeast  (white)  and  hyphae  (black)  of C.  albicans
biofilms  grown  on  dentine  surface  over a period  of 96  h  using  artificial  saliva a
nutrient medium. (Shown is the average percentage n = 6).
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Figure 3.4:  Overnight suspensions of C.  albicans grown in:  a)  YPD,  b)  artificial 
saliva, c) artificial saliva without Lab-lemco, d) artificial saliva without mucin and, 
e) artificial saliva without Lab-lemco and without mucin (x 400 magnification).
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Figure 3.5a: Viable counts of C. albicans biofilms grown on three different surfaces 
over a period of 96 h using YPD as a nutrient medium. Filled diamonds - acrylic, 
filled  squares  -   enamel,  filled  triangles  -   dentine.  Error  bars  represent  standard 
deviations (n = 6).
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Table  3.5:  Mean  ± the  standard  deviation  of yeast  and  hyphal  cell  counts  of C. 
albicans biofilms grown on acrylic, enamel and dentine over 96 h using YPD as a 
nutrient medium (n = 6).
Acrylic Enamel Dentine
Biofilm Yeast cell Hyphal Yeast cell Hyphal Yeast cell Hyphal
age counts cell counts counts cell counts counts cell counts
6 h 1.3x10s 4xl03 3.5xl06 3xl04 5x10s 1.7xl04
± 4.4x104 ± 2.6x103 ±4xl06 ±lxlO 4 ± 2.4x104 ± 8.5x103
24 h 8.5x10s 1.3xl04 2xl06 5.3xl04 l.lxlO6 2.6x104
± 6.3x10s ± 7.6x103 ± 6.6x10s ± 2.4x104 ± 5.3x10s ± lxlO4
48 h 2.9x10s lxlO4 1.4xl06 1.3x10s 2.3xl06 1.4x10s
± 1.6x10s ± 5xl03 ± 1.3xl06 ± 5xl04 ± 1.4xl06 ± 8.1xl04
72 h 1.3xl06 1.7x10s 3xl06 3.2x10s 4.8x106 2.7x10s
± 5.6x10s ± 3x104 ± 3.2x10s ±3.1xl04 ± lxlO6 ± 2.5x104
96 h 1.6xl06 3.8x10s 5.8xl06 1.5x10s 8.1xl06 1.9xl06
± 6.1x10s ± 1x10s ± 3.2x106 ± 7.6x10s ±4.1xl06 ± 8.1x10s
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Figure  3.5b:  The  percentage  of yeast  (white)  and  hyphae  (black)  of C.  albicans 
biofilms  grown on acrylic  surface over a period of 96  h using  YPD  as  a nutrient 
medium. (Shown is the average percentage n = 6).
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Figure  3.5c:  The  percentage  of yeast  (white)  and  hyphae  (black)  of C.  albicans 
biofilms  grown on enamel  surface over a period of 96 h using YPD as a nutrient 
medium. (Shown is the average percentage n = 6).
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Figure  3.5d:  The  percentage  of yeast  (white)  and  hyphae  (black)  of C.  albicans
biofilms  grown on dentine  surface over a period of 96 h using YPD as a nutrient
medium. (Shown is the average percentage n = 6).
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3.4 DISCUSSION
Infections  caused  by  Candida  spp.  are  increasing  as  the  numbers  of 
immunocompromised patients in the community increase. Adherence of C. albicans 
is  thought  to  be  an  essential  event  in  the  pathogenesis  of  candidosis  and  is 
considered  as  a  virulence  factor  (Haynes,  2001).  The  aim  of this  study  was  to 
establish the growth of C. albicans in vitro as a biofilm likely to represent the in vivo 
scenario.
The model used, the Constant Depth Film Fermentor, is particularly suited to studies 
of biofilms of oral microbes in that it provides an environment similar to that found 
in the oral cavity (Morgan and Wilson, 2001). Biofilms are able to grow on a solid 
substratum  with nutrients being provided in a thin film of liquid over the  surface, 
which  is  continually  replenished.  The  action  of the  scraper  blades  simulates  the 
continuous removal of the outermost layers of dental plaque due to the shear forces 
present  in the  mouth  (Wilson,  1999).  By  growing  biofilms  in  the  CDFF  over  an 
extended period of 384 h, it was possible to determine that a stable population was 
achievable. A biofilm will always be spatially heterogeneous, but biofilms grown in 
the CDFF have been shown to become quasi-steady state (Wimpenny,  1999). The 
results from previous studies (Pratten et al.,  1998a) have suggested that the base of 
the biofilm may be occupied by deteriorating or lysing cells. Cells undergoing lysis 
will generate substrates enabling re-growth. The observation of a decrease in viable 
counts after 150 h before increasing later in the experiment may be explained by this 
cycle  of  re-growth,  even  within  a  simple  single-species  biofilm.  The  ability  to 
produce biofilms in a steady state is an important aspect of the model and provides 
the opportunity for the reproducible testing of antimicrobials which will be discussed 
further in later chapters.
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No synthetic solution can be a complete substitute for natural saliva, however, due to 
the  constraints  of sterilisation and the  need of large volume  of human  saliva,  the 
nutrient medium carried out in the present study (apart from one run with YPD) was 
artificial saliva formulated by Russell and Coulter (1975). This synthetic substitute 
was  needed  to  reproduce  features  of  saliva  which  are  considered  important  in 
cultural studies of dental plaque while remaining relatively inexpensive and simple 
to produce (Pratten et al,  1998c). The artificial saliva used in this study provides a 
suitable  growth  medium  and  an adequate  conditioning  film  on the  surfaces  used, 
hence both the yeast and hyphal forms of C. albicans were able to grow and form a 
structured  biofilm.  The  use  of mucin  (containing  glycoproteins)  does  mimic  the 
protein  pellicle  present  on  oral  surfaces  and  can  act  as  receptors  for  adhesion 
molecules.  Glycoproteins  which  are  found  in  human  saliva  have  been  shown 
previously  to  form  a  salivary  pellicle  in  bacterial  biofilm  studies  (Pratten  et  al., 
1998b; Mulligan et al., 2003). The salivary pellicle is known to have an important 
function  in  the  formation  of dental  plaque.  Through  this  pellicle,  saliva  exerts  a 
profound influence on microbial adhesion to oral surfaces. However, its role in the 
formation  of  denture  plaque  is  less  well  documented  as  there  is  considerable 
variation in results from different studies (Radford et al.,  1999). For example, it has 
been shown that mixed human saliva reduces candidal adhesion to acrylic surfaces 
and denture base materials (Samaranayake et al.,  1980; Radford et al.,  1998b) and 
can reduce microbial adhesion to silicon rubber (Busscher et al.,  1997), while other 
studies reported enhanced adhesion of C.  albicans to saliva-coated acrylic surfaces 
and denture  lining materials (Edgerton et al,  1993; Nikawa et al,  1993). Nikawa 
and co-workers have investigated the effect of a serum pellicle on the formation of 
Candida biofilm formation on acrylic surfaces. They found a significant increase in
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biofilm growth of Candida spp. on protein coated acrylics. They concluded that the 
increase in serum content in the proteinaceous pellicle prompted biofilm formation 
of most Candida spp. (Nikawa et al., 2000). Indeed the results of the present study 
showed  that  artificial  saliva  permits  the  growth  of  both  forms  of  C.  albicans 
confirming previous studies (Edgerton et al., 1993; Nikawa et al., 1993).
There have  only been few studies carried out on the differences  between self and 
heat-cured  acrylic  and  the  adhesion  of C.  albicans  to  these  materials.  In  1972, 
Davenport showed that there was no difference in surface roughness of heat and self­
cured  acrylic  resin.  This  is  in accordance  with the  results  of the  current  study in 
which the numbers of C.  albicans grown on self and heat-cured acrylic resin were 
not  significantly  different.  It  was  suggested  that  the  fine  texture  and  absence  of 
porosity  of  the  denture  surface  would  not  permit  plaque  retention  through 
penetration  of  surface  defects  or  mechanical  attachment  to  surface  irregularities 
(Davenport, 1972).
In  addition  to  acrylic,  there  are  several  other  hard  tissues  present  in  the  mouth 
available for colonisation such as enamel, dentine and cementum. Hyphae are able to 
penetrate into cracks, follow the ridges and migrate into dentinal tubules (Sen et al., 
1997).  Limited data exist on the formation of C.  albicans biofilms on dental hard 
tissues  and  few  clinical  reports  clearly  show  fungal  invasion  of dentinal  tubules. 
Hodson and  Craig  studied dental plaque  and carious teeth in  100  children for the 
incidence of C. albicans. Their investigation included histological examination of 30 
extracted teeth, which included a few cases in which fungal organisms had entered 
dentinal  tubules  (Hodson  and  Craig,  1972).  Later,  in  1983,  Kinirons  reported 
Candidal invasion of dentinal tubules in a patient with severe hypodontia (Kinirons, 
1983). Another example of dentinal invasion was made by Damm and co-workers
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that presented two cases of dentinal candidiasis that occurred in two cancer patients, 
one with acute myelogenous leukaemia and the  second with carcinoma (Damm et 
al.,  1988). In the present study, tooth surfaces (enamel and dentine) were shown to 
have more growth of C. albicans than acrylic. Thus dental hard tissues can present a 
reservoir  for  disseminating  of  candidal  infections.  Although  a  useful  tool  for 
comparing  two  or  more  different  surfaces  in terms  of their profile,  Ra values  are 
limited  as  they  do  not  give  an indication  of the  true  nature  of the  roughness  e.g. 
whether the surface contains ‘spikes’ or ‘scratches’.
Traditionally, Yeast extract, Peptone and Dextrose broth is used as a growth medium 
to grow C.  albicans.  A planktonic overnight growth of C.  albicans in YPD in the 
current study allowed only the growth of the yeast form of C. albicans. These results 
were also shown by Imanishi and co-workers (2004). In contrast, when C.  albicans 
was grown in YPD in the presence of a surface, both the yeast and hyphal form were 
observed  eventually.  The  process  by  which  morphogenesis  in  C.  albicans  is 
regulated  is  poorly  understood  at the  molecular  level.  Hawser  and  Douglas  have 
observed  by  SEM  that  the  adherence  of C.  albicans  blastoconidia  to  catheters  is 
followed  by  conversion  to  hyphae.  These  events  indicate  that  a  contact-induced 
regulation  of  gene  expression  may  be  occurring  (Hawser  and  Douglas,  1994). 
Hyphal cells may sense and respond to changes in surface contours, follow grooves 
and  ridges  and  invade  the  surface  (Gow  et  al.,  1994;  Watts  et  al.,  1998).  It  is 
therefore  likely  that  during  biofilm  formation,  hyphal  emergence,  particularly 
thigmotropic reaction, a well known characteristic for cells that grow in close contact 
to the surface, may be involved.
The effect of different surfaces (acrylic, enamel and dentine) was also investigated in 
the CDFF  over 96 h using YPD as a nutrient medium. Variation in the number of
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organisms  attached  was  observed  between  the  different  materials  used.  In 
comparison to artificial saliva, YPD growth medium showed higher viable counts of 
C.  albicans per biofilm when grow on acrylic, enamel and dentine.  Samaranayake 
and MacFarlane (1980) showed that sucrose enhanced the adhesion of C. albicans to 
acrylic  suggesting  that  the  soft,  carbohydrate-rich  diets  consumed  frequently  by 
denture  wearers  could  induce  yeast  to  colonise  and  adhere  more  tenaciously  to 
denture surfaces. Additionally, diets rich in glucose or galactose may modify biofilm 
formation of Candida spp.  on denture acrylic  surfaces  (Nikawa et al.,  1997).  The 
increased adherence of yeast, possibly induced by sucrose, to dentures could play an 
important role in the pathogenesis of the candidal diseases affecting denture wearers. 
It can be  concluded  from  this  series  of experiments that the  type  of surface  upon 
which C.  albicans is grown and the growth media used affect the initial formation 
and development of C. albicans biofilms. The next chapter will focus on the effect of 
one  of the  surface  properties  (surface roughness)  on the  formation of C.  albicans 
biofilms.
142Chapter 4
The effect of surface roughness and strain variability on the biofilm 
forming ability of Candida albicans
143Chapter 4__________  The effect of surface roughness and strain variability on the biofilm forming ability of Candida albicans
4.1  INTRODUCTION
The roughness of a surface is considered an important aspect in the ability of dental 
plaque to form, and may contribute to microbial colonisation and plaque maturation 
on the surface (Quirynen and Bollen,  1995). Surface roughness has previously been 
shown to affect the adhesion of microorganisms to catheters (Tebbs et al., 1994) and 
enamel surfaces (Gurgan et al., 1997).
Roughness  of  materials  used  in  dentistry  influences  microbial  retention  and 
adhesion. The increase in surface roughness can increase retention of microbial cells 
to acrylic surfaces. Indeed this has been reported for C. albicans (Verran et al., 1991; 
Verran  and  Maryan,  1997;  Radford et al.,  1998b).  Surface  roughness  can provide 
niches  in which microorganisms  are protected from  shear forces  and oral hygiene 
measures  as  bacteria  can  be  irreversibly  attached  easily  and,  more  frequently,  in 
these sites (Quirynen and Bollen,  1995). This in turn may lead to the importance of 
surface roughness in plaque formation and mucosal inflammation.
Dentures may function as a reservoir of infection (Davenport, 1970, Budtz-Jorgensen 
et  al.,  1996)  as  these  enhance  denture  plaque  attachment  which  may  in  turn 
predispose to DRS.  Both the type of denture acrylic and its surface roughness can 
affect  the  early  stages  of  biofilm  formation  (Morgan  and  Wilson,  2001).  The 
presence  of  surface  irregularity  and  roughness  in  the  denture  may  increase  the 
likelihood  of microorganisms  retention  on  the  surface  after  cleaning  the  denture. 
Thus  smooth denture  surfaces are more desirable than rougher surface as this will 
facilitate  denture  cleaning  and  hygiene  (Verran  and  Maryan,  1997).  However, 
adjustment of the denture base is frequently required in the clinic and this may leave 
unpolished areas, especially if they involve the denture fitting surface. Hence these 
areas may enhance plaque accumulation and infection.
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Candida  albicans  remains  the  most common  fungal  commensal  of the  mouth.  In 
addition,  it  is  recognised to be one of the most pathogenic  of Candida species.  It 
exhibits  a  number  of  pathogenic  mechanisms  that  contribute  to  its  virulence 
including the cell wall (McCullough et al., 1996), the ability of phenotypic switching 
(Soli,  1992; Calderone and Fonzi, 2001), the ability to form germ tubes, to adhere to 
host  cells,  and  to  secrete  proteinases  and  phospholipases  (Ibrahim  et  al.,  1995; 
Kretschmar  et  al.,  1999;  Haynes,  2001;  Naglik  et  al.,  2003).  This  has  been 
previously  reviewed  in  detail  (refer to  section  1.1.2).  An  association  of these  are 
important contributory factors for pathogenicity of C. albicans (Ghannoum and Abu- 
Elteen,  1986;  Abu-Elteen  et  al.,  2001).  Different  strains  of  C.  albicans  show 
variations in their virulence factors (Al-Karaawi et al., 2002 and 2004)
The structural organisation of biofilms is a key characteristic which defines biofilm 
growth.  The  advent  of  modem  imaging  techniques  such  as  CLSM  allow  the 
researcher to examine a biofilm in a fully hydrated living state (Baillie and Douglas, 
1999b).  The  study of bacterial biofilm  structure using CLSM is well  documented; 
however, there are few studies on the structure of fungal biofilms using CLSM.
The aim of these experiments was to investigate the effect of surface roughness on 
biofilm formation using different strains of C. albicans with high and low adherence 
properties which have been determined from previous non-biofilm related studies.
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4.2  MATERIALS AND METHODS
In  order  to  investigate  the  ability  of various  strains  of C.  albicans  to  adhere  to 
materials with different surface roughness with relation to the oral cavity, the CDFF 
was  employed  as  a  model  system.  Both  self and heat-cured  acrylic  were  used  as 
substrata for biofilm growth as described previously (refer to section 2.1.1).
Clinical isolates (refer to section 2.2.2) of defined species of high and low adherence 
genotype A and B (total of four strains) C. albicans were cultured overnight in 10 ml 
of artificial  saliva to be used as inoculum and added to  500 ml of sterile artificial 
saliva and pumped into the CDFF as described previously (refer to section 2.4.2.1 
and 2.4.3).  Samples were then removed at 2 h for both acrylic type and at various 
time intervals up to maximum 72 h for the other experiments.
The  CFU, hyphae  and yeast counts were determined (refer to  section 2.4.5.1) and 
images  of C.  albicans  biofilms  were  taken  for  different  surface  roughness  using 
CLSM with a fluorescent stain (refer to section 2.7). Five to six images were taken 
and the most representative of these were presented in the results section. A scanning 
laser  profilometer  (ProScan  1000)  was  used  to  accurately  measure  the  surface 
roughness of the substrata as described previously (refer to section 2.8). The surface 
roughness was  expressed as Ra, this value is the  arithmetic  mean deviation of the 
surface height from the mean line through the profile. Changes in surface topography 
were also confirmed by SEM (refer to section 2.6).
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4.3  RESULTS
To  assess  the  contribution  of surface  roughness  on  the  formation  of C.  albicans 
biofilms, self and heat-cured acrylic were prepared and polished with abrasive paper 
and used as a substratum for biofilm growth over a 2 h period. Table 4.1  shows the 
viable counts of C.  albicans biofilms on both types of acrylic with different surface 
roughness. At 2 h, the CFU per biofilm on self-cured acrylic was higher than heat- 
cured  acrylic  for all  the  surface roughness,  although none  of the  differences were 
significant  (p >  0.05).  The yeast and hyphal  cell  counts  from this  experiment are 
presented  in  Table  4.2.  Again  there  were  no  significant  differences  (p  >  0.05) 
between the two types of acrylic. Interestingly, there were no hyphae on both types 
of acrylic on the smoothest surface (Ra = 2.5  pm), hence, the percentage of hyphal 
cells (Figure 4.1) increased with increasing surface roughness for both acrylic types. 
The  self and heat-cured  acrylic  contained the highest hyphal  cells at Ra = 3.6  pm 
with 12.5 % and 14.3 % respectively.
C. albicans genotypes A and B, each one with different adherence properties were 
additionally investigated over a 72 h period. Figure 4.2 represents the viable counts 
of two strains from genotype A with high and low adherence properties over 72 h on 
acrylic. At 2 h biofilm growth, the high adherence strain showed the higher CFU per 
biofilm on the roughest surface (Ra = 9.3). After 4 h, the viable counts were lower 
for all surface roughness compared to the low adherence strain. Towards the end of 
the experiment at 48 and 72 h, the high adherence strain contained the highest CFU
n
per biofilm  for  all  of the  surface roughness with a maximum  growth of 1.2 x  10 
CFU per biofilm. Figure 4.3 shows the number of yeast cells (a) and hyphal cells (b) 
on different surface roughness over 72 h for high adherence genotype A. At 6 h there 
were  significant  differences  between  the  number  of yeast  cells  present  and  the
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roughness of the surface (p < 0.05), the highest number of yeast cells were found on 
the roughest surface while fewer yeast cells were detected on the smoothest surface 
(Figure 4.3a). After 6 h there was no correlation between the surface roughness and 
the number of yeast cells present.  The number of hyphae present on each surface 
(Figure 4.3b)  was  related to the  surface roughness  at 6 and 24 h with the highest 
number of hyphae  on the  roughest surfaces  (p  <  0.05).  As  the  biofilm  developed 
there  was  no  significant difference  (p >  0.05) between the numbers of hyphae on 
each of the different surfaces.
Figure  4.4  shows  the  yeast  cell  counts  (a)  and  hyphal  cell  counts  (b)  of  low 
adherence genotype A biofilms grown on the different surface roughness. The yeast 
and hyphal  cell  counts were  increased over time (2 -  72 h) at all different surface 
roughness in which yeast cell counts were always higher than the hyphal cell counts. 
During initial biofilm  formation, the highest numbers of yeast cells were found on 
the roughest surface while fewer yeast cells were detected on the smoothest surface 
(Figure 4.4a). The number of hyphae present on each surface was also related to the 
surface roughness (Figure 4.4b).
C.  albicans  genotype  B  strain  was  also  investigated  over  the  same  time  period 
(Figure 4.5). During early biofilm formation (2 and 6 h), the high adherence strain of 
genotype B were higher than the low adherence strain at all surface roughness (p < 
0.05), however,  at 24 h biofilm, there was no difference between the two strains at 
all surface  roughness.  The same results were obtained for low and high adherence 
genotype A (Figure 4.2). In contrast, the low adherence genotype B strain was higher 
than  the  high  adherence  strain until  the  end  of the  experiment (72  h).  Figure  4.6 
showed the yeast cell counts (a) and hyphal cell counts (b) of high adherence strain 
genotype B. There were increased number of yeast and hyphal cell counts over time
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(2 -  72 h) at all different surface roughness in which yeast cell counts were always 
higher than the hyphal cell counts (same results obtained by genotype A). At initial 
biofilm  formation  (6  h),  the  highest  numbers  of yeast  cells  were  found  on  the 
roughest  surface  while  fewer  yeast  cells  were  detected  on  the  smoothest  surface 
(Figure 4.6a). The number of hyphae present on each surface was also related to the 
surface  roughness  (Figure 4.6b).  The  same results  were also  obtained of the yeast 
and hyphal cells counts of the low adherence strain genotype B (Figure 4.7a and b). 
The biofilms were also examined by CLSM. Using this technique, it could be seen 
that the  structure  of the  biofilms was  also  dependent upon the  surface  roughness. 
Figure 4.8a-c shows the initial attachment of C.  albicans biofilm on various surface 
roughness after 6 h. Abrasions are visible on the surfaces in these figures from the 
bottom  left to the top right where the material has been machined with the silicon 
carbide grit. At this time point (6 h), on all the surfaces, the images are dominated by 
the  yeast  form  of the  Candida.  Interestingly,  a  germ  tube  form  is  visible  (Figure 
4.8b). After 24 h biofilm growth (Figure 4.9), the smoothest surface (Ra = 2.5  pm) 
shows biofilm  formation in micro-colonies with fewer hyphal  cells visible (Figure 
4.9a). There seem to be more hyphal forms visible on the roughest surface, while the 
formation  appears  to  be  in  alignment with the  etchings  (Figure  4.9b-c).  At  72  h, 
mature  biofilms  were  present  on  the  surfaces  (Figure  4.10a-c).  On  the  smoother 
surface the biofilm has formed in discrete, well defined stacks with a large surface 
area not colonised and the hyphal form of the yeast was associated with the base of 
the biofilm  (Figure  4.10a).  The roughest surfaces  showed that the hyphal cells are 
also  established  towards  the  base  of the  biofilm  (Figure  4.10b-c).  In  these  basal 
layers  the  yeast  form  seems  to  be  positively  associated  with  the  hyphal  forms. 
Additionally,  there  are  some  areas  with little  or no  colonisation and  channels and
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voids are apparent within the biofilm.
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Table 4.1:  Mean ± the standard deviation of viable counts of C.  albicans biofilms 
grown on self and heat-cured acrylic with different surface roughness (Ra = 2.5 Jim, 
Ra = 3.6 Jim and Ra = 9.3 jim) over 2 h.
Surface roughness (Ra) Self-cured acrylic Heat-cured acrylic
Ra = 2.5 Jim 2.1xl03 l.lxlO3
±4.5xl02 ± 1.3xl02
Ra = 3.6 jim 3.5xl03 3.1xl03
± 3xl02 ±6.8xl02
Ra = 9.3 jim 2.6xl03 2.4x103
± 8.7X102 ± 7.2x102
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Table  4.2:  Mean  ±  the  standard  deviation  of yeast  and  hyphal  cell  counts  of C. 
albicans  biofilms  grown  on  self  and  heat-cured  acrylic  with  different  surface 
roughness (Ra = 2.5 pm, Ra = 3.6 pm and Ra = 9.3 pm) over 2 h.
Average surface 
roughness (Ra)
Self-cured acrylic Heat-cured acrylic
Yeast cell 
counts
Hyphal cell 
counts
Yeast cell 
counts
Hyphal cell 
counts
Ra = 2.5 pm 2.3x103 0 4xl03 0
± 5.8xl02 0 ±lxlO 3 0
Ra = 3.6 pm
©
X
! lxlO3 8xl03 1.3xl03
±4xl03 0 ± 3.5xl03 ± 5.8xl02
Ra = 9.3 pm 1.3xl04 1.3xl03 1.4xl04 1.4xl03
±8xl03 ± 5.8xl02 ±5.5xl03 ± l.lxlO3
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Figure 4.1: The percentage of yeast (white) and hyphal cells (black) of C.  albicans 
biofilms grown on different surface roughness of self and heat-cured acrylic (Ra = 
2.5 pm, Ra = 3.6 pm and Ra = 9.3 pm) over 2 h.
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Figure  4.2:  The  viable  counts  of two  genotype  A  C.  albicans biofilms  grown on 
acrylic over 72 h.  High adherence strain with black line  (Filled diamond: Ra = 2.5 
pm,  filled  square:  Ra = 3.6  pm  and  filled triangle:  Ra =  9.3  pm).  Low adherence 
strain with dotted line (open diamond: Ra = 2.5  pm, open square: Ra = 3.6 pm and 
open triangle: Ra = 9.3 pm). Error bars represent standard deviations.
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Figure 4.3: The number of yeast (a) and hyphal (b) cell counts of high adherence C. 
albicans  biofilms  genotype  A  grown  on  different  surface  roughness  of denture 
acrylic over 72 h (Filled diamond: Ra = 2.5 pm, filled square: Ra = 3.6 pm and filled 
triangle: Ra = 9.3 pm). Error bars represent standard deviations.
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Figure 4.4:  The  number of yeast (a) and hyphal  (b)  cell  counts  of low adherence 
genotype A C.  albicans biofilms grown on acrylic with different surface roughness 
over 72 h (open diamond: Ra = 2.5 pm, open square: Ra = 3.6 pm and open triangle: 
Ra = 9.3 pm). Error bars represent standard deviations.
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Figure  4.5:  The  viable  counts of two  genotype  B  C.  albicans biofilms  grown on 
acrylic over 72 h.  High adherence strain with black line (Filled diamond: Ra = 2.5 
pm,  filled  square:  Ra =  3.6  pm  and filled triangle:  Ra =  9.3  pm).  Low adherence 
strain with dotted line (open diamond: Ra = 2.5  pm, open square: Ra = 3.6 pm and 
open triangle: Ra = 9.3 pm). Error bars represent standard deviations.
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Figure 4.6:  The number of yeast (a) and hyphal (b) cell counts of high adherence 
genotype B  C.  albicans biofilms grown on acrylic with different surface roughness 
over  72  h  (Filled  diamond:  Ra  =  2.5  pm,  filled  square:  Ra  =  3.6  pm  and  filled 
triangle: Ra = 9.3 pm). Error bars represent standard deviations.
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Figure  4.7:  The  number of yeast (a) and hyphal (b)  cell  counts of low adherence 
genotype B  C.  albicans biofilms grown on acrylic with different surface roughness 
over 72 h (open diamond: Ra = 2.5 pm, open square: Ra = 3.6 pm and open triangle: 
Ra = 9.3 pm). Error bars represent standard deviations.
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Figure  4.8:  CLSM  images  showing  C.  albicans  biofilms  formation  on  denture 
acrylic of various surface roughness after 6 h growth in the CDFF. a) Ra = 2.5 pm, b) 
Ra = 3.6 jim and c) Ra = 9.3 pm. Bar = 200 pm.
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Figure 4.9: CLSM images showing C. albicans biofilm formation on denture acrylic 
of various surface roughness after 24 h growth in the CDFF. a) Ra = 2.5 pm, b) Ra = 
3.6 pm and c) Ra = 9.3 pm. Bar = 200 pm.
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Figure  4.10:  CLSM  images  showing  C.  albicans  biofilms  formation  on  denture 
acrylic of various surface roughness after 72 h growth in the CDFF. a) Ra = 2.5 pm, 
b) Ra = 3.6 pm and c) Ra = 9.3 pm. Bar = 200 pm.
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4.4  DISCUSSION
Surface roughness is a significant factor that facilitates attachment and retention of 
microorganisms to surfaces. It is thought that this is due to the greater surface area 
(Lytle et al.,  1989) available for microbial adhesion and the provision of protected 
sites for colonisation (Quirynen and Bollen,  1995). The effect of surface roughness 
has  been  reported  previously  (Verran  et  al.,  1991;  Verran  and  Maryan,  1997; 
Radford  et  al.,  1998b)  with  an  increase  in  surface  roughness  causing  increased 
retention  of cells  on  acrylic  surfaces.  Surface  roughness  can  be  considered  as  an 
important factor in plaque accumulation and microbial biofilm formation (Quirynen 
etaL, 1990).
In this  study,  self and heat-cured denture  acrylic were prepared and polished by a 
number  of different  abrasive  papers  with  different  surface  roughness  in  order to 
mimic  an oral  prosthesis  in  vivo.  These were  subsequently used to  investigate the 
colonisation  of C.  albicans  in  the  CDFF  over  a  2  h  period.  Morgan  and  Wilson 
(2001) have shown that heat-cured acrylic was colonised by fewer bacteria than self­
cured  acrylic  after  2  h  with  increased  colonization  for both  types  of acrylic  with 
increase surface roughness. However, after 4 h, while the effect of the type of acrylic 
on colonisation was evident, this was not the case for the surface roughness effect. 
Hence, after this time, the increase in surface roughness had no effect on the number 
of organisms attached to either acrylic. The results of the current study demonstrated 
no significant difference (p > 0.05) in C. albicans biofilm formation at 2 h for either 
self or  heat-cured  acrylic  in  both  CFU  and  yeast  and  hyphal  cell  counts  at  any 
surface  roughness.  This  is  in accordance  with previous  studies by Davenport who 
showed  no  difference  in  surface  roughness  of heat  and  self-cured  acrylic  resin 
(Davenport, 1972).
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It  has  been  shown  that  C.  albicans  can  preferentially  adhere  to  rough  surfaces 
compared  to  smooth with  greater adherence to  the  machined  soft lining materials 
compared with acrylic (Radford et al., 1998b). The results of the current study are in 
line  with  the  previous  study  (Verran  et  al.,  1991)  in  which  C.  albicans  adhered 
significantly in higher numbers to roughened acrylic than to smooth acrylic. Verran 
and Maryan also showed a significantly higher number of cells were observed on the 
rough surfaces than on smooth surfaces, with more C. albicans cells on rough silicon 
than  rough  acrylic  surfaces  (Verran and  Maryan,  1997).  Ramage  and  co-workers 
(2004) visualised Candida biofilms from two denture samples and showed that yeast 
and hyphal cells of these biofilms were embedded into cracks and imperfections of 
the  biomaterial  (Ramage  et  al.,  2004).  This  observation  indicated  that  surface 
roughness  and  cracks  within  the  acrylic  support  attachment  and  colonization  of 
Candida.  These  investigations  may  reveal  the  importance  of surface  imperfection 
that facilitates retention of cells.
In the present study, two different C.  albicans genotypes (A and B) each with high 
and low adherence properties were used to study C.  albicans biofilm formation on 
self-cured acrylic with different surface roughness in the CDFF for 72 h. Ghannoum 
and Abu-Elteen emphasized the role played by some  specific properties of certain 
strains of C.  albicans in the pathogenesis of candidosis. For example, those isolates 
which adhered  most  strongly to  buccal  epithelial  cells were  found to be the most 
pathogenic  organisms  (Ghannoum  and Abu-Elteen,  1986).  The  strains used in the 
current study were previously isolated and several factors associated with virulence 
were  assessed  in  a  separate  non-biofilm  study.  The  results  of the  current  study 
showed that surface roughness has an effect on the ability of hyphae to adhere to the 
acrylic  denture  during  the  first  24  h  of  biofilm  formation.  Interestingly,  no
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differences were seen in the ability of the organisms to form biofilms. Certainly, it is 
clear from these results that any differences in variability for high and low adherence 
strains  were  not  seen  in  the  subsequent  growth  and  formation  of more  complex 
biofilms.
CLSM  biofilm  images  were  displayed  in three-dimensional  (3-D)  projections  and 
showed  the  structure  of  C.  albicans  biofilm  on  different  surface  roughness  on 
denture acrylic.  Previous studies which have evaluated the structure of C.  albicans 
biofilms  by  CLSM  (Chandra  et al.,  2001a)  showed  that  C.  albicans has  a highly 
heterogeneous architecture composed of cellular and acellular elements and consists 
of  three  phases  of  organised  growth  structure  through  early,  intermediate  and 
maturation  phases.  Similar  phases  have  been  also  reported  for  bacterial  biofilm 
formation  (O'Toole  et  al.,  2000).  Other  studies  using  scanning  electron  and  light 
microscopy on catheter disks have shown that biofilm consist of a thin, basal yeast 
layer and a thicker, but more open, hyphal layer (Baillie and Douglas, 1999b). Under 
the  conditions  of this  study,  it  has  been  shown  that  a  developmental  process  of 
biofilm  formation  with  early  colonisation  by  the  yeast  form  and  subsequent 
colonization  by  the  hyphal  form  may  be  important  in  biofilm  structure  and 
formation. Chandra and co-workers showed that the proportions of yeast and hyphal 
cells present in the biofilm were dependent upon the nutrient source.  For example, 
biofilms  grown  in  a  nitrogen  based  medium  contained  mainly  the  yeast  form, 
whereas filaments predominated in RPMI-grown biofilms (Chandra et al., 2001a). In 
the  current  study,  where  biofilms  were  supplied  with  artificial  saliva  in  an 
environment  similar to the  in vivo situation, it appears that the presence of hyphal 
cells at the substratum interface may be integral to the formation and development of 
Candida albicans biofilm structure.
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Previous  studies  showed  that  the  adhesion  of  Staphylococcus  epidermidis  was 
reduced when a PMMA  surfaces with various surface roughness were coated with 
bovine  serum  albumin,  whereas  the  adhesion  of  Pseudomonas  aeruginosa 
unchanged (Taylor et al., 1998). Radford and co-workers showed that when denture 
base materials were pre-coated with saliva, the adhesion of C.  albicans is reduced 
and  also  the  effect  of  surface  roughness  is  diminished  (Radford  et  al.,  1998b). 
Hence,  although  surface  roughness  can  affect  bacterial  adhesion,  the  presence  of 
salivary pellicle may mask or modify these effects.  In the present study mucin was 
included in the nutrient source (artificial saliva) to provide a pellicle similar to that 
which  is  found  in  the  mouth.  This  may  diminish  the  effect  of different  surface 
materials  (i.e.  self and  heat-cured acrylic)  as  demonstrated in the present study as 
well as surface roughness on the different surfaces.
In conclusion, the  experimental results reported in this chapter showed that surface 
roughness had  a significant effect on the  initial adhesion of C.  albicans, however, 
further biofilm development was unaffected by either surface roughness or strain of 
the organism.  Additionally, by using CLSM to investigate biofilm development on 
surfaces with different roughness, under these in vitro conditions, the organisation of 
biofilms may centre upon the roughness of the surface and the hyphal form of the 
organism. Clinically, surfaces that promote plaque development should be handled in 
such  a  manner  to  produce  smooth  surfaces.  This  will  reduce  the  ability  of  C. 
albicans,  a commonly opportunistic pathogen associated with DRS, to adhere and 
colonise denture surfaces.
Such structurally organised biofilms are known to be more resistant to antimicrobial 
agents.  Hence  the  next  chapter  will  focus  upon  the  susceptibility  of C.  albicans 
biofilms to antimicrobial and antifungal agents used in the treatment of DRS.
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5.1  INTRODUCTION
Biofilms are a protected niche of microorganisms that can create a source of persistent 
infection due to their resistance to antibiotic treatment. They can form on a variety of 
implanted medical devices resulting in biofilm-associated infections that constitute a 
significant public  health  problem  (Costerton  et  al.,  1999).  Biofilm  grown  Candida 
species, like their bacterial counterparts, are highly resistant to antimicrobials (Hawser 
and Douglas, 1995).
Biofilm  formation  is  critical  in  the  development  of DRS,  in  which  Candida  spp. 
biofilms play a key role (Ramage et al., 2004). It has been noted that the symptoms of 
DRS often return shortly after treatment (Budtz-Jorgensen et al.,  1988; Bissell et al., 
1993), suggesting that C.  albicans biofllms associated with DRS  are resistant to the 
action of antifungal drugs (Ramage et al., 2004).
Many  studies  have  demonstrated  drug  resistance  of Candida  spp.  biofilms.  These 
include the  growth  of Candida biofilms  on  different  surfaces  including,  cylindrical 
cellulose filter (Baillie and Douglas,  1998b; Baillie and Douglas,  1999b), polystyrene 
(Ramage et al., 2001), silicon elastomer (Chandra et al., 2001a), polyurethane (Lewis 
et al., 2002) and denture acrylic (Chandra et al., 2001b).
The mechanisms by which C.  albicans biofilms resist the action of antifungal agents 
are, as yet, not known, however, various mechanisms have been proposed to explain 
the recalcitrance resistance of C.  albicans biofilms to antimicrobial agents (Douglas, 
2003).  It has  been  suggested  that  drug resistance  may  arise  as  a  result  of surface- 
induced  gene  expression  (Baillie  and  Douglas,  2000)  and  may  also  depend on the 
phase  of  biofilm  growth  (Mukheijee  et  al.,  2003).  These  have  been  described 
previously in more detail (refer to section 1.4.2).
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In order to study biofilm perturbation, results must be comparable and reproducible 
from experiment to experiment, hence in this study, CDFF was used in order to grow 
replicate biofilms over time in a steady-state system.
The aim of this chapter was to assess the in vitro susceptibility of C. albicans biofilms 
to fluconazole, miconazole and chlorhexidine.
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5.2  MATERIALS AND METHODS
Previously  characterized  clinical  isolates  of Candida  albicans  genotype  A  and  B 
(refer to section 2.2.2) were used as the inoculum for the susceptibility experiments. 
The nutrient source  in all experiments was an artificial saliva (refer to section 2.3). 
Self-cured  acrylic  denture  disks  were  used  as  substrata  and  prepared  to  the  same 
surface  roughness  (Ra =  2.5  pm) using  silicon carbide  grit as  described previously 
(refer to section 2.1.1).
Antifungal  agents  commonly  used  to  treat  DRS  were  tested  against  C.  albicans 
biofilms.  Firstly,  the  planktonic  MIC  of fluconazole,  miconazole  and chlorhexidine 
was determined for C.  albicans genotype A and B, as described previously (refer to 
section  2.5.1  and  2.5.2).  The  MIC  of fluconazole  and miconazole  was  read  as  the 
lowest concentration  that prevented  a colour change  from  blue  to  pink.  Figure  5.1 
shows examples of the MIC for some of the isolates utilising Alamar blue to indicate 
a  colour  change  and  C.  albicans  growth  from  those  isolates.  The  MIC  for 
chlorhexidine was assessed by the lowest concentration of the agent that prevented the 
growth of C. albicans on SDA.
Using  the  previously  determined  planktonic  MIC  as  a  reference,  different 
concentrations of fluconazole, miconazole (Table 5.1) and chlorhexidine (Table 5.2) 
that correspond  to  times  planktonic  MIC  (X MIC) were  subsequently used  against 
both genotypes of C. albicans biofilms.
Initially, biofilms of C. albicans genotype A and B were grown on the acrylic disks in 
the CDFF for 72 h before being removed and treated with fluconazole (0.125, 0.25, 
0.5,  1   and  2  pg/ml)  for  1,  24  and  48  h.  Subsequently,  higher  concentrations  of 
fluconazole or miconazole were used (0.25, 2,  16, 64 and 256 pg/ml). Chlorhexidine 
was also used (0.019, 0.15, 0.3, 1.25 and 2.5 %) against these biofilms for 1, 5 and 15
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minutes.
In separate  experiment, the  susceptibility of biofllms of different ages  (2,  6, 24, 48 
and 72 h) was  also  investigated.  These biofilms were treated for  1, 24 and 48 h in 
fluconazole or miconazole (256 pg/ml) or in chlorhexidine (0.019 %) for 1, 5 and 15 
minutes. The biofilms were then removed from the antifungal agents and placed in 1  
ml of PBS and vortexed vigorously for  1   minute to remove any organisms from the 
surface  and  plated  onto  SDA.  Plates  were  then  incubated  at  37  °C  for  24  h. 
Subsequently,  the  post-biofilm MIC  of any remaining  colonies present on the  agar 
was determined.  This is achived using NCCLS susceptibility testing using the same 
protocol as described previously (refer to section 2.5).
171Chapter 5_______________________________ The susceptibility of Candida albicans biofilms to antifungal and antimicrobial agents
Table  5.1:  Different  concentrations  of fluconazole  or  miconazole  used  against  C. 
albicans biofilms related to the planktonic MIC.
Times planktonic MIC Fluuconazole or miconazole 
concentration (pg/ml)
0.5 X MIC 0.125
MIC 0.25
2 X MIC 0.5
4 X MIC 1
8 X MIC 2
64 X MIC 16
256 X MIC 64
1024 X MIC 256
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Table  5.2:  Different  concentrations  of  chlorhexidine  used  against  C.  albicans 
biofilms related to the planktonic MIC.
Times planktonic MIC Chlorhexidine concentrations 
(%)
0.5 X MIC 0.019
MIC 0.04
4 X MIC 0.15
8 X MIC 0.3
32 X MIC 1.25
64 X MIC 2.5
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Figure  5.1:  Almar  blue  containing  multiwell  plate  used  to  test  the  antifungal 
susceptibility  of  C.  albicans.  Wells  arranged  within  columns  contain  different 
concentrations of fluconazole and each row contains a different isolate.
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5.3 RESULTS
The  susceptibility  of  C.  albicans  biofilms  to  fluconazole,  miconazole  and 
chlorhexidine was investigated using CDFF. Initial studies showed that the planktonic 
MIC of C. albicans genotype A and B was 0.25 pg/ml for fluconazole and miconazole 
and 0.04 % for chlorhexidine.
Figure 5.2 shows the exposure of 72 h genotype A C.  albicans biofilms to different 
concentrations of fluconazole (0.125, 0.25, 0.5, 1 and 2 pg/ml) for 1, 24 and 48 h. The 
results show that C. albicans biofilms were resistant to the action of fluconazole at all 
concentrations used up to 8 X MIC (2 pg/ml). Accordingly, higher concentrations of 
fluconazole were used against biofilms for the second experiment (Figure 5.3). These 
biofilms were still found to be resistant to fluconazole up to 1024 X MIC (256 pg/ml). 
Similar results were also observed for genotype B (Figure 5.4). Indeed there was no 
difference  between  the  values  obtained  for  biofilms  of  each  genotype.  The 
susceptibility of genotype A C. albicans biofilms of various ages (2 -  72 h) was also 
investigated  by  exposing  these  biofilms  to  sub-biofilm  MIC  concentration  (256 
pg/ml) of fluconazole for 1, 24 and 48 h (Figure 5.5a-c). At an early biofilm age (2 h), 
C.  albicans  biofilms  were  susceptible  to  fluconazole,  however,  the  degree  of 
susceptibility decreased with an increase in biofilm age. At no time point were there 
any significant differences  (p >  0.05) between any of the  control  and test biofilms. 
However, compared to the control biofilms, a decrease of approximately  1   logio (p < 
0.05)  was  observed  during  early  biofilm  formation  at  2  and  6  h  and  at  2  h when 
exposed to fluconazole for 24 h (Figure 5.5b) and 48 h (Figure 5.5c) respectively.
The same series of experiments were also carried out for miconazole (Figure 5.6, 5.7 
and 5.8). It was also demonstrated that 72 h biofilms of C. albicans genotype A and B 
were resistant to miconazole up to 1024 X MIC (256 pg/ml). Again no difference was
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observed  between  the  two  genotypes.  When  genotype  A  C.  albicans  biofilms  of 
various ages were  exposed to  (256  pg/ml) miconazole (Figure  5.8a-c), a significant 
decrease (p < 0.05) in CFU was observed during early biofilm formation at 2 and 6 h 
compared to the control biofilms.
Figure  5.9  shows  the  susceptibility  of genotype  A  C.  albicans  biofilms  to  various 
concentrations  (0.019,  0.15,  0.3,  1.25  and 2.5  %)  of chlorhexidine  for  1,  5  and  15 
minutes.  The  results  show  that  chlorhexidine  was  effective  at  inhibiting  biofilm 
growth at a concentration of 0.3 %, however, significant reductions (p < 0.05) of over 
2 logio CFU was also observed when the biofilm was exposed to 0.15 % for 5 and 15 
minutes, compared to a 1   minute exposure. In contrast, when C.  albicans genotype B 
biofilms  were  treated  under  the  same  conditions  (Figure  5.10),  there  was  total 
inhibition of growth at a concentration of 0.15 %. When biofilms of various ages were 
exposed to sub-MIC (0.019 %) concentration of chlorhexidine for 1, 5 and 15 minutes 
(Figure 5.1 la-c), a decrease in CFU of C. albicans were observed during early biofilm 
formation  (2-6  h).  When the  exposure time  was  extended to  15  minutes,  greater 
reductions in viable counts were observed at the early time periods. When the MIC of 
post biofilm  organisms  were  determined,  the  results  were  found to  be the  same  as 
those obtained by planktonic cells prior to treatment with antifungals.
In summary, the results have shown that C. albicans biofilms were highly resistant to 
(<1024  X  MIC)  fluconazole  and  miconazole  compared to  the  same  cells  grown in 
suspension. However,  in contrast, chlorhexidine inhibited the growth of C.  albicans 
biofilms at concentration of up to 8 x MIC (Table 5.3). When biofilms of different age 
were  exposed  to  sub-MIC  levels  of  antifungal  agents,  both  miconazole  and 
chlorhexidine were effective in inhibiting growth of early biofilm formation (2 and 6 
h).
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Figure 5.2: Growth of genotype A C. albicans biofilms grown on denture acrylic for 
72 h and exposed to concentrations up to 2 pg/ml of fluconazole for 1, 24 and 48 h. 
Error bars represent standard deviations.
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Figure 5.3: Growth of genotype A C. albicans biofilms grown on denture acrylic for 
72 h and exposed to concentrations up to 256 pg/ml of fluconazole for 1, 24 and 48 h. 
Error bars represent standard deviations.
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Figure 5.4: Growth of genotype B C. albicans biofilms grown on denture acrylic for 
72 h and exposed to concentrations up to 256 pg/ml of fluconazole for 1, 24 and 48 h. 
Error bars represent standard deviations.
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Figure 5.5: Growth of genotype A C. albicans biofilms grown on denture acrylic for 
2, 6, 24, 48 and 72 h and exposed to 256 pg/ml of fluconazole for; a) 1  h, b) 24 h and 
c) 48  h.  Open bars  = control  and filled bars =  exposure to  fluconazole.  Error bars 
represent standard deviations.
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Figure 5.6: Growth of genotype A C. albicans biofilms grown on denture acrylic for 
72 h and exposed to concentrations up to 256 pg/ml of miconazole for 1, 24 and 48 h. 
Error bars represent standard deviations.
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Figure 5.7: Growth of genotype B C. albicans biofilms grown on denture acrylic for 
72 h and exposed to concentrations up to 256 pg/ml of miconazole for 1, 24 and 48 h. 
Error bars represent standard deviations.
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Figure 5.8: Growth of genotype A C. albicans biofilms grown on denture acrylic for 
2, 6, 24, 48 and 72 h and exposed to 256 pg/ml miconazole for; a) 1  h, b) 24 h and c) 
48  h.  Open  bars  =  control  and  filled  bars  =  exposure  to  miconazole.  Error  bars 
represent standard deviations.
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Figure 5.9: Growth of genotype A C. albicans biofilms grown on denture acrylic for 
72  h  and  exposed to  concentrations up to  2.5  %  of chlorhexidine  for  1,  5  and  15 
minutes. Error bars represent standard deviations.
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Figure 5.10: Growth of genotype B C. albicans biofilms grown on denture acrylic for 
72 h  and  exposed  to  concentrations  up  to  2.5  %  of chlorhexidine  for  1,  5  and  15 
minutes. Error bars represent standard deviations.
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Figure 5.11: Growth of genotype A C. albicans biofilms grown on denture acrylic for 
2,  6,  24,  48  and  72 h and exposed to 0.019 % chlorhexidine  for;  a)  1   minute, b) 5 
minutes  and  c)  15  minutes.  Open  bars  =  control  and  filled  bars  =  exposure  to 
chlorhexidine. Error bars represent standard deviations.
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Table 5.3:  Concentration of fluconazole, miconazole  and chlorhexidine required to 
inhibit growth of C. albicans.
Agent  Planktonic  72 h biofilms  x MIC
Fluconazole (qg/ml)  0.25  >256  >1024
Miconazole (ng/ml)  0.25  >256  >1024
Chlorhexidine digluconate (%)  0.04  0.3  8
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5.4: DISCUSSION
Biofilm resistance  is a phenomenon consistently expressed across microbial biofilm 
systems  (Hawser  and  Douglas,  1995;  Donlan  and  Costerton,  2002;  Gilbert  et  al., 
2002).  Such resistance may explain the persistence of many infections (Costerton et 
al., 1999) and is likely to be of great clinical relevance (refer to section 1.3.7).
The mechanisms contributing to increased antifungal resistance of candidal biofilms 
have not been defined. Several possibilities have been investigated, including effect of 
growth rate  (Baillie  and  Douglas,  1998a),  nutrient limitation  (Baillie  and Douglas, 
1998b),  the  protective  nature  of exopolymer  matrix  (Baillie  and  Douglas,  2000), 
multidrug  efflux  pumps  (Ramage  et  al.,  2002a)  and  the  differential  expression  of 
candidal biofilm genes that are not expressed when in the planktonic phase of growth 
(Chandra  et  al.,  2001a).  Additionally,  Baillie  and  Douglas  have  also  shown  that 
biofilms  formed  on  two  different  types  of  catheter  material  posses  different 
susceptibilities to amphotericin B, suggesting that drug resistance may be related to 
the expression of surface-induced genes (Baillie and Douglas, 2000).
Previous  studies  have  showed  that  C.  albicans  biofilms  grown  on  denture  acrylic 
exhibits  resistance  to  antifungal  agents  (amphotericin  B,  nystatin,  fluconazole  and 
chlorhexidine) used to treat DRS (Chandra et al., 2001b). The results of the present 
study are  in agreement with earlier studies in that C.  albicans biofilms were highly 
resistant to the  antifungal  agents (fluconazole and miconazole) and an antimicrobial 
agent (chlorhexidine), although this agent was able to inhibit biofilm growth at lower 
concentrations. It has been shown previously that fluconazole was ineffective against 
candidal biofilms (Ramage et al., 2002b). Indeed Kuhn and co-workers showed that 
Candida  biofilms  formed  on  silicon  elastomer  rapidly  (within  6  h)  exhibited 
fluconazole resistance compared to planktonic cells (Kuhn et al., 2002a). Hawser and
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Douglas also showed that C. albicans biofilm (48 h) formed on catheter material were 
more  resistance  than  planktonic  cells  to  the  action  of  five  clinically  important 
antifungal  agents  (amphotericin  B,  flucytosine,  fluconazole,  itraconazole,  and 
ketokonazole) (Hawser and Douglas, 1995).
It  has  been  shown  previously  using  planktonic  cells  that  strains  of  C.  albicans 
genotype A, B and C have different susceptibilities to flucytosine (McCullough et al., 
1999a). The results of the present work have also highlighted differences between the 
susceptibilities of two genotypes when exposed to chlorhexidine. However, exposure 
to fluconazole or miconazole showed no such differences.
When re-suspended cells were grown on solid media and then the MIC tested, these 
were no longer resistant to the three agents thus demonstrating that the phenotype was 
reversible,  a  phenomenon  which  has  previously  been  demonstrated  (Baillie  and 
Douglas,  1998a). Kuhn and co-workers have investigated the effect of pre-incubation 
of initial culture of C. albicans with sub-MIC levels of antifungal drugs. They showed 
a decrease in the ability of C. albicans cells to form a biofilm (Kuhn et al., 2002b). In 
the present study C. albicans biofilms of different ages were also exposed to sub-MIC 
level of antifungal  agents  and the results show more  susceptibility of early biofilm 
formation than mature biofilm thus indicating the importance of this formation phase. 
Biofilm  resistance  mechanisms  are  complex  and  multifactors  may  be  involved 
(Ramage  et al.,  2002a).  Although the exact mechanism  of biofilm resistance is not 
known, a possible resistance mechanism may be related to a slow growth rate within 
biofilms that delay the uptake of drugs (Donlan and Costerton, 2002; Douglas, 2003), 
and  increased  EPS  production.  Previously,  it has  been  shown that mature  biofilms 
contain  more  EPS  material  than  younger  biofilms  (Chandra  et  al.,  2001a).  This 
material may preclude drug penetration (Gilbert et al.,  1997; Douglas, 2003). In the
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current study,  early biofilms were more  susceptible to  drugs  compared to a mature 
biofilms,  and  biofilm  resistance  increased with  increasing  biofilm  age.  This  would 
expect that cells  within young biofilms have  a higher  growth rate  and contain less 
EPS material. However, a previous study has shown that low growth rate did not have 
a major influence on the susceptibilities of a biofilm to the drug (Baillie and Douglas, 
1998a). In addition, it has been demonstrated that biofilm matrix does not constitute a 
significant barrier to antifungal drugs indicating that drug resistance is unrelated to the 
extent  of  matrix  formation  (Baillie  and  Douglas,  2000).  Thus  the  matrix  may 
contribute  to  overall  resistance,  but  is  not  considered  as  a  sole  determinant  of 
resistance (Ramage et al., 2002a) and that it may play only a minor role in biofilm 
resistance (Baillie and Douglas, 1998a).
Chandra  and  co-workers  have  evaluated  the  structure  of C.  albicans  biofilms  and 
indicated  three  phases  of growth;  early,  intermediate  and  mature  phases  extending 
over 72  h.  They  showed  that mature  biofilms were  highly  resistant to  fluconazole, 
amphotericin B, nystatin and chlorhexidine and this resistance developed over time, 
coincident with biofilm maturation (Chandra et al., 2001a). Hence, the current study 
was carried out over the same time period to encompass these phases.
Recently, it has been reported that newly developed antifungal agents were effective 
against Candida biofilms.  For example, caspofungin displayed > 99 % killing of C. 
albicans cells  within a biofilm  (Ramage  et al.,  2002b).  Kuhn and co-workers have 
shown that Candida biofilms were resistance to two new triazoles (voriconazole and 
ravuconazole),  however,  lipid  formulations  of amphotericin  B  and  echinocandins 
appeared to have  activity against Candida biofilm  (Kuhn et al., 2002b). Bachmann 
and  co-workers  also  showed  that  caspofungin  can  affect  cellular  morphology  and 
metabolic  status  of cells within the biofilm  and displayed a potent in vitro activity
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against C. albicans biofilms (Bachmann et al., 2002). These drugs have been recently 
introduced and all of the experiments were carried out in vitro using biofilm or animal 
models. Hence, the efficacy of these drugs with its pharmacokinetic and toxicological 
properties needs further investigation before these new antifungals can be used for the 
treatment of oral candidosis in vivo.
To understand biofilm  development,  data must be reproducible  from  experiment to 
experiment.  One  approach  to  reproducibility  is  to  develop  constant  depth  reactors 
where surface growth is periodically removed to maintain a constant geometry. Such a 
device, which employs a mechanical scraper bar, is the CDFF which was designed to 
investigate  the  growth of dental  plaque  organisms.  Although previous  studies  have 
indicated  differences  in  susceptibilities  between  antifungal  compounds  over  time 
(Chandra et al., 2001a), none have demonstrated this using an in vitro model designed 
to  study  oral  biofilms.  Indeed,  although  this  model  has  been  used  extensively  for 
studying the susceptibility of bacterial biofilms this work describes its first application 
for studying the susceptibility of fungal biofilms.
In  conclusion,  the  results  of this  study shown that  C.  albicans  biofilms  are  highly 
resistant to both antifungal and antimicrobial agents and this resistance depends upon 
the age of biofilm and on the type of the agent used.  Interestingly, there were large 
differences  in  the  degree  of  susceptibility  of  C.  albicans  biofilms  between 
fluconazole,  miconazole  and  chlorhexidine  with the  latter being the most effective. 
The observed differences for biofilms of different ages gives some indication as to the 
mechanism involved in reduced biofilm susceptibility.
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6.1  INTRODUCTION
Previous chapters have focused upon single species C.  albicans biofilms. However, 
in order to study the microflora associated with DRS in which a combination of C. 
albicans and other microorganisms is to be expected (Kulak et al.,  1997), a mixed 
species biofilm will be investigated in this chapter.
Most  biofilms  formed  in  the  oral  cavity  are  composed  of  a  mixture  of 
microorganisms.  This  adds  to  the  inter  and  intra-species  interactions  and  to  the 
complexity  of the  mixed-species  biofilm  present.  C.  albicans  remains  the  most 
commonly isolated fungal  species from the mixed bacterial-fungal biofilm of DRS 
patients  (Martin-Mazuelos  et  al.,  1997;  McMullan-Vogel  et  al.,  1999).  The 
formation of Candida biofilms on dentures may assist the  survival of fungal cells 
and  contribute  to  the  progression  of  the  disease  process  in  patients  with  DRS 
(Ramage et al., 2004).
Although the primary causative organism in DRS is C.  albicans, other oral bacteria 
(Koopmans et al.,  1988) and non-albicans Candida species (McMullan-Vogel et al., 
1999;  Dorko  et  al.,  2001)  are  also  present.  Adhesion  interactions  between  C. 
albicans and oral bacteria are generally thought to play a critical role in microbial 
colonisation  of denture  acrylic  and consequently  DRS  (Millsap  et al.,  1999).  For 
example, oral bacteria play a complex role in regulating the adhesion of C. albicans 
to acrylic denture surfaces (Samaranayake et al.,  1980) and possibly enhance fungal 
attachment via co-aggregation and synergistic interactions with the fungi (Sato et al., 
1997).
Dentures  are  considered  as  an  important  predisposing  factor  for  DRS  (Budtz- 
Jorgensen,  1990).  Denture  plaque  can  function  as  a  biofilm  and  represent  a 
protective reservoir for oral microbes (Budtz-Jorgensen et al.,  1996; Chandra et al.,
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2001b)  especially  in  ill-fitting  dentures  and  in  patients  with  poor  oral  hygiene 
(Ellepola  and  Samaranayake,  1998).  In  an  examination  of 50  denture  stomatitis 
patients,  it was  found that greater numbers  of Candida  spp.  were recovered from 
smears prepared from the  fitting surface of upper dentures than from those on the 
palatal mucosa.  It was  concluded that treatment intended to  reduce the  number of 
Candida  spp.  present  should  be  directed  to  the  denture  rather  than  the  mucosa 
covering the denture (Davenport,  1970).  However, removal of these biofilms from 
dentures is difficult due to the inherent resistance of biofilms to antimicrobial agents 
(Gilbert et al., 1997).
Traditional treatment of candidal infections is bimodal: firstly to remove the source 
and  secondly  to  eliminate  the  infection  from  tissues  (McIntyre,  2001).  These 
procedures  include  oral  and  denture  hygiene  improvement,  discontinuation  of 
nocturnal denture wear, the use of topical or systemic antifungal agents and eventual 
denture replacement (Webb et al., 1998c; Pires et al., 2002). Fundamentally, patients 
must maintain adequate oral and denture hygiene in order to reduce the likelihood of 
DRS (Pires et al., 2002). For more detailed of DRS treatment, refer to section 1.5.6. 
Several  studies  have  investigated  the  susceptibility  of C.  albicans  single-species 
biofilms  to  antifungal  agents  (Chandra et al.,  2001a).  However,  there  are no  data 
concerning antimicrobial susceptibility of fungi within a microflora more likely to be 
associated  with  DRS.  Hence,  the  aim  of the  present  study  was  to  determine  the 
composition of the in vivo and in vitro denture plaque population in which Candida 
spp. are maintained and the susceptibility of this organism when it is part of mixed 
fungal and bacterial biofilms in vitro.
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6.2  MATERIALS AND METHODS
Samples were obtained from  10 individuals attending the Eastman Dental Hospital, 
UCLH,  as  described  previously  (refer  to  section  2.2.3).  Ethical  approval  for this 
study  was  granted  by  the joint  University  College  of London/University  College 
London Hospital Trust Committee on the ethics of Human Research (refer to section 
2.2.1).  Serial dilutions were plated onto a range of non-selective and selective agars 
(refer to section 2.4.5.2). Images of Candida spp. grown on SDA of both control and 
DRS patients were visualised microscopically (x 400 magnification).  Candida spp. 
which were recovered from the denture and mucosa samples were further identified 
to the species level using different methods including, CHROMagar, API® Candida 
kit and ComMeal Agar as described previously (refer to section 2.9).
Denture acrylic (self-cured) disks were used as the substrata for biofilm production. 
All  the  disks  were  prepared  to  the  same  surface  roughness  (Ra  =  2.5  pm)  using 
silicon carbide grit on a Knuth Rotor as described previously (refer to section 2.1.1). 
The  Ra  values  for  denture  acrylic  among  patients  wearing  dentures  vary 
considerably;  however,  the value used is within the  range  expected for the fitting 
surface  of denture  acrylic.  Artificial  saliva  was  used  as  nutrient  source  in  these 
experiments (refer to section 2.3).
A 2 ml mixture consisting of denture and mucosa samples from each DRS patient 
was used as an inoculum for the CDFF experiments as described previously (refer to 
section 2.4.2.2). Biofilms were allowed to grow on acrylic disks in the CDFF for 504 
h. At various times interval (2, 6, 24. 48, 72, 96, 336 and 504 h), pans were aseptically 
removed  from  the  CDFF  and the  predominant bacterial  and candidal  genera were 
determined.  Biofilms  from  the  same  experiment  were  tested  against  fluconazole, 
miconazole  and chlorhexidine.  Disks, containing the biofilms, were removed from
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the  CDFF  after  72  h  growth  and  placed  in  fluconazole  or  miconazole  each  at 
concentrations  of 0.25,  2,  16,  64,  and 256  pg/ml and chlorhexidine digluconate at 
concentrations of 0.019, 0.15, 0.3,  1.25, and 2.5 %. The biofilms were then treated 
for 24 h in fluconazole or miconazole or for  15  minutes in chlorhexidine at 37°C. 
The biofilms were then vortexed vigorously for  1   minute to remove any cells from 
the surface and plated onto SDA for all antifungal agents and onto CBA and FAA 
for chlorhexidine sample.
In  a  separate  experiment,  the  microbial  genera  from  patients  suffering  from  DRS 
were compared to those from 72 and 240 h biofilms obtained from CDFF prior to 
pulsing  of the  antifungal  agents.  After 240 h biofilm  growth,  the  susceptibility of 
biofilms  was  determined against miconazole gel  solutions  (Daktarin® gel, Johnson 
and Johnson, Beerse, Belgium; dissolved in dF^O to give a final concentration of 48 
pg/ml) and chlorhexidine (0.2 %) being pulsed into the CDFF for 5 minutes, twice 
daily  for  168  h.  All  of  the  CDFF  experiments  were  carried  out  in  duplicate. 
Statistical  analysis  was  performed  using  the  student’s  t-test  (two-sample)  to 
determine p-values.
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6.3  RESULTS
The aim of this part of the  study was to produce denture plaque biofilms in an in 
vitro  model.  Firstly,  bacteria and  Candida  genera recovered from patient samples 
were identified from control subjects and from those patients with DRS (Table 6.3). 
The number of Candida recovered from the denture fitting surface was higher than 
those  originating  from  the  mucosal  surface.  Through  the  visualization  of colony 
morphology  on  SDA,  4  different  isolates  were  observed  from  the  control  group 
(Table 6.1), while 6 isolates were seen in the DRS group (Table 6.2). An attempt was 
made  to  further  identify  Candida  to  the  species  level  using  three  different 
identification  methods  (CHROMagar,  API®  Candida  kit  and  ComMeal  Agar).  C. 
albicans  was  the  most  predominant  species  identified  from  both  groups  i.e.  the 
mucosa and denture samples.  However, using the CHROMagar and API® Candida 
tests, identification of one species was not always possible.
Table 6.3 shows the range in CFU of selected genera within the patient samples and 
the mixed-species biofilms  grown from these  samples.  There was a large range in 
microbial numbers between the control group and those patients with denture related 
stomatitis.  Hence,  there  were  no  significant  differences  between  any  of the  two 
patient groups (p > 0.05) or the sample sites (p > 0.05).  Interestingly, 50 % of the 
sites from the control group contained no Candida species (range 0 - 3.7 x 105 CFU 
per sample), but all the DRS patients harboured this genus at both sites (range 8.2 x 
10-2.8 x 10  CFU per sample). Candida spp. were always isolated in vitro from the 
CDFF with a range of 2.7 x 106 - 1  x 107 CFU per biofilm.
The percentage range of genera in DRS patients and in the CDFF is shown in Table 
6.4. The Streptococcus spp. and Actinomyces spp. predominated with up to 76 % and 
55 % of the population represented by these genera respectively. The proportions of
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Candida  spp.  in  vitro  and  in  vivo  were  similar  with  a  smaller  percentage  range 
observed in the model system.
The growth of in vitro mixed-species biofilms derived from DRS patients sample is 
shown in Figure 6.1. The results show that all microbial genera originally recovered 
from the DRS patients were able to grow in the model system. There was a steady 
increase  in  both  bacterial  and  fungal  numbers  until  96  h  with  a  total  count  of 
approximately  2  X  108   CFU/biofilm.  After  this  time  biofilm  growth  was  stable 
except  for  the  Lactobacillus  spp.  which  dropped  dramatically  at  336  h  before 
recovering towards the  end of the experiment.  The  susceptibility  of Candida spp. 
within  this  mixed-species  biofilms  (72  h)  were  tested  against  fluconazole  or 
miconazole  as  detailed  in Figure  6.2.  This  genus  was  resistant to  both  antifungal 
agents at a concentration of < 256 pg/ml. Chlorhexidine was ineffective at inhibiting 
growth when used in a concentration of up to 0.3 % (Figure 6.3). However, growth 
of the Candida spp. was significantly reduced (p < 0.05) by approximately 4 logio in 
1.25  %  chlorhexidine  and  no  growth  was  observed  in  2.5  %  chlorhexidine 
concentration.  Figure  6.4  shows  the  effect  of  different  concentrations  of 
chlorhexidine  on  both  the  aerobic  and  anaerobic  bacterial  species  compared  to 
Candida spp.  It can be  seen that the total  aerobic  and  anaerobic populations were 
resistance to chlorhexidine at concentrations of up to 0.3 %. When the mixed-species 
biofilms  were  exposed  to  1.25  %  concentration  of  chlorhexidine,  a  significant 
reduction (p < 0.05) of approximately 3 logio was observed. However, these bacteria 
were  still  resistance  to  2.5  %  concentration  of chlorhexidine  despite  a  significant 
reduction (p < 0.05) of approximately 2 logio at this higher concentration.
The  susceptibility  of the  microcosm  denture  plaque  was  also tested by pulsing in 
miconazole and chlorhexidine to represent a treatment regime for 168 h (Figure 6.5).
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The total anaerobic count was unaffected by the initial pulse, but over a period of 96 
h the total count was reduced by approximately 3.5 logio (p < 0.05). After this time, 
between 144h and 168 h post-pulsing, there was an increase in the total viable counts 
by over  1   logio.  The number of Candida spp. was also reduced by over 2 logio (a 
99.9 % kill) until after 120 h where again an increase in numbers was observed.
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Table 6.1: Identification of different Candida spp. of control patients.
Description  Image  Mucosa  Denture  Identification  Identification  Identification
on SDA  by  by API®  by CornMeal
CHROMagar  Candida Kit  agar
Large convex 
circular white
+  C. albicans/  C. a
C. tropicalis /
others
Medium + + C. albicans / C. albicans / C. albicans
convex r  4 R jr  -   ;   '   if
C. tropicalis C. tropicalis
circular white i i iii iiii
Small convex ■H
•   3
+ + C. albicans / C. albicans / Not identified
circular white  ,
.  «
tf-.  a Pv *   - I   tin
l i i i i l i
C. tropicalis/ 
C. krusei
C. keyfer
+ C. krusei Not identified Not identified Hazy raised |  +
transparent  •
l i i i i l i
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Table 6.2: Identification of different Candida spp. of DRS patients.
Description  Image  Mucosa  Denture  Identification  Identification  Identification
on SDA  by  by API®  by CornMeal
CHROMagar  Candida Kit  agar
Large convex  ■  
circular white
+ C. albicans C. albicans C. albicans
H B iiU i;; huma
Medium
'  •  ]
convex p*  iff-*
circular white [ j
Small convex
3m
circular white  j
1
Very small 
convex 
circular white
Irregular 
convex shape 
large
Irregular 
convex shape 
small
+
+
+
+
+
+
+
C. albicans /  C.  albicans /  C. albicans
C. tropicalis  C.  tropicalis/
C. famata
C. albicans /  C.  albicans /  Not identified
C. tropicalis /  C.  keyfer/C.
C. krusei  famata
Others Not identified C. kefyr /
Saccharo-
cerevisiae
c. albicans/  C. albicans
C. tropicalis /
C. krusei
C. albicans /  q  albicans /   ^ ot identified
C. tropicalis /  C. famata
C. krusei
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Table 6.3:  The  range  in number (CFU) of selected genera from patients with and 
without DRS compared to the numbers obtained in vitro (72 -  240 h).
Control: 
mucosa 
n = 5
Control: 
Denture 
n = 5
DRS: 
Mucosa 
n = 5
DRS:
Denture
N = 5
Microcosm 
denture 
plaque 
n = 12
Total aerobes 2.6x105 - 2.2x10s - 8.3x10s - 7.4x10s- 7.8xl07-
8.2x106 1.8xl06 1.3xl07 2.2xl07 5.1x10®
Total anaerobes 7.2x105  - 4.5x10s- 1.7xl06- 5.7x10s - 1.6x10®-
1.2xl08 7.4xl07 7.2x106 7.7xl07 3.3x10®
Actinomyces spp. 3.4xl05  - 4.8x10s - 2.9x10s - 2x10s - 4.7xl07-
5.3xl06 1.4xl07 2.8xl06 3.5xl07 8.8xl07
Candida spp. 0 - 0 - 8.2x103  - 1.5xl04- 2.7xl06-
2.4xl04 3.7x10s 6.5x10s 2.8xl06 lxlO7
Lactobacillus spp. 0 - 0 - 0 - 0 - 3.9x10s-
7.6x105 4.8xl07 3.4x104 6.6x103 5.4x10s
Streptococcus spp. 2.2x10s- 2xl04- 3.6x10s - 3.7x10s- 5.2xl07-
9.1x10s 8.9x106 2.1xl06 2.8xl07 2.5x10®
Veillonella spp. 4.9xl04- 1.2xl04- 0 - 0 - lxlO7-
1.4xl06 1.1x10s 2.9x10s 1.2xl07 1.3xl07
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Table  6.4:  The  range  (%)  in  compositions  of genera  present  on the  mucosa and 
denture surfaces of patients suffering from DRS and from the CDFF (combined data 
from 72 and 240 h). Data represent the range of each type of organism expressed as a 
percentage of the total anaerobic viable count.
% range in DRS 
patients
% range in microcosm 
denture plaque
Actinomyces spp. 17-45 14-55
Candida spp. 0.5-9 2-3
Lactobacillus spp. 0-0.5 0.2-0.3
Streptococcus spp. 21-65 33-76
Veillonella spp. 0-15 3-8
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Figure 6.1: Viable count of microorganisms present in a mixed-species biofilm after 
growth  in  CDFF  for  504  h.  Symbols  represent:  aerobic  count  (open  squares), 
anaerobic count (open triangles), Actinomyces spp.  (filled diamonds), Candida spp. 
(dotted  line),  Lactobacillus  spp.  (filled  squares),  Streptococcus  spp.  (crosses)  and 
Veillonella spp. (filled triangles).
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Figure  6.2:  Viable  counts  of  Candida  spp.  of  the  72  h  biofilm  in  different 
concentrations  of fluconazole  (open  bars)  or  miconazole  (filled  bars).  Error  bars 
represent standard deviations.
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Figure  6.3:  Viable  counts  of  Candida  spp.  of  the  72  h  biofilm  in  different 
concentrations  of  chlorhexidine.  Error  bars  represent  standard  deviations. mi.
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Figure 6.4: Viable counts of Candida species, aerobic and anaerobic bacteria of the 
72  h  biofilm  in  different  concentrations  of  chlorhexidine.  Error  bars  represent 
standard deviations.
■ Candida spp.
■ Aerobic bacteria
□ Anaerobic bactere
203Chapter 6 Composition of in vitro denture plague biofilms and susceptibility to antifungals
l.E+09
l .E+08  -
l.E+07
l.E+06
o  l .E+05
l.E+04
l.E+03
l.E+02
l.E+01
l.E+OO
450 400 50 350 100 250 300 150 200
T im e (hours)
Figure 6.5: Number of microorganisms of a mixed-species biofilm prior to pulsing 
with  miconazole  and  chlorhexidine  and  after  240  h  pulsing.  Further  pulsing  was 
carried out twice-daily.  Symbols represent: aerobic count (open squares), anaerobic 
count  (open  triangles),  Actinomyces  spp.  (filled  diamonds),  Candida  spp.  (dotted 
line), Lactobacillus spp. (filled squares), Streptococcus spp. (crosses) and Veillonella 
spp. (filled triangles).
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6.4 DISCUSSION
Denture  related  stomatitis  is  a  chronic  infection  which  associated  with  denture 
wearers  (Webb et al.y   1998b).  However, there have been relatively few studies on 
such mixed bacterial-fungal biofilms generated in vitro.
Adherence of C.  albicans to the acrylic surface is considered as the first step in the 
pathogenesis  of DRS  (Ellepola  and  Samaranayake,  1998).  The  denture  acts  as  a 
reservoir  for dissemination of fungal cells and continuous infection of the mucosa 
despite the presence of salivary antimicrobial factors (Budtz-Jorgensen etal., 1996). 
Additionally, the surface of the denture usually has micropits and imperfections that 
can harbour microorganisms (Ramage et al., 2004) and may obscure mechanical or 
chemical removal of these organisms.
Different microbial species have frequently been reported and associated with DRS. 
The  clinical  samples  from  the  present  study  were  evaluated  for  the  presence  of 
several  key  oral  microbial  genera  including  Candida  spp.,  Actinomyces  spp., 
Lactobacillus  spp.,  Streptococcus  spp.,  and  Veillonella  spp.  Candida  spp.  were 
recovered  from  all  of the  DRS  patients  compared  to  only  half from  the  control 
samples, a result also observed by previous workers (Cross et al., 2004).
The predominant organisms were streptococci, an observation which has also been 
reported  previously  (Koopmans  et  al.,  1988).  The  development  of multi-species 
biofilm  communities  is  influenced  by  co-aggregation  (Foster  and  Kolenbrander, 
2004) and bacteria are often associated with Candida spp. in mixed-species biofilms 
in  vivo  (Douglas,  2003).  There  is  also  evidence  that  co-aggregation  of  oral 
streptococci enhances fungal colonisation on denture surfaces thereby increasing C. 
albicans  attachment  (Verran  and  Motteram,  1987).  Nair  and  Samaranayake  also 
shown that adhesion of yeasts to  acrylic  surfaces is modulated by the pre-existing
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bacterial flora on these surfaces (Nair and Samaranayake,  1996). Thus it is possible 
that this  interaction of bacteria with C.  albicans  can influence colonization of the 
yeast to soft and hard surfaces in the oral cavity (Jenkinson et al., 1990).
The increase of immunocompromised patients has resulted in the emergence of non- 
albicans Candida spp. that are associated with DRS  (Egusa et al., 2000; McIntyre, 
2001).  Several  studies  have  demonstrated  different  Candida  spp.  isolated  from 
patients with DRS  (Cross et al.,  1998; McMullan-Vogel et al.,  1999; Dorko et al., 
2001; Pires  et al.,  2002).  However,  other studies have  show that only C.  albicans 
were  isolated  from  the  palatal  and  denture  surfaces  of study  patients {Lai  et al., 
1992).  The  results  of the  present  study  have  shown  that the  number  of Candida 
recovered  from  the  denture  fitting  surface was  higher than those  originating from 
mucosal surface. This observation was consistent with previous findings (Davenport, 
1970;  Budtz-Jorgensen  et  al.,  1996)  and  supports  the  opinion  that  the  infection 
originates  from  the  area  underneath the  denture  in  which  the  acid  and  anaerobic 
bacteria  beneath  the  close-fitting  denture  favour  yeast  proliferation  (Budtz- 
Jorgensen, 1990).
The ideal method of identification of microorganisms should be highly reproducible 
and allow rapid examination of a large number of isolates with a minimum cost. The 
results  of  this  work  showed  that  there  was  a  variation  in  the  identification  of 
Candida  spp.  using  the  tests  employed.  For  example,  although  CHROMagar is  a 
convenient  method  for  identification  of  different  Candida  species,  it  can  be 
unreliable and may underestimate the presence of some Candida spp. particularly on 
secondary  culture  (Tintelnot  et  al.,  2000)  indicating  that  the  use  of traditional 
identification  techniques  may  be  unsuitable  in  characterising,  to  species  level,
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Candida spp. from DRS patients. Further work should employ molecular techniques 
in identifying species present (Al-Karaawi et al., 2002).
Due to the site specificity of plaque related diseases and the heterogeneous nature of 
dental  plaque  there  are  many  problems  associated  with  microbiological  sampling 
from the  oral  cavity.  Additionally, there are ethical problems with carrying out in 
vivo  studies  related  to  antibiotics,  antimicrobials  and  antifungals.  Testing  of such 
agents against denture biofilms has thus required the use of relevant in vitro models. 
Drake and co-workers have developed an in vitro bacteria-yeast colonization model 
to assess the efficacy of denture soaking agents against the microorganisms (Drake et 
al.,  1992).  In  the  present  study,  the  Constant Depth  Film  Fermentor was  used to 
model  in  vitro  growth  of DRS  by  growing  a  mixed-species  biofilm  on  denture 
acrylic disks which produced microcosm plaques of similar proportions to those seen 
in the patient samples. The development of in vitro models may help in studying the 
oral microflora implicated  in DRS. Previous  studies using this model  system have 
also  demonstrated  the  ability to  grow oral  microcosms  representing  dental plaque 
derived from saliva (Pratten et al.,  1998b) and malodorous tongue plaque (Pratten et 
al.,  2003).  The  results  of  the  current  study  have  shown  that  mixed  microbial 
populations  derived  from  clinical  isolates  recovered  from patients with DRS were 
able to form biofilms in vitro using the CDFF. However, the growth of some species, 
such as lactobacilli, was variable through the course of the experiment. This may be 
explained by the microbial interactions between different genera within the mixed- 
species biofilm. Such interactions within dental plaque include nutrition competition, 
dictating  the  prevalence  of particular  species  over  the  others,  or  as  a  secondary 
feeder in  which  the  metabolic  product of one  organism provide  a main source of 
nutrients  for  another  (Marsh,  1995).  These  interactions  help  different  microbial
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species to survive in environments where they may not otherwise persist.
Despite the use of antifungal drugs to treat DRS, the persistence of denture plaque on 
the denture fitting surfaces remains a problem. Chandra and co-workers (Chandra et 
al., 2001b) showed that C. albicans biofilms, grown in vitro, were highly resistant to 
the antifungal agents (fluconazole, nystatin, amphotericin B and chlorhexidine) used 
to treat DRS.  The results of the present study also showed that Candida spp. within 
mixed-species biofilms exhibit resistance to antifungal agents. As seen in the single­
species  work,  there  were  large  differences  in  the  degree  of  susceptibility  to 
fluconazole, miconazole and chlorhexidine. When Candida spp. were part of mixed- 
species  biofilm,  they were  still  able to  grow in concentrations  of antifungal  agent 
comparable to concentrations used against C.  albicans single-species biofilms (refer 
to  chapter  5).  Interestingly,  bacterial  species  were  resistance  to  chlorhexidine  at 
concentrations of up to 2.5  % compared to Candida spp.  which were killed at this 
concentration.
The clinical effectiveness of chlorhexidine in DRS has been known since the 1970’s. 
Budtz-Jorgensen and Loe have investigated the use of 2 % chlorhexidine gluconate 
as a denture disinfectant. They showed a significant amelioration of inflamed tissues 
beneath the denture (Budtz-Jorgensen and Loe,  1972).  Spiechowicz and co-workers 
also  showed  that  chlorhexidine  gluconate  was  totally  effective  in  preventing 
attachment and growth of C. albicans on acrylic resin (Spiechowicz et al., 1990). 
When the  antimicrobial  and antifungal  agents were used  in combination, although 
relatively  effective  over  short  periods  of time,  the  biofilms  became  increasingly 
resistant  to  the  dual-therapy.  It  appears  that  the  presence  of  C.  albicans  may 
modulate  the  action  of antibiotics  while  bacteria  can  affect  antifungal  activity  in 
mixed  fungal-bacterial  biofilms  thus  increasing  the  resistance  of a  mixed-species
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biofilm. For example, interactions between different matrix polymers, or indeed the 
viscosity  of  the  biofilm  matrix,  produced  by  different  species  may  reduce  the 
penetration of antifungal agents (Adam et al., 2002).
In  the  clinical  scenario  the  effect  of  fluconazole  alone  and  fluconazole  and 
chlorhexidine applied to the fitting surface of the denture has been evaluated. It was 
found  that  treatment  of DRS  for 2  weeks  with  fluconazole  tablets  once  a day  in 
conjugation with  2  %  concentration of chlorhexidine  solution  applied to the inner 
surface  of the  denture  twice  daily  resulted  in  a  greater  improvement  of palatal 
inflammation with a decrease in candidal  colonization than the use  of fluconazole 
alone or fitting new dentures without medication (Kulak et al.,  1994; Arikan et al., 
1995). Although relapse was observed after treatment, the incidence of recurrence in 
those  patients  treated  with  fluconazole  alone  was  higher  than  that  seen  after 
treatment with fluconazole in addition to chlorhexidine (Kulak et al., 1994).
In this study a model of denture plaque which contains Candida spp was developed. 
In vivo the heterogeneity of such biofilms may have an impact on the ability of an 
infection to respond to antimicrobial therapy (El Azizi et al., 2004). Hence, a better 
understanding  of denture  plaque  biofilms  may  help  to  the  development  of new 
therapeutic approaches for the treatment of DRS.
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Although  there  has  been  a  reduction  in  the  population  of edentulous  people  in 
developed  countries,  this  would  not necessarily  reflect  a reduction in DRS  in the 
population  group  wearing  complete  dentures  (Radford,  et  al.,  1999).  Dentures 
provide a suitable environment for growth and colonization of microorganisms. The 
yeast  Candida albicans is  frequently encountered as  a harmless commensal in the 
oral  cavity  (Akpan  and  Morgan,  2002).  However,  oral  candidosis  is  a  common 
opportunistic infection seen most commonly in compromised patients. Additionally, 
oral  yeast may be  more  strongly influenced by the presence  of local  oral  factors, 
such as the presence of dentures.
Denture  related  stomatitis  is the commonest form  of oral  candidosis.  It associated 
with wearing of dentures in which Candida albicans is the most common organism 
isolated (Wilson,  1998). It has been suggested that a combination of this yeast and 
oral  bacterial  species  are  likely  to  be  responsible  for the  disease.  Together,  these 
organisms can form denture plaque biofilm (Keng and Lim,  1996; Kulak-Ozkan et 
al.,  2002)  which  is  difficult  to  treat  because  of the  inherent  resistance  of these 
biofilms  to  antifungal  agents  (Ramage  et  al.,  2004).  Hence,  despite  the  use  of 
antifungal  drugs  to  treat  DRS,  the  recurrence  of this  disease  remains  a  problem 
(Budtz-Jorgensen et al., 1988; Bissell et al., 1993).
The  initial  aim  of this  work  was  to  set  up  an  in  vitro  model  to  establish  the 
conditions  suitable  for  the  development  of  C.  albicans  biofilm  formation  and 
evaluating  the  effectiveness  of antimicrobial  agents  against  candidal  biofilms.  A 
CDFF  was  used  to  grow the  biofilms  in order to  mimic  the  in vivo  scenario;  the 
biofilms  were  grown  in  an  aerobic  environment  on  relevant  oral  surfaces,  with 
nutrients  supplied  by  artificial  saliva.  The  results  of the  studies  showed  that  the 
model  produced  a  large  number  of  reproducible  biofilms  of  C.  albicans.  By
211Chapter 7 Conclusions and suggestions for further work
establishing  the  growth  of C.  albicans  biofilms  in  vitro,  it  allowed  the  study  of 
various factors which may be important in the disease process to be investigated.
The  first  of these  parameters  was  to  grow  C.  albicans  biofilm  on  relevant  oral 
surfaces (acrylic, enamel and dentine) and acrylic with different surface roughness. 
The results showed that the type of surface and the growth media used affected the 
initial  formation and development of C.  albicans biofilms.  Although there was no 
difference  between  biofilms  formed  on  self and  heat  cured  acrylic,  growth  of C. 
albicans biofilm on the dental hard tissues (enamel and dentine) was different when 
compared  to  biofilm  formed  on  self-cured  acrylic.  This  indicates  that  attention 
should  also  be  concentrated  on  dental  hard  tissues,  and  not  only  on  the  denture 
acrylic,  as these surfaces may harbour this organism and can present an additional 
reservoir for candidal infections.
The use of artificial  saliva in this work provided an appropriate growth medium in 
which both the yeast and hyphal forms of C. albicans were able to form by providing 
a conditioning film and consequently salivary pellicle formation on the surfaces and 
thus  help  to  initiate  biofilm  formation.  The  use  of YPD  (commonly  used  for the 
growth of C.  albicans) enhanced the initial growth of C.  albicans. This may be due 
to  the  sugar  content  of YPD  that has  been  shown to  improve  the  adhesion of C. 
albicans to the surface (Nikawa et al., 1997). However, artificial saliva and YPD can 
produce  characteristic  biofilms  containing  both  the  yeast  and  hyphal  forms  of C. 
albicans.
The  effect of surface roughness has been reported previously (Verran et al.,  1991; 
Verran  and  Maryan,  1997;  Radford  et  al.,  1998b).  However,  the  present  work 
evaluates  the  effect of surface roughness  on the  formation of C.  albicans biofilms 
using  CDFF.  Denture  acrylic  were  prepared  and  polished  with  different  surface
212Chapter 7 Conclusions and suggestions for farther work
roughness  in  order  to  mimic  an  oral  prosthesis  in  vivo.  The  results  showed  that 
surface  roughness  had  a  significant  effect  on  the  initial  biofilm  formation  of C. 
albicans,  however,  this  was  not true  for the  type  of acrylic  used.  When  different 
genotypes  of C.  albicans,  with  different  adherence  properties  were  used,  biofilm 
development was  unaffected by the  strain of organism, regardless of its virulence, 
highlighting the differences between adhesion assays and biofilm formation. 
Confocal laser scanning microscopy was used to investigate biofilm development on 
the various surfaces. It proved to be a convenient method of observing the structure 
of the biofilms. The use of this technique to investigate biofilm structure allowed the 
study  of the  spatial  arrangement  of the  biofilm.  The  results  showed  that  surface 
roughness had  a  significant effect on the initial  formation of C.  albicans biofilms. 
Previous study (Howser and Douglas,  1994) has shown that adhesion of C. albicans 
blastoconidia  to  a  surface  is  followed  by  its  conversion  to  hyphae,  indicating  a 
contact-induced regulation  of gene  expression.  The  use  of CLSM  in this  study to 
investigate  biofilm  development  on  different  surface  roughness  revealed  that  the 
hyphal  form was associated with biofilm development and structure.  It is therefore 
hyphal  emergence  by  thigmotropic  reaction  that  may  be  involved  during  biofilm 
formation by sensing surface changes (Watts et al., 1998).
To study biofilm treatment, all experiments must be reproducible using a steady state 
model. Indeed the CDFF was originally designed for this purpose. Hence, the model 
was  used  to  assess  the  in  vitro  susceptibility  of C.  albicans  biofilms  against the 
commonly used antifungal agents (fluconazole, miconazole and chlorhexidine) used 
to  treat  DRS  in  vivo.  Although  this  model  has  been  used  broadly  to  assess  the 
susceptibility  of bacterial  biofilms,  this  work  demonstrated  its  first use  for fungal 
biofilms.  The  results  of this  work  confirm  earlier  study  of C.  albicans  biofilm
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resistance  (Chandra et al., 2001b) in which these biofilms were highly resistant to 
both  antifungal  and  antimicrobial  agents.  Large  differences  in  the  degree  of 
susceptibility  of  C.  albicans  biofilms  were  observed  between  fluconazole, 
miconazole and chlorhexidine with the latter being the most effective. This may be 
due to the  fungicidal  effect of this agent compared to the fungistatic  action of the 
azole-group  of antifungals.  There  are  several  suggested  explanations  for  reduced 
susceptibilities  of  biofilms,  as  described  in  the  introduction,  including  reduced 
growth  rate  of  organisms  comprising  biofilms;  the  production  of  EPS  by  the 
organisms forming a barrier to antimicrobial agents and that bacteria in biofilms are 
genetically distinct from their planktonic counterparts.
Differences  in susceptibility were also observed for biofilms of different ages. It is 
well documented that cells within young biofilms, which have a higher growth rate 
are more susceptible than mature biofilms (which have a low growth rate and contain 
more EPS material). However, it has been shown that the low growth rate does not 
have a major influence on the resistance of C.  albicans biofilms to antifungal drugs 
and the matrix material may play only a minor role in biofilm resistance (Baillie and 
Douglas,  1998a). The results of the present study indicate that biofilms in the early 
phases  of growth were  more  susceptible to the drugs;  however, these  biofilms (or 
indeed  single  cells  attached  to  a  surface)  were  still  far  more  resistant  than  their 
planktonic counterparts. Hence, a combination of effects including both the growth 
rate  and  EPS  may  play  only  a  minor  role  in  the  susceptibility  of these  younger 
biofilms  and  it is  more  likely that surface-associated changes to the cell  are more 
important.
These  results  highlight  the  importance  of  early  detection  of  biofilm  formation 
associated  with  DRS  which  can  be  achieved  via  prevention  of denture  biofilm
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formation  through  frequent  denture  hygiene  before  the  establishment  of a  more 
resistance mature biofilm.
Although  C.  albicans  is  considered  the  primary  causative  organism  in DRS,  oral 
bacteria  (Koopmans  et  al.,  1988)  and  other,  non-albicans  Candida  species, 
(McMullan-Vogel et al.,  1999; Dorko et al., 2001) are also present. Hence, the final 
aim  of the  study  was  to  determine  the  composition  and  susceptibility  of multi­
species  (i.e.  fungi  and  bacteria)  denture  plaque  associated  with  DRS.  The 
development of in vitro models will assist to study the oral microflora implicated in 
DRS.  Bacterial-fungal  interactions  play  a  critical  role  in  colonization  of  these 
microorganisms  on  denture  acrylic  and  the  development  of DRS  (Millsap  et  al., 
1999). Clinical samples recovered from patients with DRS were used as an inoculum 
to form  in vitro  biofilms which mimicked the microflora present in these patients. 
The  results  demonstrated  that  C.  albicans  was  the  most  prominent  fungal  spp. 
identified from the patient samples and that this organism, when present in a mixed- 
species biofilm, exhibited increased resistance to antifungal agents. It has also been 
shown  that  bacterial  species  were  resistant  up  to  a  concentration  of  2.5  % 
chlorhexidine  compared  to  Candida  species.  These  remaining  bacteria  may  be 
beneficial  and  constitute  a  normal  microflora,  however,  they  may  enhance  the 
growth  of other  species.  Additionally,  when  a combined pulse  of miconazole  and 
chlorhexidine  was  applied  to  a  mixed-species  biofilm,  the  biofilms  became 
increasingly resistant to the dual-therapy. Beside the already mentioned mechanisms 
of biofilm  resistance,  a more recent suggestion  is the presence  of some  persistent 
cells  within  a  biofilm.  These  cells  are  able  to  survive  and  proliferate  under 
antimicrobial administration thus bringing about considerable recalcitrance upon the 
biofilm environment (Gilbert et al., 2002). Further understanding and realization of
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the nature of these cells may help to understand the mechanisms involved in biofilm 
resistance.  It  has  been  shown  that the  symptoms  of DRS  often  return  soon  after 
treatment (Budtz-Jorgensen et al.,  1988; Bissell et al.,  1993). It may be that both a 
combination of biofilm resistance by, for example, persister cells and re-colonisation 
by  commensal  organisms  are  important  factors  in  the  development  of  an  oral 
microflora which is able to cause inflammation and recurrence of the disease.
The  present  study  used  a  biofilm-based  model  to  assess  the  formation  and  the 
susceptibility  of C.  albicans biofilm  against denture  plaque microorganisms under 
conditions  similar to  those  which would  exist  in vivo.  The  CDFF  proved to be  a 
convenient and versatile means of generating large numbers (up to 75 replicates) of 
candidal biofilms. The model is particularly suited to studies of oral biofilms in that 
it provides an environment similar to that found in the oral cavity. The biofilms were 
grown on a solid substratum with nutrients being provided in a thin film of liquid, 
continually replenished, trickling over the surface of the biofilm. The removal of the 
surfaces of the biofilms by the scraper blade simulates the continuous removal of the 
outermost  layers  of  plaque  by  chewing  and  tongue  movements.  Most  studies, 
however, have employed single-species biofilms rather than mixed fungal and bacterial 
biofilms characteristic of DRS. The CDFF was used to grow single and multi-species 
biofilms under conditions similar to those prevailing in the oral cavity. In terms of the 
microcosm plaques the composition of the various species within these biofilms was 
similar to that found in DRS. The results of susceptibility studies of the present work 
revealed differences between antifungal and antimicrobial agents in their effectiveness 
against microcosm denture plaque generated in the CDFF. The screening of potential 
anti-plaque  and  antimicrobial  agents  for use  in preventing  and/or treating plaque- 
related diseases using this approach is of considerable value. It may be able to reduce
216Chapter 7 Conclusions and suggestions for further work
the need for large numbers of expensive clinical trials by selecting compounds, and 
the concentrations at which to use them, prior to expensive clinical trials.
In  summary,  oral  candidosis  in  the  form  of  DRS  is  a  chronic  inflammation 
associated  with  denture  wearers.  Dentists  should  accept  the  responsibility  of 
providing complete care of the denture patient.  Insertion of dentures should not be 
considered as a final stage of treatment, but dentists should continue maintaining and 
caring  for the  health of oral  tissues.  Early diagnosis  and treatment of this disease 
should  be  undertaken  and  post-insertion  of denture  hygiene  instruction  should be 
given  routinely  to  motivate  the  patient.  As  the  denture  can  act  as  a  reservoir 
harbouring  a  microbial  flora,  time  should  be  taken  to  remove  these  biofilms  by 
plaque control and the use of antifungal agents.
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Future work
The  present  work  has  established  that  the  CDFF  is  a  reliable  in  vitro  system  to 
undertake  studies  of  the  structure  and  antifungal  susceptibility  of  biofilms  of 
Candida  albicans.  This  system  may  thus  provide  a  means  of investigating  other 
perhaps  more  clinically  significant  fungal  infections  such  as  pseudomembraneous 
candidosis  (thrush).  In particular, there  is  a need to establish the biological events 
that  lead  to  a  reduced  antifungal  sensitivity  of pseudomembraneous  candidosis  in 
immunocomporomised patients.
It  has  been  established,  by  using  the  CDFF,  that  both  the  surface  type  and  its 
roughness can affect biofilm formation and structure as well as other environmental 
conditions.  Hence,  other biofilms of C.  albicans associated with non-orally related 
surfaces could be investigated, for example, arterial catheters.
All of the present work was undertaken growing biofilms on a solid substratum with 
nutrients  being  provided  over the  surface  of the  biofilm.  The  results  of this  study 
(and others) has shown that the mucosa which is covered by the denture also harbour 
this mixed microbial plaque. Hence, the use of a mucosal surface as a substratum to 
form biofilms may produce interesting results especially with regard to cell invasion 
and susceptibility. In order to carry out such studies a different model, such as a flow 
cell,  which  permits  the  direct  visualisation  of attachment  and  growth  over  short 
periods  of time,  may  be  required  for  the  co-culture  of mucosal  cells  and  yeasts. 
Additionally,  by  using  this  technique  it would  be  possible  to  evaluate  growth  on 
shedding versus non-shedding surfaces, for example, by evaluating attachment onto 
cells under various shear rates.
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